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INTRODUCTION 
The integrable plasmids originally developed for genetic analysis of 
Bacillus subtilis have the following properties : 1) they are selectively 
maintained in Escherichia coli because they contain both a Gram-negative 
origin of replication and a selectable marker(s); 2) they can also be 
selected in B. subtilis because they contain a Gram-positive selectable 
marker(s); 3) they cannot be maintained autonomously in B. subtilis because 
they do not harbor a Gram-positive origin of replication; and 4) they can 
be inherited in B. subtilis because they contain a fragment of DNA 
homologous to the B. subtilis chromosome (Saunders et al., 1984b). 
Insertion vectors are established in a Gram-positive host upon 
recombination between DNA sequences present on the plasmid and homologous 
chromosomal sequences. Integrable plasmids have found use for cloning 
promoters and genes involved in sporulation (Youngman et al., 1985b), 
generating random transcriptional fusions (O'Kane et al., 1986), cloning 
origins of replication (Niaudet and Ehrlich, 1979), stabilizing the 
inheritance of heterologous genes (Saunders et al., 1984a), chromosomal 
mapping (Haldenwang et al., 1980), and generating deletions (Stahl and 
Ferrari, 1984). 
It has been difficult to apply recombinant DNA. methodology toward 
genetic analysis of Staphylococcus aureus NCTC 8325 because the genetics 
and molecular biology of this organism are not well-characterized, 
especially when compared to E. coli or even B. subtilis. Progress has also 
been hampered by the poorly defined and low-frequency transformation system 
of S. aureus. The specific aim of this study, therefore, was to develop an 
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integrable plasmid to facilitate genomic analysis of S. aureus. A novel, 
temperature-sensitive integrable plasmid (designated pPQ126) was 
constructed by removing a 1.3 kilobase-pair (kb) fragment from plasmid 
pTVlts and replacing it with a 2.5 kb gentamicin-resistance determinant 
from transposon Tn4001. The recovery of the recombinant molecule pPQ126, 
directly in S. aureus. was accomplished by using a restrictionless 
recipient strain and an improved procedure for protoplast transformation 
that was developed in this study. Plasmid pPQ126 is recovered as an 
autonomous replicon following transduction into an appropriate recipient 
strain at the permissive temperature (30 C). When cells containing 
autonomous pPQ126 are shifted to non-permissive conditions (39 C), portions 
of Tn917 or Tn4001 direct the integration of pPQ126 into homologous 
target sequences (chromosomal insertions of Tn551 or Tn4001). By insisting 
for retention of pPQ126 at 39 C on media containing gentamicin, 
erythromycin, and chloramphenicol, it is possible to recover cells that 
contain pPQ126 integrated at a predetermined chromosomal site. This study 
describes the construction, transfer, and properties of pPQ126 in S. 
aureus. 
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LITERATURE REVIEW 
Staphylococcus aureus is a Gram-positive, non-motile, catalase-
positive, facultatively anaerobic coccus usually arranged in irregular 
clusters. S. aureus is a potent human and animal pathogen responsible for 
infections ranging from boils (Noble and White, 1983) and food poisoning 
(landolo and Dyer, 1981) to toxic shock syndrome (Gemraell, 1982; Todd et 
al., 1978) and endocarditis (Karchmer, 1985). Although one of the earliest 
recognized and best studied human pathogens, S. aureus remains a common 
agent of severe infection in immunocompetent patients (Cohen, 1986; Kaplan 
and Tenenbaum, 1982). S. aureus also elaborates a variety of interesting 
macromolecules (Arvidson, 1983; Gemmell, 1985), including protein A 
(Langone, 1982), lipases (Kotting et al., 1985), coagulase (Jeljaszewicz et 
al., 1983), and several hemolysins and enterotoxins (Bergdoll, 1985; 
Bergdoll et al., 1985; Rogolsky, 1979; Rogolsky, 1985; Todd, 1985). 
Because of the clinical significance as well as the commercial applications 
of this organism, considerable effort has been directed to analyze the 
genome of S. aureus. Molecular cloning as an approach to genomic analysis 
in S. aureus. however, has been largely unexplored. A practicable cloning 
system developed for S. aureus would facilitate the study of the molecular 
biology and genetic organization of this complex and interesting 
microorganism. 
Cloning Vehicles 
Several obstacles must be circumvented to successfully clone a 
particular fragment of DNA: initially, the DNA must be introduced into the 
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interior of host cells, and then once inside the cell, this DNA must be 
both expressed and maintained to be detected and studied. Under most 
circumstances, the cloning vector imparts the replicative functions to the 
recombinant molecule. Because the nature of the cloning vehicle will place 
constraints on both the size and analysis of the DNA fragment to be cloned, 
the selection of a suitable cloning vector is of paramount importance. 
Bacteriophage (e.g., charon phage), plasmids (e.g., pBR322), and 
bacteriophage-plasmid combinations (e.g., cosmids and phasmids) have served 
as suitable cloning vehicles for the in vitro manipulation and study of DNA 
fragments. This discussion will be limited to specialized plasmid vectors 
(integrable plasmids); the other vectors listed above will be considered 
only briefly. 
Charon phage 
Charon vectors are derivatives of wild-type phage lambda that have 
been specifically altered for cloning purposes. Recombinant molecules are 
constructed by either replacing a segment of nonessential lambda DNA 
(defined by restriction sites) with a similar length of passenger DNA 
(replacement vectors), or by the insertion of passenger DNA into a single 
restriction site of a deleted derivative of lambda (insertional vectors). 
Lambda derivatives have three main advantages over plasmid vectors for 
cloning purposes: 1) thousands of recombinant phage plaques on a single 
petri plate can easily be screened for a given DNA sequence by using 
hybridization probes; 2) in vitro packaging of recombinant DNA molecules 
provides a very efficient means of introducing cloned DNA into bacteria; 
and 3) millions of independently packaged recombinant phage can be 
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replicated and conveniently stored in a single solution as a library in 
which all sequences of a large genome are likely to be represented. 
Additional material on lambda packaging and general information on charon 
phage are available in reviews by Rosenberg et al. (1985) and Blattner et 
al. (1977), respectively. 
Cosmids 
Cosmids are specially constructed plasmids containing the phage lambda 
cos site, an origin of replication, and a selectable marker, such as an 
antibiotic-resistance determinant. The cos site is required for packaging 
recombinant molecules into phage lambda particles for the introduction of 
the recombinant DNA into an appropriate recipient strain. Thereafter, 
cosmids are replicated as typical plasmids. In this system the recombinant 
vector, a plasmid containing the lambda cos site plus passenger DNA, is 
packaged in vitro into lambda heads and then is transduced into a recipient 
cell. The advantage of the cosmid system over other lambda derivatives 
(e.g., charon vectors) is the smaller size of cosmids, allowing for larger 
segments of passenger DNA to be cloned. An advantage of the cosmid system 
over plasmid cloning vehicles is the high selectivity of the cosmid 
packaging system for recombinant molecules. This last advantage eliminates 
complicated screening procedures, and the pretreatment of vector (e.g., 
removal of 5'-phosphate groups with alkaline phosphatase) to prevent 
vector-vector ligation. For a more thorough discussion of cosmid packaging 
and cosmid cloning, the reader is referred to the following articles: Feiss 
et al., 1982; Murray, 1983; and Palva and Liljestrom, 1981. 
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Phasmids 
Additional phage lambda/plasmid combinations that consist of a plasmid 
plus the lambda attachment site (att site) have been constructed. Such 
plasmids can insert into an intact lambda genome via the usual lambda mode 
of integration: the term phasmid refers to the moiety generated by the 
reversible recombinational insertion of the plasmid into the lambda genome. 
Advantages of the phasmid system are that the recombinant molecules can be 
propagated as phage or plasmids, and that these molecules can be 
conveniently stored almost indefinitely as phage particles. A disadvantage 
of the phasmid system is the occurrence of spontaneous rearrangements. The 
interested reader is referred to the following articles for more 
information concerning phasmids: Brenner et al., 1982; and Kahn and 
Helinski, 1978. ' 
Plasmids 
Plasmids are extrachromosomal, autonomously replicating, covalently 
closed circular (CCC), double-stranded DNA molecules, ranging in size from 
2 to 200 kilobases (kb) in length. Although only smaller segments of DNA 
can be cloned with plasmids (approximately 15 kb) as compared with charon 
(approximately 25 kb) or cosmid (approximately 45 kb) vectors, plasmids are 
often easier to manipulate because a viral life cycle and packaging process 
are avoided (Maniatis et al., 1982). An efficient plasmid cloning vehicle 
would contain several features: 1) one or more readily selectable markers 
(such as antibiotic resistance determinants); 2) one or more unique sites 
for restriction endonucleases; 3) a relatively low molecular weight [less 
than 10 megadaltons (md)] to facilitate the isolation, transfer, and 
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analysis of the recombinant molecule, as well as the accommodation of 
larger segments of passenger DNA; and 4) a relaxed mode of replication so 
the plasmid replicates in high copy number for the isolation of large 
amounts of plasmid DNA, and to facilitate the purification of proteins 
encoded by cloned genes. In addition, the vector should be constructed 
such that only vectors containing cloned DNA confer a detectable phenotype 
upon the cloning strain (e.g., insertional inactivation vectors). Many 
cloning vehicles meet the first four requirements, but not all vectors 
fulfill the last requirement. It should be noted, however, that plasmid 
cloning vehicles have been constructed that replicate in low copy number 
(Hasnain and Thomas, 1986; Stoker et al., 1982). Low copy number vectors 
have been used for cloning genes encoding for products that would be 
deleterious if overproduced, such as surface structural proteins (e.g., 
ompA: Hashimoto-Gotoh et al., 1981), or the rat insulin gene (Brosius, 
1984). Although low copy number plasmid vectors prevent cell death, 
decreased expression of the gene complicates the purification of gene 
products. This problem may be circumvented by using runaway plasmid 
vectors (Masui et al., 1983; Remaut et al., 1983; Uhlin et al., 1979). The 
control of plasmid copy number for runaway vehicles is lost at elevated 
temperatures, resulting in significant accumulation of plasmid DNA and 
plasmid gene products. Cell proliferation eventually ceases, but by this 
time plasmid DNA may account for up to 75% of the DNA in the cell (Uhlin et 
al., 1983). 
Initially, recombinant plasmids were constructed by the controlled 
shearing of resistance factor (R-factor) DNA. Upon transformation into 
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competent cells of Escherichia coli. the sheared R-factor DNA 
recircularized, forming new autonomously replicating plasmids (Cohen and 
Chang, 1973). For example, the plasmid pSClOl, encoding for resistance to 
tetracycline, was constructed by shearing plasmid R6-5 and subsequent in 
vivo recircularization upon transformation into E. coli (Cohen and Chang, 
1973). With the discovery of restriction endonucleases, a procedure was 
described for the construction of "hybrid" or "chimeric" plasmids via in 
vitro annealing of DNA fragments from separate plasmids (Cohen et al., 
1973). It was also determined that plasmids linearized with EcoRI would 
transform E. coli. but at a frequency 10-fold lower than CCC or nicked 
circular molecules of the same plasmid. The transformation frequency could 
be increased slightly if the restricted plasmid mixture was treated with 
DNA ligase before transformation (Cohen et al., 1973). From restriction 
endonuclease analysis, pSClOl was found to contain a single EcoRI site that 
was not within the genes encoding for plasmid replication or tetracycline 
resistance. Although it was one of the first plasmid cloning vehicles 
(Cohen et al., 1973), pSClOl has found little use for in vitro cloning 
because it carries only a single selectable marker, and insertional 
inactivation cannot be used to screen for clones carrying recombinant 
molecules. 
Plasmid pBR322 is perhaps the best-characterized recombinant plasmid: 
pBR322 exhibits all of the salient features described earlier for an 
efficient cloning vehicle (Bolivar et al., 1977). pBR322 has facilitated 
the cloning, isolation, and analysis in E. coli of many genes from 
eukaryotes, prokaryotes, and viruses (Itakura et al., 1977; Kreiswirth et 
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al., 1983; Peden et al., 1980; Yelverton et al., 1983). More information 
concerning plasmids can be found in Helinski et al. (1985). 
Recombinant DNA or genetic engineering methodology, as well as the 
depth of knowledge about the genetic systems involved are less 
sophisticated for most Gram-positive bacteria than for Gram-negative 
bacteria. Furthermore, genetic exchange mechanisms (e.g., transformation 
of plasmids) are more straightforward in E. coli than in Gram-positives; 
direct cloning into competent cells of Bacillus subtilis requires plasmid 
multimers (Canosi et al., 1978; Contente and Dubnau, 1979). For this 
reason, many Gram-positive cloning schemes utilize E. coli as the host 
organism for expression and analysis of cloned DNA fragments. Although 
many heterologous genes (DNA not originating from E. coli) are expressed in 
E. coli. it is often difficult to isolate the products of these cloned 
genes because generally they become trapped in the periplasmic space. 
Therefore, it would be of both practical importance and general interest to 
construct more sophisticated plasmid cloning vehicles (and more efficient 
genetic exchange processes) for the transfer and the subsequent analysis of 
recombinant vectors in a Gram-positive organism. To accomplish these 
goals, several recombinant plasmids have been constructed which serve as 
shuttle vectors between Gram-positive and Gram-negative bacteria (Ehrlich 
et al., 1976; Ishiwa and Shibahara, 1985; Macrina et al., 1982; Macrina et 
al., 1983; Wirth et al., 1986), between different Gram-positive bacteria 
(Harris-Warrick and Lederberg, 1978; Kreft et al., 1982; Luczak et al., 
1985; Vasseghi and Claverys, 1983), and between different Gram-negative 
bacteria (Danner and Pifer, 1982). Shuttle plasmids are hybrid vectors 
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that are replicated and selectively maintained in either of two different 
host strains because they encode for both a selectable marker(s) and 
origin(s) of replication functional in each host. Cloning Gram-positive 
genes into E. coli by using shuttle vectors obviates the requirement for 
plasmid multimers for successful transformation of B. subtilis. Recently, 
E. coil-Bacillus shuttle vectors were constructed that function as runaway 
plasmids in E. coli: these versatile vectors should become invaluable for 
genetic engineering of both Gram-positive and Gram-negative organisms 
(Andreoli, 1985). Shuttle vectors have been useful for cloning a variety 
of interesting genes (Fouet et al., 1982; Kiss and Baldauf, 1983; Kreft et 
al., 1983). As discussed below, other hybrid vectors have been constructed 
that replicate in only one host (integration vectors). 
Integrable Plasmids 
Plasmid integration vectors (integrable plasmids or plasmid insertion 
vectors) are hybrid vectors that are selectively maintained and 
autonomously replicated in one host (replicating host), and that contain 
genetic determinants expressible in a different host (non-replicating host) 
under certain circumstances. Typically, the replicating host is a 
genetically well-defined Gram-negative organism (e.g., E. coli). and the 
non-replicating host is a Gram-positive organism (e.g., B. subtilis). 
Integrable plasmids result in the insertion of non-homologous DNA (e.g.. 
Gram-negative origin of replication) into the chromosome of the non-
replicative host by recombination between the vector containing cloned DNA 
fragments (derived from the non-replicative host) and homologous 
chromosomal sequences of the non-replicative host. 
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One of the first reported integrable plasmids (pl949) was constructed 
for use in B. subtilis (Haldenwang et al., 1980). Ferrari et al. (1983) 
utilized an integrable plasmid, pJHlOl, to clone and map several genes in 
B. subtilis• A similar plasmid, pHV32, was used for insertional 
mutagenesis in B. subtilis (Niaudet et al., 1982); both pHV32 and pJHlOl 
yielded equivalent results for the generation of auxotrophic mutations 
(Ferrari et al., 1983). Additional integrable plasmids have been utilized 
for molecular cloning and genomic analysis in Gram-positive systems 
(Fahnestock et al,, 1986; Gryczan and Dubnau, 1982; LaFauci et al., 1986; 
Niaudet et al., 1982; Pozzi and Guild, 1985; Prozorov et al., 1983; 
Vasseghi and Claverys, 1983; Young, 1983). Integrable plasmids have found 
extensive use because they are genetically and physically well-
characterized, and because they replicate in E. coli. Plasmid construction 
and purification can be accomplished more readily in E. coli than in any 
Gram-positive system. Insertion vectors have been used to clone the 
replication origins of other replicons, to determine the map position of 
cloned fragments of unknown origin, to generate deletions, to clone 
specific DNA sequences from different strains of the same organism, to 
stabilize the inheritance of genes that are not easily established on 
plasmid vectors, and to expand the chromosomal map of genetically ill-
defined organisms (Haldenwang et al., 1980; Mejean et al., 1981; Niaudet 
and Ehrlich, 1979; Niaudet et al., 1982; Saunders et al., 1984a; Stahl and 
Ferrari, 1984). 
The insertion plasmid pJHlOl (see Figure 1) has several features that 
are desirable for both mapping and cloning studies (Ferrari et al., 1983). 
Figure 1. Restriction map of pJHlOl 
pJHlOl is a 5,391 base-pair integrable plasmid encoding 
for resistance to ampicillin (AMP), tetracycline (TET), and 
chloramphenicol (CAT). 
Approximately 4.3 kl) of pJHlOl [the AMP and TET genes and the 
origin of replication (Ori)] are derived from plasmid pBR322. 
The remaining 1.0 kb of pJHlOl harbors the chloramphenicol 
acetyl transferase gene (CAT) from S. aureus plasmid pC194. 
Arrows demonstrate the direction in which genes are transcribed 
(taken from Ferrari et al., 1983). 
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pJHlOl will be discussed in further detail because it exemplifies many of 
the attributes common to all insertion vectors. Approximately 4.3 kb of 
pJHlOl are derived from pBR322; the remaining 1 kb consists of a 
chloramphenicol acetyl transferase gene (from the S. aureus plasmid pC194) 
cloned into the PvuII site of pBR322. pJHlOl has three antibiotic-
resistance markers (Ampicillin, Ap^; Tetracycline, Tc^; and 
Chloramphenicol, Cmf), as well as several unique cut sites for restriction 
endonucleases, including a PstI site within the region coding for Ap^, and 
at least three restriction sites within the tetracycline gene (Hindlll, 
BamHI. and Sail). The restriction sites within the tetracycline 
determinant of pJHlOl are best suited for the insertion of passenger DNA 
into this vector: 1) inactivation of the tetracycline determinant by the 
insertion of passenger DNA facilitates the rapid and facile screening of a 
large number of transformants containing putative recombinant plasmids; and 
2) evidence suggests that overproduction of the tetracycline resistance 
gene product is lethal for B. subtilis (Ferrari et al., 1983; Kreft et al., 
1983). 
One approach for utilizing this vector consists of digesting both 
pJHlOl and B. subtilis chromosomal DNA with a restriction endonuclease, and 
then ligating and transforming this mixture into E. coli with selection for 
Ap^. Plasmid DNA is isolated from clones containing pJHlOl plus passenger 
fragments (recombinant pJHlOl), and transformed into an appropriate 
recipient strain of B. subtilis with selection made for Cmf. pJHlOl does 
not contain an origin of replication for B. subtilis. thus precluding 
autonomous replication of recombinant pJHlOl in this host. 
15 
Chloramphenicol-resistant transformants of B. subtllis are (most likely) 
the result of integration of recombinant pJHlOl into the host chromosome 
because areas of homology exist between the cloned fragment of passenger 
DNA (chromosomal DNA from B. subtilis) and the host chromosome. 
Integration is believed to occur via a Campbell-type (single crossover) 
recombinational event (Duncan et al., 1978; Ferrari et al., 1983; 
Haldenwang et al., 1980; Harris-Warrick and Lederberg, 1978), much like the 
integration of phage lambda. It should be noted, however, that passenger 
DNA alone can also integrate into the host chromosome via a double-
crossover event often resulting in the exclusion of the non-homologous 
vector-only portion of the plasmid, and accompanied by the deletion of 
chromosomal material (Pozzi and Guild, 1985; Young, 1983). Pozzi and Guild 
(1985) constructed a donor-recipient system to test the mode of integration 
of plasmid DNA into the chromosome of Streptococcus pneumoniae : the double-
crossover mechanism produced 600-fold more transformants than the single-
crossover event. For the integration of pJHlOl derivatives into the 
chromosome of B. subtilis. a 2-to 10-fold decrease in recovery of 
transformants was observed when selection was made for the single-crossover 
event (Ferrari et al., 1983). If integration occurs via a Campbell-type 
recombination event, the entire plasmid, plus adjacent chromosomal DNA, can 
be recovered as follows; B. subtilis chromosomal DNA from a 
chloramphenicol-resistant transformant is digested with a restriction 
enzyme that does not cut within the plasmid, and after religation, the 
mixture is transformed into E. coli with selection made for resistance to 
ampicillin. Figure 2 depicts a Campbell-type recombination of a typical 
Figure 2. Recombination and recovery of an integrable plasmid 
The diagram shows a typical integrable plasmid that 
contains a Gram-negative selectable marker (arapicillin 
resistance; Ap^), a Gram-positive selectable marker 
(chloramphenicol resistance; Cmf), and a fragment of cloned DNA 
[denoted by arrows and bordered by BamHI (Bam) sites]. Jagged 
lines denote recognition sequences present on the chromosome 
for the restriction endonuclease Belli. Integration is 
directed into the chromosome via Campbell-type recombination 
between the cloned DNA on the plasmid and homologous 
chromosomal sequences. The entire plasmid and chromosomal DNA 
flanking the insertion site are recovered by digesting the 
chromosomal DNA with Belli (no Belli sites within plasmid 
sequences), ligating the fragments, and transforming the 
resulting mixture into E. coli (taken from Old and Primrose, 
1986). 
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integrable plasmid into a homologous chromosomal target, and the removal 
and subsequent recovery in E. coli of the vector plus adjacent chromosomal 
DNA. The above approach provides a convenient and rapid means for cloning 
B. subtilis chromosomal DNA into E. coli for further analysis. pJHlOl was 
successfully used in this manner to study the spoOB locus (Ferrari et al., 
1983), and several rRNA opérons in B. subtilis (LaFauci et al., 1986). 
Transposable Elements 
Transposable elements have been identified in a variety of prokaryotic 
and eukaryotic (yeast, maize, fruit flies) organisms (Calos and Miller, 
1980; Kleckner, 1977; Kopecko, 1980). These elements do not exist 
autonomously (e.g., apart from a plasmid or chromosomal replicon). 
Kleckner (1981) grouped the prokaryotic transposable elements into four 
major classes based on mechanistic differences, DNA sequence homologies, 
and correlated relationships in genetic organization. Included in this 
system are the insertion sequences (commonly referred to as IS elements, 
Class I); the translocatable antibiotic resistance elements (commonly 
referred to as Tn elements or transposons. Class II and some members of 
Class I); a few bacteriophage such as phage Mu (Class III); and elements 
that remain unclassified because of their uniqueness and/or the paucity of 
information available for classification (Class IV). Transposons have been 
defined as large DNA sequences that express a phenotypically identifiable 
trait unrelated to their own insertion and that are capable of recA-
independent transposition, usually in either of two physical orientations, 
as a discrete, linear non-permuted unit (Kopecko, 1980). 
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Figure 3 depicts the components of the structure of a typical 
transposon: a central region containing accessory genetic determinants, and 
in some instances information required for transposition; repeated terminal 
segments of various length and orientation (e.g., direct or inverted with 
respect to each other); and direct repeated segments of target DNA. The 
inverted terminal repeats present on most transposons allow for formation 
of stem-and-loop or hairpin-loop structures under the electron microscope, 
following denaturation and inter- or intra-strand reannealing (Kopecko, 
1980). 
Because they are relevant to this study, brief mention will be made of 
Class I and Class II transposons. Although similar in many respects, the 
major differences between Class I and Class II transposons are the length 
of the terminal repeats and the location and regulation of the genes 
involved in transposition. Class I transposons (composite elements) have 
long terminal repeats [about 786 to 1800 base pairs (bp)], that contain all 
of the information required for transposition. In fact, the ends of most 
Class I transposons are IS sequences, and therefore, are capable of 
transposition independent of the composite genome; one end is usually fully 
functional for providing transposition activity, while the other end is 
either totally defective or reduced in providing this activity (Berg et 
al., 1980; Kleckner, 1983). The inverted terminal repeats on Class II 
transposons are 35 to 40 bp in length, and do not encode for transposition 
activity (Heffron, 1983). Class II transposons share DNA sequence homology 
in the short terminal repeats, as well as throughout their entire length; 
very little DNA sequence homology exists among Class I transposons. Both 
Figure 3. Structure of a typical transposon 
The wavy lines denote central sequences that contain 
accessory genetic determinants, and in some instances (e.g., 
Kleckner Class II transposons) the information required for 
transposition. The repeated terminal sequences, varying in 
length from 38 base pairs (Class II) up to 768 to 1800 base 
pairs (Class I), are shown by the rectangles. Terminal repeat 
sequences can be in direct or indirect orientation. As a 
consequence of insertion, a 3 to 12 base-pair direct repeat of 
target DNA (broken lines) is duplicated on either side of the 
element. The target replicon is shown by thin continuous lines 
(taken from Kopecko, 1980). 
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the transposition and accessory genetic information are encoded in the 
central region of a Class II transposon. The two classes also differ with 
regard to the length of duplicated target DNA: Class I transposons generate 
a 3 to 12 bp duplication, and all Class II elements characteristically 
generate a 5 bp duplication of target DNA (Heffron, 1983; Kleckner, 1981). 
Transposition of composite Class I elements generates either precise 
transposition events, or relatively stable cointegrate structures 
(Kleckner, 1981), Class II elements transpose via a two-step mechanism; 
the donor and recipient replicons fuse concomitant with the duplication of 
the transposon, and then recombination between the two copies of the 
element yields a precise transpositional event (Kleckner, 1981). Finally, 
Class II elements exhibit cis-acting transposition immunity: a resident 
copy of a Class II transposon precludes further insertions of the same or a 
similar element onto the same replicon (Robinson et al., 1977; Wallace et 
al., 1980). 
Transposons are valuable tools for genomic analysis. Tn elements are 
particularly useful for constructing strains and vectors, isolating 
mutants, providing portable regions of homology, selecting chromosomal 
duplications, chromosomal mapping, cloning genes, constructing gene 
fusions, and introducing well-defined deletions (Hille and Schilperoort, 
1981; Kleckner, 1981; Kleckner et al., 1977; Luchansky and Pattee, 1984; 
Shapiro, 1982; Youngman et al., 198Aa; Youngman et al., 1985a). Most 
transposons range in size from about 4 kb to 20 kb, and contain genes 
required for transposition, as well as accessory genetic information, such 
as gènes involved in antibiotic resistance, heavy metal resistance. 
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carbohydrate metabolism, and toxin production (Calos and Miller, 1980; 
Cornells et al., 1978; Kopecko, 1980; Schmitt et al., 1980; So et al., 
1980). Transposition frequencies range from 10"^ to 10"? per generation, 
and insertion into a structural gene causes insertional inactivation and 
can also cause polar effects on promoter-distal genes in an operon 
(Kleckner, 1981). The preference for an insertion site varies: transposons 
such as Tn554 (Krolewski et al., 1981; Phillips and Novick, 1979) and Tn7 
(Lichtenstein and Brenner, 1982) demonstrate site-specific insertion, 
whereas most other elements can transpose to several sites on a particular 
replicon (Calos and Miller, 1980). For many Tn elements, transposition 
occurs via a duplication/transposition event: a copy of the element is 
present at both the original and new site (Kleckner, 1981). Recently, 
however, transposons Tn916. Tn554. and TnlO have been shown to transpose 
via an excisive mechanism, resulting in loss of the element at the original 
site (Bender and Kleckner, 1986; Gawron-Burke and Clewell, 1984; Murphy and 
Lofdahl, 1984). For transposition of plant transposons, the excision/re­
insertion mechanism is the rule rather than the exception (Saedler and 
Nevers, 1985). 
The concept of selfish DNA (Orgel and Crick, 1980) has been applied to 
transposons: they do not exist to specifically contribute to the phenotype 
of the host organism, but transpose simply for perpetuation and 
dissemination purposes only. More recently, however, Tn elements were 
postulated to have an evolutionary role as mutator genes. Strains of E. 
coli harboring Tn5 or TnlO displayed an advantage over otherwise isogenic 
strains when grown together in a chemostat (Biel and Hartl, 1983; Chao et 
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al,, 1983). TnlO conferred an advantage by Increasing the mutation rate of 
the host bacterium. The IS elements of TnlO were responsible for the 
mutator effect (Chao et al., 1983). The reader is referred to the 
following publications for a more thorough discussion of transposons and 
their mode of transfer: Bender and Kleckner, 1986; Berg et al., 1980; 
Bukhari, 1981; Casadaban et al., 1980; Foster et al., 1981; Grindley and 
Reed, 1985; Harshey et al., 1982; Heffron, 1983; Kopecko, 1980; Saedler and 
Nevers, 1985; Shapiro, 1980; and Shapiro, 1982). 
Transposons in Gram-positive Bacteria 
As mentioned previously, more is known about the genetic systems of 
Gram-negative bacteria (e.g., E. coli) than about Gram-positive systems 
(e.g., S. aureus). Furthermore, most Gram-negative systems are replete 
with a diverse set of well-characterized Tn elements, whereas relatively 
few Gram-positive elements have been identified and characterized. Until 
recently, only two phenotypically distinguishable classes of transposons 
were recognized in Gram-positive systems: a tetracycline-resistant 
transposon (Tn916). and three erythromycin-resistant transposons (Tn554, 
Tn551. and Tn917). Because Tn917 was the only transposon available for use 
in B. subtilis. De Lencastre et al., (1983) employed a Gram-negative 
transposon, TnlOOO. in E. coli to mutagenize B. subtilis DNA cloned onto 
the shuttle plasmid pHM2; approximately 23% of the inserts recovered in 
pHM2 were in B. subtilis DNA. Upon transfer of PHM2: :TnlOOO into B. 
subtilis. two insertions of TnlOOO were identified that affected the spoIIA 
gene (De Lencastre et al., 1983). As discussed below, the identification 
of additional Gram-positive transposons obviated the use of Gram-negative 
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transposons for mutagenesis and analysis of Gram-positive genes. Before 
providing more detailed information on the Tn elements essential to this 
study (Tn551. Tn4001. and Tn917), brief mention will be made of the other 
transposons available for genetic analysis in Gram-positive systems. 
Besides Tn916 and Tn917. several other streptococcal transposons have 
been identified: Tn918. Tn925. and Tn3871 in Streptococcus faecalis: Tn919 
in Streptococcus sanguis : and Tnl545 in Streptococcus pneumoniae. Tn916. 
Tn918. Tn919. and Tn925 all encode for resistance to tetracycline, Tnl545 
encodes for aminoglycoside and MLS (macrolide, lincosamide, and 
streptogramin B) resistance, and transposons Tn917 and Tn3871 encode for 
inducible erythromycin resistance. Tn916. a 15.0 kb transposon first 
reported by Franke and Clewell (1980), has been employed for genomic 
analysis in several Gram-positive organisims (Gawron-Burke and Clewell, 
1982; Ike et al., 1983; Ivins et al., 1986; Nida and Cleary, 1983). In 
addition to the excision/re-insertion mechanism for transposition, the 
conjugal behavior of Tn916 also distinguishes this element from other 
transposons; transfer of Tn916 was demonstrated in membrane-filter 
conjugations in the absence of detectable plasmid DNA (Clewell, 1981; Guild 
et al., 1982). 
More recently, three related tetracycline-resistance transposons, all 
approximately 15 kb in length, were described in Streptococcus : Tn918 
(Clewell et al., 1985); Tn919 (Fitzgerald and Clewell, 1985); and Tn925 
(Korman et al., 1986). All of the tetracycline-resistant streptococcal 
transposons are similar with respect to size and restriction pattern to the 
prototype element, Tn916. Although Tn919 is also a conjugal transposon, it 
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differs from Tn916 with respect to an internal Hindi fragment (Fitzgerald 
and Clewell, 1985). DNA hybridization studies demonstrated that Tn916 and 
Tn918 share strong sequence homology (Clewell et al., 1985). Tn916. Tn918. 
and Tn919 are unstable in E, coll; in the absence of tetracycline 
selection, all three elements are lost from the vector (Clewell et al., 
1985; Fitzgerald and Clewell, 1985; Gawron-Burke and Clewell, 1984). Tn925 
also transferred as a conjugal element from a chromosomal locus in B. 
subtilis to Streptococcus faecalls (Korman et al., 1986). 
Banai and LaBlanc (1984) described a 5.1 kb transposon (Tn3871) in S. 
faecalls that encoded for inducible resistance to erythromycin and was 
similar in restriction digest pattern to Tn917. The 18.5-kb element Tnl545 
(earlier and Courvalin, 1982) was the first Gram-positive transposon 
operational in a Gram-negative bacterium (E. coli). Gawron-Burke and 
Clewell (1984) demonstrated low frequency transposition of Tn916 in E. coll 
under special circumstances. Most recently, the Gram-positive transposons 
Tn917 and Tn4430 (see below) were also shown to transpose in a Gram-
negative host (Kuramitsu and Casadaban, 1986; Lereclus et al., 1986). 
Several transposons have been described in S. aureus. Phillips and 
Novick (1979) identified Tn554 as a 6.9-kb repressor-controlled, site-
specific element, encoding for spectinomycin resistance, as well as for 
resistance to erythromycin F fermA): Murphy et al., 1981]. As mentioned 
previously, Tn554 transposes via the excision/re-insertion mechanism, and 
has not been associated with detectable extrachromosomal DNA (Murphy and 
Lofdahl, 1984; Wyman et al., 1974). Two novel features of Tn554. 
determined from DNA sequence analysis of Tn554/target junctions, are: 1) 
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the absence of direct or indirect terminally repeated DNA; and 2) the 
absence of duplicated target DNA (Murphy and Lofdahl, 1984; Murphy et al., 
1985). Townsend et al. (1984) described the 5.2-kb gentamicin resistant 
transposon, Tn3851. Although hybridization studies have not yet been 
performed, Tn3851 is believed to be similar to the other S^ . aureus 
gentamicin element, Tn4001. because Tn3851 also shows cross resistance to 
tobramycin and kanamycin, and transposes to both chromosomal and plasmid 
loci (Townsend et al., 1984). Two apparently different penicillin-
resistant S. aureus transposons have been described: a 7.3-kb element 
Tn3852 (Kigbo et al., 1985), and a 6.6-kb element Tn4201 (Goering and 
Weber, 1985). Trees and landolo (1986) reported the discovery and 
preliminary characterization of Tn4291. a 5.2-kb methicillin-resistance 
transposon in S. aureus. Tn4291 transposes to multiple, although limited, 
insertion sites; a primary insertion site bordering segments 10 and 11 on 
the circular map of S. aureus NCTC 8325 (see Luchansky and Pattee, 1984), 
and a secondary insertion site on plasmid pI524 (within the blaz gene) 
[David Trees, personal communication]. 
Most recently, Lereclus et al. (1986) identified a transposon, 
designated Tn4430. in B. thuringiensis. Tn4430 is related in structure and 
transposition behavior to the Kleckner Class II elements: Tn4430 generates 
a 5-bp duplication of target DNA, and contains identical 38-bp inverted 
terminal repeats similar in sequence to the ends of Tn3 (Lereclus et al., 
1986). Other than genes required for transposition, no additional 
information (e.g., accessory genetic determinants) has yet been associated 
with Tn4430. 
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TnSSl 
The Gram-positive transposon, Tn551. occurs naturally on plasmid pI258 
in S. aureus. and transposes to various chromosomal and plasmid sites at a 
frequency of 10'^  to 10"^ events per donor genome (Luchansky and Pattee, 
1984; Pattee et al., 1977; Novick et al., 1979a, 1979b). Tn551 is 5.2 kb 
in length, and contains the ermB gene encoding for constitutive resistance 
to erythromycin. As a Class II transposon, Tn551 harbors terminal inverted 
repeats 40 bp in length, and duplicates 5 bp of target DNA as a consequence 
of insertion. Through DNA sequence analysis. Khan and Novick (1980) 
d e t e r m i n e d  t h a t  t h e  e n d s  o f  T n 5 5 1  w e r e  s i m i l a r  t o  t h o s e  o f  T n 3  ( e . g . ,  
fourteen of the first 18 nucleotide pairs of both transposons were 
identical). Furthermore, Tn551 and Tn917 share extensive DNA sequence 
homology throughout their entire lengths (Perkins and Youngman, 1984; Shaw 
and Clewell, 1985). As mentioned previously, Kleckner Class II elements 
share high DNA sequence homology, and a common origin has been proposed to 
account for the conservation of base pairs among the Class II transposons 
Tn2, Tn551. and Tn917 (Khan and Novick, 1980; Kleckner, 1981; Perkins and 
Youngman, 1984). 
Restriction endonuclease maps of plasmid pl258 and Tn551 have been 
published (Novick et al., 1979a, 1979c). The use of Tn551 for genomic 
analysis was facilitated by the isolation of a thermosensitive mutation in 
the replication origin of plasmid pI258 (Novick, 1974). Briefly, cells 
containing pI258 are grown under non-permissive conditions in the presence 
of erythromycin to eliminate the plasmid and to select for chromosomal 
transposition events (Luchansky and Pattee, 1984; Pattee, 1981). Tn551 is 
29 
used extensively for cloning and mapping genes of interest in S. aureus 
(Berger-Bachi, 1983; Breidt and Stewart, 1986; Luchansky and Pattee, 1984; 
Pattee, 1981; Recsei et al., 1986; Schroeder and Pattee, 1984; Stahl and 
Pattee, 1983a, 1983b). 
Tn4001 
Lyon et al. (1984) reported the discovery of Tn4001. a 4.7-kb 
transposon encoding for resistance to gentamicin, tobramycin, and kanamycin 
(Gmf, Tm^ , Km^ ). The 1.35-kb terminal inverted repeats on this element 
identify Tn4001 as a Kleckner Class I transposon. Tn4001 was originally 
detected in plasmid pSKl from a multiresistant clinical isolate of S. 
aureus from Australia (Lyon et al., 1984). pSKl is a 27.0-kb plasmid which 
also encodes for resistance to trimethoprim (Tp^), ethidium bromide (Eb^ ), 
and quaternary ammonium compounds [(Qa^); Lyon et al., 1984; Tennent et 
al., 19-85]. Tn4001 transposes at a frequency of 10"^ between plasmid and 
chromosomal sites (Lyon et al., 1984; Tennent et al., 1985). Although an 
extensive restriction map and DNA sequence for the element are not 
available, it is known that a 2.5-kb HindiII fragment carries the complete 
gentamicin resistance determinant [(the aacA-anhP gene); Lyon and Skurray, 
1987; Lyon et al., 1984; Tennent et al., 1985]. As mentioned previously, 
Tn4001 is similar to the gentamicin-resistant transposon Tn3851 (Townsend 
et al., 1984). Insertions of Tn4001 have been isolated on the temperature-
sensitive delivery vehicles pI258 and pII147 and in several regions of the 
S, aureus 8325 chromosome (Mahairas et al., manuscript in preparation). 
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Tn917 
The erythromycin resistance transposon Tn917 was initially detected on 
plasmid pAD2 in S. faecalis strain DS16 (Tomich et al., 1978, 1980). Both 
erythromycin resistance and transposition of Tn917 are erythromycin 
inducible (Clewell et al., 1982; Perkins and Youngman, 1984). Although 
transposition of an E. coli mercury resistance transposon (TnSOl) is 
enhanced by exposure to mercury ions, Tn917 is the only element that 
undergoes antibiotic-induced transposition (Clewell et al., 1982; Shaw and 
Clewell, 1985). The entire DNA sequence (5,257 base pairs) of Tn917 has 
been determined (Shaw and Clewell, 1985). Transcription and DNA-sequence 
analyses revealed that induction of MLS^ and transposition are coupled; 
transcriptional readthrough of a termination site at the end of the erm 
gene extends the mRNA transcript into the transposase gene (Shaw and 
Clewell, 1985). The actual induction of Tn917 MLS^ , however, is a 
posttranscriptional event that involves translational attenuation of the 
mRNA transcript, similar to the mechanism reported for induction of the 
ermC gene of pE194 and the erm gene of plasmid pAM77 (Horinouchi et al., 
1983) . 
The ends of Tn917 were shown by DNA sequence analysis to be similar to 
the ends of other Kleckner Class II elements such as Tn3 and Tn551 (Perkins 
and Youngman, 1984; Shaw and Clewell, 1985). As mentioned previously, 
Tn917 shares extensive DNA sequence homology with transposons Tn551 and 
Tn3871 throughout the entire length of the element. It is thought that 
Tn917-like elements are widespread in S. faecalis (Rollins et al., 1985; 
Shaw and Clewell, 1985). Tn917 has been utilized extensively for genomic 
31 
analysis in B, subtilis (Vandeyar and Zahler, 1986; Youngman, 1985; 
Youngman et al., 1983), S. faecalis (Clewell et al., 1982; Ike and Clewell, 
1984), and S,. aureus (C. Hasegawa, Department of Microbiology, Iowa State 
University, Ames, Iowa, personal communication; J. B. Luchansky, Department 
of Microbiology, Iowa State University, Ames, Iowa, unpublished data). 
Recently, Tn917 was successfully introduced and demonstrated to transpose 
in B. amvloliquefaciens (Hartley and Paddon, 1986), B. megaterium (Bohall 
and Vary, 1986), and B. thuringiensis (Crawford et al., 1986). 
Transposition of Tn917 has also been demonstrated in E. coli. Tn917 was 
transposed from a B. subtilis-E. coll shuttle vector into an f' plasmid, 
and then from the F' plasmid onto pACYC184 (Kuramitsu and Casadaban, 1986). 
As described below, several novel plasmid vectors were constructed for 
recovery and utilization of Tn917 transpositions in Gram-positive bacteria. 
Figure 4 contains a restriction map of Tn917. and shows the location 
of all 6 open reading frames (ORFs) of the element. 0RF2 was identified as 
the region of Tn917 that encoded for the methylase that is responsible for 
conferring resistance to erythromycin. The erm gene of Tn917 differs by 
only four base pairs from the erm gene of plasmid pAM77 (Shaw and Clewell, 
1985). A small control peptide (36 amino acids in length) encoded from 
ORFl is believed to participate in the translational attenuation control of 
methylase synthesis (Shaw and Clewell, 1985). Using insertion and deletion 
mutagenesis, Perkins and Youngman (1984) identified a segment of Tn917 that 
was essential for transposition; deletion of a 1.3-kb HindiII fragment from 
Tn917 precluded transposition. The region of Tn917 encoding for the 
putative transposase is contained in 0RF5. More recent evidence suggested 
Figure 4. Diagram of Tn917 
Tn917 is a 5,257 base-pair transposon that encodes for resistance to erythromycin. 
The orientation and location of the characteristic short (38 base pair) left and right 
inverted repeats, and an internal 38 base pair repeat, are designated as LR, RR, and IR, 
respectively, and are depicted by the thick arrows. The location of six likely open 
reading frames (ORF) are shown by the small open rectangles. Key restriction sites and 
position numbers for base pairs are delineated on the large rectangle. Although not 
clearly shown in the diagram, the IR is almost completely within the 3' end of 0RF3 (taken 
from Shaw and Clewell, 1985). 
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that the gene product encoded by 0RF6 may also be required for 
transposition of Tn917 (Shaw and Clewell, 1985). DNA sequence analysis of 
Tn917 revealed that 0RF4 shared significant homology (30%) with the 
recombinase gene of Tn3. The occurrence of a Tn3-like res site between 
0RF3 and 0RF4 further supports the role of the 0RF4 gene product as a 
recombinase (Shaw and Clewell, 1985). Finally, Tn917 harbors a 38-bp 
internal repeat (IR), located between 0RF3 and 0RF4, identical in sequence, 
and in the same orientation, as the left terminal repeat (LR) of the 
transposon (see Figure 4). The flanking of the erm gene of Tn917 by IR and 
LR creates an internal minor transposon present within a larger element. A 
similar situation exists within the Kleckner Class II element, Tnl721 
(Schmitt et al., 1980). 
Several plasmid vectors have been constructed to utilize Tn917 in B. 
subtilis. and other Gram-positive organisms, for both mapping and cloning 
genes of interest (Youngman, 1985; Youngman et al., 1984c; Youngman et al., 
1985b). Many of these vectors are variations of plasmid pTVl, a 12.4-kb 
plasmid that contains a temperature-sensitive origin of replication (from 
plasmid pE194), and genes encoding for chloramphenicol resistance [(Cmf); 
cat gene from S. aureus plasmid pC194] and inducible erythromycin 
resistance [(Emf); Tn9171 (Youngman et al., 1983). A physical-genetic map 
of pTVl is given in Figure 5. Plasmid pE194 is a 3.7-kb multicopy plasmid 
originating from S. aureus (Gryczan et al., 1982). When maintained in B. 
subtilis. plasmid pE194 displays a progressively decreasing copy number 
with increased temperature; replication of pE194 does not occur at 
temperatures of 45 C or greater (Youngman, 1985). 
Figure 5. Physical and genetic map of pTVl 
Plasmid pTVl is a 12.4 kb plasmid containing a 
temperature-sensitive origin of replication derived from S. 
aureus plasmid pE194 (pE194rep), and genes encoding for 
chloramphenicol resistance (cat gene from S. aureus plasmid 
pC194) and erythromycin resistance (erm gene of transposon 
Tn917 from Streptococcus faecalisi. Arrows over the drug-
resistance genes show the direction of transcription. The 
location of Tn917 is denoted by the large rectangle on the 
right-hand portion of the circle. The darkened box on each end 
of Tn917 delineates the 38 base pair terminal repeats. Kilo-
base pair coordinates are given on the inner arc of the circle, 
and the location of key restriction sites are shown on the 
outer arc of the circle. Closed circles (T ) position TagI 
cleavage sites and open boxes (7 ) position SauIIIfMboI) 
cleavage sites. The order of the closely spaced pair of Aval-
Ncol cleavage sites, in parentheses, was not determined (taken 
from Perkins and Youngman, 1984). 
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Plasraid pTVl was utilized as a temperature-sensitive delivery vehicle 
for isolating chromosomal Tn917 insertions in B. subtilis: several silent, 
auxotrophic, and insertional sporulation mutants of Tn917 were recovered at 
a frequency of 2 to 8 x 10"^  (Youngman et al., 1983). When a pTVl-
containing population of cells is grown at 30 C in the presence of the 
appropriate antibiotics, pTVl is maintained as an autonomous replicon; 
however, when the temperature is shifted to at least 38 C, pTVl is lost 
from this population of cells. If erythromycin is included in the medium 
when the cells are grown at a non-permissive temperature, erythromycin-
resistant cells are recovered that no longer harbor autonomous pTVl, but 
contain a chromosomal copy of Tn917. Plasmid pTVl has been used in this 
manner as a temperature-sensitive Tn917 delivery vehicle in various host 
strains (see above). As described below, pTVl is used in this study as an 
insertion vector in S. aureus. 
Youngman et al. (1984b) identified a unique Hpal restriction site 
within Tn917 in a region not affecting expression of erythromycin 
resistance or transposition functions (approximately 300 base pairs from 
the erm-proximal end of the element). To further extend the utility of 
this cloning site within a non-essential region of Tn917. the Hpal site was 
replaced by a 30 bp fragment of DNA containing BamHI and Smal sites 
(Youngman et al., 1984b). Fragments of DNA [blunt-ended restriction 
fragments, or fragments generated by restriction enzymes in the 
BamHI/BclI/BglII/MboI(Sau3A) family] up to 4.5 kb in length have been 
inserted into this modified cloning site without affecting transposition 
(Youngman et al., 1985a). Genes encoding for resistance to thiostrepton or 
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chloramphenicol were inserted into the cloning site of Tn917. conferring 
new phenotypes on Tn917 (Youngman et al., 1985a, 1985b). The substituted 
derivatives of Tn917 will be of value for organisms where the Em^ phenotype 
could not be used (e.g., various species of Strentomvces which are 
naturally Emf). 
Other derivatives of Tn917 were constructed to recover chromosomal DNA 
surrounding an insertion of Tn917 within or near a gene of interest. 
Tn917/PBR322 hybrids (e.g., pTV20) were constructed, containing the 
ampicillin resistance determinant and origin of replication from pBR322, 
plus the cat gene from pC194, inserted into the Sail site near the center 
of Tn917 (Youngman et al., 1984a). Upon transformation of competent B. 
subtilis containing a specific chromosomal insertion of Tn917 with 
linearized pTV20 (digested with an enzyme that does not cut within 
transposon sequences), the entire transposon (including the Gram-negative 
sequences inserted at the Sail site) becomes integrated via homologous 
recombination between plasmid-borne and chromosomal copies of Tn917. 
Transformants containing integrated pTV20 are selected for on 
chloramphenicol-containing media. Thus, a Gram-negative replicon (pBR322) 
becomes incorporated into a specific chromosomal locus in a Gram-positive 
host. Chromosomal DNA is isolated from a Cm^ transformant, and then 
digested with an enzyme having a single recognition site within the Gram-
negative portion of the integrated transposon (e.g., EcoRI for integrated 
pTV20). The EcoRI fragments of B. subtilis chromosomal DNA containing 
integrated plasmid are ligated and transformed into E. coli: selection is 
made for resistance to ampicillin. In this manner, DNA adjacent to a 
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chromosomal insertion of Tn917 is rapidly and efficiently cloned into E. 
coli for further analysis (Youngman, 1985; Youngman et al., 1984a, 1984c). 
Finally, several derivatives of Tn917 and pTVl were constructed for 
generating transcriptional gene fusions. A promoterless lacZ gene, 
furnished with a functional B. subtilis rlbosome-blnding site, was inserted 
into the Hpal site of Tn917. The lacZ-substituted derivatives of Tn917 
were fully functional for transposition. Transposon-mediated gene fusions 
were generated when lacZ-substituted Tn917 was inserted in the proper 
orientation within a chromosomal gene (Youngman et al., 1985a, 1985b). A 
fusion of a chromosomal promoter to the lacZ gene results in the production 
of beta-galactosidase instead of the normal gene product, and permits 
detection and quantitation of changes in the expression of the chromosomal 
promoter via the easy and rapid assays available for measuring the activity 
of beta-galactosidase. For the study of temporally regulated genes, such 
as the sporulation genes of B. subtilis. promoterless cat and lacZ genes 
were tandemly inserted into the Hpal site of Tn917 (Tn917 cat-lac). 
Transpositional fusions of Tn917 cat-lac to sporulation promoters were 
identified by the production of beta-galactosidase and chloramphenicol 
acetyl transferase during later stages of growth, but not early vegetative 
growth (Youngman et al., 1985a, 1985b). The derivatives of Tn917 and pTVl 
described in this section are adaptable for use in Gram-positive organisms 
other than B. subtilis. and should prove invaluable for gaining better 
insight into the molecular biology and genomic organization of these 
bacteria. 
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Recombinant DNA Methodology Applied to S. aureus 
Chang and Cohen (1974) first reported the successful cloning of DNA 
fragments from S, aureus into E. coll. EcoRI-generated fragments of the 
staphylococcal plasmid pI258 (Lindberg and Novick, 1973; Novick and 
Bouanchaud, 1971), encoding for resistance to penicillin, erythromycin, 
cadmium, and several other heavy metal ions, and the E. coli tetracycline-
resistance plasmid pSClOl were ligated and transformed into E. coli. A 
hybrid plasmid, designated pSC112, that conferred resistance to both 
penicillin and tetracycline was obtained (Chang and Cohen, 1974). Plasmid-
containing transformants were not recovered when either CCC or linearized 
pI258 DNA alone were transformed into E. coli. The recovery of pSC112 
demonstrated that aureus DNA (Gram-positive) was expressed in E. coli 
(Gram-negative). It was later shown that plasmid DNA from S. aureus would 
also replicate and express in a heterologous Gram-positive host, B. 
subtilis: one Tc^ (pT127) and four Cm^ (pC194, pC221, pC223 and pUB112) 
plasmids were successfully transformed into competent cells of B. subtilis 
(Ehrlich, 1977). In this same study, two additional S. aureus plasmids, 
pS120 and pK545, would not transform competent B. subtilis to either 
streptomycin (Smf) or kanamycin/neomycin (Kmf/Nm^ ) resistance, 
respectively. It was suggested that these plasmids may fail to replicate 
and/or express in B. subtilis. or perhaps their detection was precluded by 
the selection procedure employed [(e.g., high rate of spontaneous host 
mutations to these antibiotics); Ehrlich, 1977]. 
In general, many Gram-negative genes are not expressed in Gram-
positive hosts when introduced as passenger DNA on recombinant molecules; 
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however, many Gram-positive genes are expressed in Gram-negative and/or 
heterologous Gram-positive hosts (Kreft et al., 1982; Trieu-Cuot et al., 
1985a). This observation indicates that the process of transcription in 
Gram-positive bacteria is more stringent than the same process in Gram-
negative bacteria. Recent evidence suggests that heterologous DNA is not 
expressed in B. subtilis because the sigma^  ^factor (now called sigma^^) of 
B. subtilis RNA polymerase does not recognize the promoter region of these 
genes [(e.g., deviations from the B. subtilis -35 and -10 consensus 
sequence); Kreft et al., 1983]. It should be noted, however, that a few 
Gram-negative genes are expressed in a Gram-positive host (Ozaki et al., 
1984; Trieu-Cuot et al., 1985b). In contrast, the major obstacles to 
acquisition of Gram-positive genes by a Gram-negative host are the transfer 
and replication of the foreign DNA (Trieu-Cuot et al., 1985b). 
Another native S. aureus plasmid, pUBllO (2.8 md; Nm^ ), was 
transformed into competent cells of B. subtilis. B. pumilis. and B. 
licheniformis (Keggins et al., 1978). pUBllO was utilized as a vector for 
cloning DNA fragments for complementation analysis of the trnC2 locus in B. 
subtilis (Keggins et al., 1978), and for cloning the alpha-amylase gene 
from B. amvloliguefaciens into B. subtilis (Palva, 1982). Noguchi et al. 
(1983) utilized deletion derivatives of another S. aureus plasmid, pTP-5 
(2.9 md; Tc^), in B. subtilis to define the regions of pTP-5 essential for 
autonomous replication and tetracycline resistance. Ehrlich et al. (1982) 
and Gryczan et al. (1978) reviewed the various plasmids of S. aureus origin 
that have been used for cloning in B. subtilis. Furthermore, S. aureus 
plasmids (or derivatives thereof) have been successfully introduced and 
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subsequently maintained in such phylogenetically distant organisms as B. 
megaterium (Brown and Carlton, 1980), B. thurindiensis (Martin et al., 
1981), E. coli (Goze and Ehrlich, 1980), Saccharomvees cerevisiae (Goursot 
et al., 1982), and Streptococcus pneumoniae (Barany et al., 1982). 
Following the discovery that S. aureus plasmid DNA would replicate and 
express in heterologous hosts (Barany et al., 1982; Chang and Cohen, 1974; 
Ehrlich, 1977; Goze and Ehrlich, 1980; Keggins et al., 1978; Noguchi et 
al., 1983), several investigators characterized and developed indigenous 
staphylococcal plasmids for the manipulation of recombinant DNA in S,. 
aureus (lordanescu, 1975; Lofdahl et al., 1978a, 1978b; Wilson and Baldwin, 
1978). The majority of these plasmids were small (less than 5 md) 
tetracycline- or chloramphenicol-resistance plasmids with unique 
restriction sites for EcoRI and/or HindiII (Lofdahl et al., 1978a; Wilson 
and Baldwin, 1978). One such recombinant plasmid, pSC194 (CmfSm^ ), was 
constructed in vivo by cotransduction of S. aureus plasmids pS194 (Smf) and 
pC194 (Cmf); 5 to 10% of the transductants recovered by the selection for 
one plasmid had also acquired the other unselected plasmid and its 
associated marker (lordanescu, 1975). Lofdahl et al. (1978a) characterized 
all three plasmids with respect to size, restriction digest pattern, and 
transforming activity. Plasmids pC194, pS194, and pSC194 are 2, 3, and 4.9 
md in size, respectively. All three plasmids yielded about 1000 
transformants/ug CGC DNA when transformed into competent cells of S. 
aureus : a linear relationship was obtained between DNA concentration and 
the number of transformants. Linearized S. aureus plasmid DNA exhibited a 
10-fold lower frequency of transformation for competent cells of S. aureus 
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compared to CGC DNA of the same plasmid. Restriction endonuclease analysis 
revealed that pS194 contained unique sites for EcoRI and Hindlll, pC194 a 
single Hindlll site, and pSC194 a single EcoRI and two Hindlll sites. In 
addition, CGC DNA of pG194 and pSC194 transformed competent cells of B. 
subtilis to Gm^  at a frequency of 100 Cm^ transformants/ug CGC DNA 
(Ehrlich, 1977; Lofdahl et al., 1978a). 
Plasmid pSC194 was proposed as a suitable cloning vector for both S. 
aureus and B. subtilis. B. subtilis was envisioned as an alternative host 
to E. coli for recombinant DNA manipulations involving Gram-positive genes. 
Plasmid pSC194 was utilized to clone fragments of staphylococcal plasmid 
pI258 to develop a physical map for pI258 (Lofdahl et al., 1978b). The str 
gene of pSG194 harbors a single EcoRI site; therefore, recombinant clones 
were readily selected by screening for Gm^ Sm® transformants. The blaZ gene 
(Saunders et al., 1984a), the ermB gene (Lofdahl et al., 1978b; Wilson and 
Baldwin, 1978), and the genes responsible for resistance to mercury (merA 
and merB) and cadmium f(cadA and cadB); Witte et al., 1986], all from 
plasmid pI258, have been cloned. The components of plasmid pI258 were 
cloned to analyze the expression of blaZ in a heterologous host (B. 
subtilis). to develop a physical map for pl258, and to determine the 
relationship between chromosomal and plasmid-borne mercury or cadmium 
resistance determinants. 
Both pG194 and derivatives of pG194 have been utilized as cloning 
vehicles in B. subtilis (Ganosi et al., 1981; Ehrlich, 1978). In these 
studies, monomeric forms of hybrid plasmids composed of pG194 and B. 
subtilis chromosomal DNA were active in transformation of competent. 
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recombination-proficient cells of B. subtilis: monomeric pC194 without an 
insert of B. subtilis passenger DNA did not transform B. subtilis (Canosi 
et al., 1981). £. aureus cloning vectors have been developed with EcoRI. 
Hindlll. Belli, and PstI cloning sites (Wilson and Baldwin, 1978). The 
cloning sites on these vectors were not within the structural genes of the 
antibiotic resistance determinants; therefore, rapid screening for 
successful clones by gene inactivation was not possible with these vectors. 
Furthermore, several of the plasmids described above were unstable in 
certain hosts (Grandi et al., 1981; Kreft et al., 1982; Primrose and 
Ehrlich, 1981). Wilson et al. (1981) improved upon several of these 
vectors by incorporating additional selectable markers, as well as unique 
restriction sites within these determinants for insertion of passenger DNA 
(gene inactivation). Keller et al. (1983) constructed and characterized 
insertional inactivation vectors (e.g., pCT20 and pCElO) that circumvented 
plasmid instability for cloning in S. aureus and S. carnosus. 
The demonstration that S. aureus DNA was replicated and expressed in 
heterologous hosts, along with the development of suitable cloning vectors, 
resulted in the cloning and/or DNA sequencing of various S. aureus genes. 
The gene for protein A (sua) was independently cloned by Duggleby and Jones 
(1983) and Lofdahl et al. (1983). A complete nucleotide sequence for the 
spa gene has been reported (Uhlen et al., 1984). Shortle (1983) 
successfully cloned the gene encoding for staphylococcal nuclease (nuc) 
into E. coli. Two genes encoding for extracellular proteins involved in 
staphylococcal food poisoning have been cloned: staphylococcal enterotoxin 
A [(SEA); entA: Betley and Mekalanos, 1985; Betley et al., 1984]; and 
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staphylococcal enterotoxin B [(SEE); entB: Ranelli et al., 1985]. Jones 
and Khan (1986) recently published the nucleotide sequence of the entB 
gene. Other genes of interest from S. aureus that have been cloned and/or 
sequenced include, staphylokinase (Sako et al., 1983), the alpha hemolysin 
structural gene (hlv: Fairweather et al., 1983; Kehoe et al., 1983), the 
gene for toxic shock syndrome toxin (tst: Kreiswirth et al., 1983), a beta-
lactamase gene (blaZ; Saunders et al., 1984a), the exfoliative toxin B 
structural gene (etb; Jackson and landolo, 1986a, 1986b), and the lipase 
structural gene fgeh: Lee and landolo, 1985; Lee and landolo, 1986). It 
should be noted, however, that molecular cloning as an approach to 
chromosomal analysis of S,. aureus has been largely overlooked. 
Chromosomal Mapping in S. aureus 
Genetic-analysis in S. aureus NCTC 8325 has been conducted extensively 
by transformation, and to a lesser degree by transduction. Beginning in 
the late 1950s and continuing to the present, several investigators have 
progressively developed generalized transduction into an invaluable means 
for fine structure analysis within defined regions of the S. aureus 
chromosome (Kloos and Pattee, 1965; Pattee et al., 1974; Proctor and Kloos, 
1970; Ritz and Baldwin, 1962; Schroeder and Pattee, 1984). Lindberg et al. 
(1972) demonstrated that S. aureus can become competent for the uptake of 
naked DNA (e.g., was amenable to transformation). Pattee and Neveln (1975) 
utilized transformation to arrange available markers into three distinct 
linkage groups. The linkage groups were further expanded by the isolation, 
and subsequent mapping via transformation, of several additional genetic 
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determinants, including mec-4916. pip-131. and purBllO (Kuhl et al., 1978; 
Pattee, 1976). 
Sufficient loci were defined for Pattee and Glatz (1980) to divide 
each of the three linkage groups into segments that overlapped; each 
segment was bordered by a pair of markers that were co-transformable. The 
size and detail of the map was expanded by using Tn551 mutagenesis to 
recover auxotrophic and silent insertions of Tn551 in different regions of 
the S. aureus chromosome (Pattee, 1981). A procedure for protoplast fusion 
analysis of S. aureus chromosomal markers was developed that predicted the 
relative orientation of all three linkage groups (Stahl and Pattee, 1983a, 
1983b). Transformation with DNA of high molecular weight confirmed the 
order of markers predicted by protoplast fusion as the correct permutation, 
and resulted in a circular (though noncontiguous) chromosomal arrangement ' 
of genetic determinants (Stahl and Pattee, 1983b). Several chromosomal 
determinants could not be mapped, however, because they did not occupy 
sites within or near any of the existing linkage groups, and/or because it 
was not possible to directly select for these markers. To circumvent these 
problems, efforts were directed to isolate chromosomal insertions of Tn551 
near markers of interest to define their location relative to known markers 
and extend the limits of the existing linkage groups (Luchansky and Pattee, 
1984). 
Recently, a conjugation system was developed for genomic analysis of 
S. aureus (Stout, 1986). A chromosomal copy of Tn551 provided homology to 
a copy of Tn551 present on a conjugal gentamicin-resistance plasmid that 
promotes chromosome mobilization. Mobilization of genes from either side 
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of the chromosomal insertion occurred, but stable F'-like plasmids were not 
observed (Stout, 1986). In the present study, a novel integrable plasmid 
(derived from plasmid pTVl^ s) was constructed to thoroughly exploit 
chromosomal transposon insertions for analyzing the genome of S. aureus. 
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MATERIALS AND METHODS 
Bacterial Strains and Flasmlds 
The bacterial strains and plasmids used in this study are listed in 
Table 1. The cloning vector-insertion plasmid pJHlOl was kindly provided 
by Dr. James Hoch. pJHlOl was constructed by inserting the chloramphenicol 
acetyl transferase (cat) gene from pC194, a 2.0-megadalton (rad) S. aureus 
plasmid, into the unique PvuII site of the E. coli plasmid pBR322. pJHlOl 
does not contain an origin of replication for autonomous maintenance in a 
Gram-positive host, but the cat gene is expressed in both E. coli and B. 
subtilis: pJHlOl replicates in E. coli by using the pBR322 origin of 
replication. The E. coll vectors pJHlOl (Ferrari et al., 1983) and pBR322 
(Bolivar et al., 1977), as well as the S. aureus plasmid pC194 (Horinouchi 
and Weisblum, 1982b), have been described previously. Plasmids pI258 and 
pPQ58 encode for resistance to erythromycin (Tn551), as well as resistance 
to several heavy metal ions, and for production of a beta-lactamase. 
Plasmid pI258 has been described previously (Novick, 1974; Novick et al., 
1979c). pI258, which contains an insertion of the gentamicin-resistance 
transposon Tn4001. is referred to as plasmid pPQ58 (pPQ58 was obtained from 
Gregory G. Mahairas, Department of Microbiology, Iowa State University, 
Ames, Iowa). 
Dr. Phillip J. Youngman kindly provided strains of B. subtilis 
containing plasmids pTV20 and pTVl^ -g. pTV20 was constructed by insertion 
of the pBR322-derived replicon pHW9 into a Sail restriction site near the 
middle of Tn917: pTV20 has been used to clone sequences adjacent to 
chromosomal Tn917 insertions (Youngman et al., 1984a). Cesium chloride 
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Table 1. Designation, genotype, and origin of strains of Staphylococcus 
aureus 
Strain Genotype Origin or Reference 
S. aureus 
ISP2 8325nov-142 pig-131 
ISP5 8325thv-101 thrBl06 ilv-129 
pig-131 
ISP8 8325-4pig-131 
ISP130 8325-4wrt)I258blaI443 asa-33 
ermB20 ret)A181500 pig-131 
ISP456 80CR3bla+ rSOA" mSO" 
rSOB" mSOB" 
ISP459 8325rl- m31+ r2- m32+ pig-131 
ISP479 8325-4(pI258 bla-401 mer-14 
repA361 pig-131 
ISP778 80CR3nov-142 
ISP794 8325pig-131 
ISP796 8325pig-131 wrchr::Tn551134 
ISP835 8325-4trp-159: :Tn551 erniB317 
pig-131 
ISP849 83251VS-115 trp-103 thrB106 
uraA141 hisGlS ilv-129 
mec-4916 nov-142 pig-131 
ala-126 tvrB282::Tn551 
tmn-3106 
ISP856 8325-4fpC194') 
Pattee and Neveln, 1975 
Thompson and Pattee, 1977 
Schwesinger and Novick, 1975 
Stobberingh^  
lordanescu and Surdeanu, 1976 
Pattee, 1981 
80a/ISP2 X ISP456^ 
Stahl and Pattee, 1983b 
Stahl and Pattee, 1983a 
Pattee et al., 1983 
Stahl and Pattee, 1983b 
RN2425C 
^Ellen Stobberingh, Biomedical Centre, State University Limburg, 
Maastricht, The Netherlands. 
I^SP456 was transduced with a phage 80a lysate prepared on ISP2. 
methods have been described (Schroeder and Pattee, 1984). 
R^ichard P. Novick stock culture collection. Department of Plasmid 
Biology, the Public Health Research Institute of the City of New York, 
Inc. , New York, NY. 
The 
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Table 1 (Continued) 
Strain Genotype Origin or Reference 
ISP874 8325rl- xT m31+ m32+ 
tvrB282::Tn551 lvs-115 
pig-131 
ISP990 8325thrB106 troESS tnin-3106 
tvrB282::Tn551 ermB321 
uraAl41 nov-142 mec-4916 
ISP997 8325mec-4916 nov-142 truESS 
uraB232::Tn551 ermB327 
tmn-3106 rib-127 
ISPlOlO 8325mec-4916 nov-142 trpE85 
uraB232::Tn551 ermB327 
tmn-3106 rib-127 
w[Chr::Tn551134 
ISP1046 80CR3nov-142 
ISP1201 8325-4his-7 recAl pig-131 
ISP1421 8325pig-131 (pSK31) 
ISP1483 80CR3nov-142 (pTVlts) 
ISP1504 8325-4pig-131 (pPQ58) 
ISP1505 8325-4plg-131 (pSK31) 
(pI258 blaI401 mer-14 repA36') 
ISP459 X ISP849(UV)d 
Luchansky and Pattee, 1984 
Stahl and Pattee, 1983b 
ISP796 DNA X ISP997® 
ISP778f 
RN981^ ; Wyman et al., 1974 
SkurrayS; Lyon et al., 1984 
ppISP1046 X ISP1479h 
80a/ISP1505 X ISP8 
80a/ISP1421 X ISP479 
°UV-irradiated ISP849 fused with protoplasts of ISP459. 
®ISP997 was transformed with strain ISP796 DNA. 
^ISP778 cured of Cd^  plasmid by protoplast formation. 
SRonald A. Skurray, Department of Microbiology, Monash University, 
Clayton, Victoria, Australia. 
^Protoplast fusion between ISP1046 and ISP1479 protoplasts. 
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Table 1 (Continued) 
Strain Genotype Origin or Reference 
ISP1506 8325-4pig-131 (pII147 
w[Tn4001]l re^ Al) 
ISP1554 8325-4wrchr: :Tn400111210 T)lg-131 
ISP1565 8325wrchr::Tn400111210 plg-131 
ISP1574 8325-4pigl31 (pE194ts) 
ISP1577 8325rl" m31+ rZ" m32+ 
piR-131 (pTVlts) 
ISP1578 8325-4plg-131 (pTVltg) 
ISP1658 8325-4r- pig-131 
ISP1800 8325-4pig-131 (pPQ61) 
ISP1801 8325.4plg.131 (pPQ61) 
his.7 recAl 
ISP1844 8325.4r- (pPQ126) 
ISP1846 8325.4trp-159: :Tn551 erniB317 
Pig-131 (pPQ126) 
80a/ISP1421 afteri 
NG mutagenesis X ISP8 
ispisoej 
80a/ISP1554 X ISP794 
Mahairas^  
80a/ISP1483 X ISP459 
80a/ISP1577 X ISP8 
RN4220; Kreiswirth et al., 
1983 
80a/ISP1505 X ISP8 
80a/ISP1800 X ISP1201 
This studyl 
phill/ISP1844 X ISP835 
^ISP8 was transduced with an 80a lysate prepared on nitrosoguanidine 
rautagenized ISP1421. 
jlSP1506 grown at 43C to cure pII147 from the culture. 
G^regory G. Mahairas, Department of Microbiology, Iowa State 
University, Ames, lA. 
^Transformant obtained from a ligation mixture of Hindlll-digested. 
CIP.treated pTVl^ s and Hindlll-digested pPQ58 presented to protoplasts of 
ISP1658. 
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Table 1 (Continued) 
Strain Genotype Origin or Reference 
JBLIO 8325thrBl06 trpE85 tinn-3106 
tvrB282::Tn551 ermB321 
uraAl41 nov-142 mec-4916 
(pLUCHlO) 
JBLll 8325thrBl06 trpE85 tmn-3106 
tvrB282: :Tn551 erniB321 
uraAl41 nov-142 mec-4916 
(pLUCHll) 
JBL14a 8325thrBl06 trpESS tmn-3106 
tvrB282::Tn551 ermB321 
uraAl41 nov-142 mec-4916 
(pTVlts) 
JBL14b 8325thrBl06 trpE85 tmn-3106 
tvrB282::Tn551 ermB321 
uraAl41 nov-142 mec-4916 
(pTVlts) 
JBL70 8325thv-101 pig-131 ilv-129 
trp-159::Tn551 ermB317 
w[Chr::pPQ126(delGm)]159.70 
This study™ 
This study' m 
This study' m 
This study' m 
This studyP 
""isolate recovered following transformation of ISP990 with plasmid 
pTVl^ s when selection was made for resistance to 10 ug/ml of 
chloramphenicol (JBLIO, JBLll, JBL14a), or 1.5 ug/ml of erythromycin 
(JBL14b). 
^Transformant obtained following transformation of ISP5 with high 
molecular weight DNA extracted from a population of cells of ISP1846 
previously grown at 43 C with appropriate selection. Contains a deleted 
derivative (Gm®) of plasmid pPQ126 presumably integrated into the trp-
159 ::Tn551 ermB317 target site of donor ISP1846 DNA. A Class D isolate 
from Table 18. 
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Table 1 (Continued) 
Strain Genotype Origin or Reference 
JBL71 8325thv-101 ilv-129 Dig-131 
trD-159 : :Tn551 erniB317 
w[Chr::pPQ126]159.71 
JBL74 8325thv-101 thrBlQ6 ilv-129 
Pig-131 
w[Chr::pPQ126]159.74 
JBL85 8325wfChr::Tn400111210 
Pig-131 (pPQ126) 
JBL87 8325thv-101 thrB106 pig-131 
(pPQ126) 
JBL88 8325thv-101 thrB106 ilv-129 
Pig-131 (pLUCHBS) 
JBL89 8325thv-101 thrB106 ilv-129 
Pig-131 (pLUCH89) 
This study® 
This studyP 
phill/ISP1844 X ISP1565 
This studyl 
This study9 
This study9 
°Transformant obtained following transformation of ISP5 with high 
molecular weight DNA extracted from a population of cells of ISP1846 • 
previously grown at 43 C with appropriate selection. A Class F isolate 
(Table 18) with pPQ126 presumably integrated at the trp-159::Tn551 ermB317 
target site of donor ISP1846 DNA. 
^Transformant obtained following transformation of ISP5 with high 
molecular weight DNA extracted from a population of cells of ISP1846 
previously grown at 43 C with appropriate selection. A Class A isolate 
(Table 18) with pPQ126 presumably integrated at the trp-159::Tn551 ermB317 
target site of donor ISP1846 DNA. 
T^ransformation of ISP5 with DNA isolated from JBL85 grown at 43 C 
with selection (see Table 19). 
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Table 1 (Continued) 
Strain Genotype Origin or Reference 
JBLlOl 8325wfChr::Tn400111210 This studyf 
t.iE-131 (DP0126) 
JBL107 8325wfChr::Tn4001]1210 This study® 
TDie-131 fDP0126) 
JBL108 8325wfChr::Tn400111210 This studyC 
piR-131 
JBL113 8325wfChr::Tn400111210 This study* 
w[Chr::pPQ126]1210.13 
pig-131 
JBL114 8325wfChr::Tn400111210 This study* 
w[Chr::pPQ126]1210.14 
plR-131 
JBL115 8325-4r- This studyV 
JBL116 8325-4r- (pPQ126) This s tudyV 
JBL117 8325-4r- (pPQ126) This study* 
I^solate from a BHI agar plate incubated at 30 C from a plasmid 
elimination experiment with JBL85. 
^Isolate from a BHI agar plate containing 10 ug/ml of erythromycin 
incubated at 30 C from a plasmid elimination experiment with JBL85. 
^Isolate from a BHI agar plate incubated at 39 C from a plasmid 
elimination experiment with JBL85. 
I^solate from a BHI agar plate containing 10 ug/ml of erythromycin 
incubated at 39 C from a plasmid elimination experiment with JBL85. 
I^solate from a BHI agar plate incubated at 30 C from a plasmid 
elimination experiment with ISP1844. 
I^solate from a BHI agar plate containing 10 ug/ml of erythromycin 
incubated at 30 C from a plasmid elimination experiment with ISP1844. 
Table 1 (Continued) 
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Strain Genotype Origin or Reference 
JBLll7a 
JBL118 
JBL119 
JBL120 
JBL121 
JBL122 
JBL177 
JBL200 
8325 
8325 
8325 
8325 
8325 
8325 
4r-
•4r-
•4r-
4r" 
•4r-
(pPQ126) 
4w[Chr::Tn4001]2000 
pig-131 his-7 recAl 
8325-4w[Chr:;Tn4001]2000 
Pig-131 (pPQ126) 
his-7 recAl 
8325-4w[Chr;:Tn400112000 
pjg-lSl his-7 recAl 
This study* 
This studyY 
This study^ 
This study^^ 
This study8& 
ISP180lbb 
phill/ISP1844 X JBL122 
This study cc 
L^oopful of cells from a BHI agar plate containing 10 ug/ml of 
erythromycin incubated at 39 C from a plasmid elimination experiment with 
ISP1844 (see Table 12). 
I^solate from a BHI agar plate containing 10 ug/ml of gentamicin 
incubated at 30 C from a plasmid elimination experiment with ISP1844. 
^Isolate from BHI agar plate incubated at 39 C from a plasmid 
elimination experiment with ISP1844. 
8&Isolate from a BHI agar plate containing 10 ug/ml of gentamicin 
incubated at 39 C from a plasmid elimination experiment with ISP1844. 
^^ ISP1801 grown at 43 C to cure pPQ61 from the culture. 
GClsolate from a BHI agar plate incubated at 30 C from a plasmid 
elimination experiment with JBL177. 
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Table 1 (Continued) 
Strain Genotype Origin or Reference 
JBL201 
JBL202 
JBL203 
JBL204 
JBL205 
JBL206 
JBL207 
JBL208 
8325-
8325-
-4w[Chr::Tn400112000 
pig-131 hls-7 recAl 
-4w[Chr::Tn400112000 
plg-131 his-7 recAl 
8325-4wfChr::Tn400112000 pig-131 
(pPQ126) his-7 recAl 
8325-4w[Chr::Tn4001]2000 pig-131 
(pPQ125) his-7 recAl 
8325-4w[Chr::Tn400112000 
pig-131 his-7 recAl 
8325-4w[Chr::Tn4001]2000 
pig-131 his-7 recAl 
8325-4w[Chr;:Tn400112000 
w[Chr::pPQ126]2000.7 
pig-131 his-7 recAl 
8325-4wfChr::Tn4001120Q0 
w[Chr::pPQ126]2000.8 
pig-131 his-7 recAl 
This study"^  ^
This study*^^ 
This study^'^ 
This study®® 
This study^  ^
This studySS 
This studyhh 
This studyhh 
d^ lsolate from a BHI agar plate containing 10 ug/ml of gentamicin 
incubated at 30 C from a plasmid elimination experiment with JBL177. 
®®Isolate from a BHI agar plate containing 10 ug/ml of erythromycin 
incubated at 30 C from a plasmid elimination experiment with JBL177. 
f^Isolate from a BHI agar plate incubated at 39 C from a plasmid 
elimination experiment with JBL177. 
SSlsolate from a BHI agar plate containing 10 ug/ml of gentamicin 
incubated at 39 C from a plasmid elimination experiment with JBL177. 
hhisolate from a BHI agar plate containing 10 ug/ml of erythromycin 
incubated at 39 C from a plasmid elimination experiment with JBL177. 
Table 1 (Continued) 
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Strain Genotype Origin or Reference 
JBL300 8325-4trp-159::Tn551 ermB317 
Pig-131 (PPQ126) 
JBL301 8325-4trt)-159: :Tn551 erniB317 
pig-131 
JBL302 8325-4trp-159::Tn551 ermB317 
Pig-131 
JBL304 8325-4trp-159!:Tn551 ermB317 
Pig-131 (pPQ126) 
JBL305 8325-4trp-159::Tn551 ermB317 
pig-131 (pPQ126) 
JBL306 8325-4trp-159::Tn551 ermB317 
w[Chr::pPQ126]159.6 
Pig-131 
JBL307 8325-4trp-159::Tn551 ermB317 
w[Chr::pPQ126il59.7 
Pig-131 
JBL310 8325-4trp-159: :Tn551 erniB317 
Pig-131 (pPQ126) 
This study^  ^
This studyii 
This studyjj 
This study^^ 
This study^^ 
This study 
This study^l 
This study' .nun 
l^ Isolate from a BHI agar plate incubated at 30 C from a plasmid 
elimination experiment with ISP1846. 
jJlsolate from a BHI agar plate incubated at 39 C from a plasmid 
elimination experiment with ISP1846. 
kkisolate from a BHI agar plate containing 10 ug/ml erythromycin 
incubated at 30 C from a plasmid elimination experiment with ISP1846. 
lllsolate from a BHI agar plate containing 10 ug/ml erythromycin 
incubated at 39 C from a plasmid elimination experiment with ISP1846. 
°™Isolate from a BHI agar plate containing 10 ug/ml of gentamicin 
incubated at 30 C from a plasmid elimination experiment with ISP1846. 
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Table 1 (Continued) 
Strain Genotype Origin or Reference 
JBL311 
JBL314 
JBL315 
JBL316 
JBL317 
JBL319 
JBL320 
8325-4trp-159::TnSSl ermB317 
pig-131 (pPQl26) 
8325-4trp-159::Tn551 ermB317 
w[Chr::pPQ126]159.14 
Pig-131 (pPQ126) 
8325-4trp-159: :Tn551 erniB317 
w[Chr::pPQ126]159.15 
Pig-131 (pPQl26) 
8325-4ptg-131 (pTVlts) 
8325-4pig-131 
8325.4piE.131 (pTVlts) 
8325.4w[Chr::Tn91712001 
Pig-131 
mm This study' 
This study™i 
This study™ 
This study°° 
This studyPP 
This study99 
This study^  ^
"^ ïsolate from a BHI agar plate containing 10 ug/ml of gentamicin 
incubated at 39.C from a plasmid elimination experiment with ISP1846. 
°°Isolate from a BHI agar plate incubated at 30 C from a plasmid 
elimination experiment with ISP1578. 
PPlsolate from a BHI agar plate incubated at 39 C from a plasmid 
elimination experiment with ISP1578. 
99lsolate from a BHI agar plate containing 10 ug/ml of erythromycin 
incubated at 30 C from a plasmid elimination experiment with ISP1578. 
z^Isolate from a BHI agar plate containing 10 ug/ml of erythromycin 
incubated at 39 C from a plasmid elimination experiment with ISP1578. 
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Table 1 (Continued) 
Strain Genotype Origin or Reference 
E. coll 
ISP1196 
ISP1213 
ISP1569 
ISP1872 
JBL4 
HBlOl P- hsd20 (rg-niB") ara-14 
lacYl palK2 rpsL20(Sm^ ) 
xvl-5 mtl-1 SUPE44 
lambda" recA13 proA2 
MM294 (pJHlOl) 
HBlOl F" hsd20 (r^'mg") ara-14 
lacYl palK2 rtisL20(Sm^') 
xvl-5 mtl-1 SUPE44 lambda" 
recA13 proA2 (pBR322) 
HBlOl F" hsd20 (rB"mB") ara-14 
lacYl ^ alK2 rpsL20(Sm^ ') 
xvl-5 mtl-1 SUPE44 lambda" 
recA13 proA2 (pPQ132) 
HBlOl F" hsd20 (rg-mB") 
ara-14 lacYl galK2 
rpsL20fSm^ ') xvl-5 mtl-1 
SUPE44 lambda" recA13 
proA2 (pLUCH2) 
Boyer & Roulland-Dussoix, 
1969 
Hochss 
This study*-^ 
This study' •uu 
This study •W 
®®James A. Hoch, Department of Basic and Clinical Research, Research 
Institute of Scripps Clinic, La Jolla, CA. 
^^ Transformant obtained from transformation of pBR322 into E. coli 
HBlOl. 
'^ '^ Transformant obtained from a ligation mixture of HindiII-digested 
pBR322 and the 1.67 md HinF fragment of plasmid pPQSS presented to 
competent cells of ISP1196. 
^Transformant obtained from a ligation mixture of Hindlll-digested, 
CIP-treated pJHlOl and the 2.8 md HinB fragment (ermB gene of Tn551) of 
plasmid pI258 presented to competent cells of ISP1196. 
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Table 1 (Continued) 
Strain Genotype Origin or Reference 
JBL6 HBlOl F" hsd20 (rg'tng") This study' 
ara-14 lacYl galK2 
rpsL20(Sm^) xvl-5 mtl-1 
SUPE44 lambda" recAl3 
proA2 (pLUCH4) 
JBL7 HBlOl P- hsd20 (rg'mB-) This study" 
ara-14 lacYl galK2 
rpsL20(Sm^ ') xvl-5 mtl-1 
SUPE44 lambda" recAl3 
proA2 (pLUCH3) 
JBL75 HBlOl F" hsd20 (rB^mg") This study^ 
ara-14 lacYl galK2 
rDsL20fSm^ ) xvl-5 mtl-1 
SUPE44 lambda" recA13 
proA2 (pLUCH75) 
B. subtllls 
ISP1479 trpC2 thr-5 (pTVlj-g) YoungmanYy 
ISP1769 BD170 (pTV20) YoungmanYY 
.WW 
w 
T^ransformant obtained from a ligation mixture of Hlndlll-digested. 
CIP-treated pJHlOl and Hindlll-digested pI258 presented to competent cells 
of ISP1196. 
^^ Transformant obtained from a ligation mixture of Hindlll-digested 
pBR322 and Hindlll-digested pI258 presented to competent cells of ISP1196. 
yyphillip J. Youngman, Department of Microbiology, University of 
Pennsylvania, School of Medicine, Philadelphia, PA. 
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Table 1 (Continued) 
Plasmidfz Phenotype Origin or Reference 
S. aureus 
pI258 Em^ Cd^ Tsr Bla+ Pattee, 1981 
pC194 Cm^  Horinouchi and Weisblum, 
1982b 
pE194 Em^ Horinouchi and Weisblum, 
1982a 
pE194ts Em^ Tsr Youngman, 1985 
pTVlts Em^ Cm^ Tsr Youngman, 1985 
pTV20 Ap^ Cm^ Em^ Youngman et al., 1984b 
pPQ61 Em^ Cdr Tsr Bla+ Gmf Pattee^ *^  
pPQ58 Em^ Cdr Tsr Bla+ Gm^  Pattee&aa 
pPQ126 Em^ Cm^ Tsr Gm^  This study^ ^^  
pLUCHlO Cm^  Em® This study^^^*^ 
pLUCHll Cm^ Em^  This study"^ "^^  
^^Abbreviations: Ap^, arapicillin; Bla*, constitutive beta-lactamase ; 
Cd, cadmium; Cm, chloramphenicol; Em, erythromycin; Cm, gentamicin; Tc, 
tetracycline; Tsr, temperature sensitive replication. 
^^ ^Peter A. Pattee, Department of Microbiology, Iowa State 
University, Ames, lA. 
bbbA recombinant plasraid composed of the 11.1 kb HindiII fragment of 
plasmid pTVl^ -g ligated to the 2.5 kb Gm^  Hindi 11 fragment of plasmid 
pPQ58. 
cccDeieted derivative of pTVl^s obtained following transformation of 
ISP990 with pTVlts and selecting for resistance to 10 ug/ml 
chloramphenicol. 
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Table 1 (Continued) 
Plasmid^ z Phenotype Origin or Reference 
pLUCH88 Em^ Cm^  Tsr Gm® This study"^ "^ *^  
pLUCH89 Em^ Cm^  Tsr Gm^  This studyddd 
pLUCH113 Em'- Cm^  Gm^ This study®®® 
E. coli 
pBR322 Apr Tc^ Bolivar et al. , 1977 
pJHlOl Ap^ Cm^  Tc^  Ferrari et al. , 1983 
pLUCH2 Ap^ Cm^  Tc® Em^ This studyf^f 
pLUCH3 Apr Gm^  Tc^  Em^ This studyff^  
pLUCH4 Apr Cmr Tc® This studySSS 
pLUCH75 Apr Tc® Emr This study^ ^^  
pPQ132 Apr Tc® Gmr This studyiii 
^^^Derivative of pPQ126 obtained following transformation of ISP5 
with high molecular weight DNA extracted from a population of cells of 
JBL85 previously grown at 43 C. All incubations and platings for the 
transformation were performed at 34 C, and selection was made for 
resistance to erythromycin (Table 19). 
®®®Plasmid(s) obtained by growing JBL113 (containing chromosomally 
integrated pPQ126) at 30 C in the presence of 3 ug/ml each of erythromycin 
and gentamicin and u ug/ml of chloramphenicol. 
^^ T^he 2.8 md HinB fragment (ermB gene of TnSSl) of plasmid pI258 
ligated into the unique HindiII site of plasmid pJHlOl. 
SSSThe HlnG fragment of plasmid pI258 ligated into the unique HindiII 
site of plasmid pJHlOl. 
hhhThe 2.8 md HinB fragment (ermB gene of Tn551) of plasmid pI258 
ligated into the unique HindiII site of plasmid pBR322. The ermB gene 
encodes for resistance to 300 ug/ml of erythromycin in E. coli HBIOI. 
iiiThe 1.67 md HlnF fragment (gentamicin-resistance determinant of 
Tn4001) of plasmid pPQ58 ligated into the unique HindiII site of plasmid 
pBR322. The gentamicin resistance determinant encodes for low-level 
resistance (at least 1 ug/ml) to gentamicin in E. coli HBIOI. 
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(CsCl) purified pTV20 DNA, isolated from B. subtilis. was provided by Dr. 
Peter A. Pattee. • pTVl was constructed by ligating the Tn917-containing 
PvuII restriction fragment of pAM(alphal) (deletionl) : :Tn9]J[, into plasmid 
pBD95 (Youngman et al., 1983). A highly temperature-sensitive derivative 
of pTVl (designated pTVlj-g) was constructed that displays an abrupt 
replication block at 38 C (Youngman, 1985). pTVl^g is a 12.4 kb plasmid 
composed of 2 HindiII fragments (Youngman, 1985); a large 11.1 kb fragment 
contains the replication functions (pE194cg origin of replication), as well 
as genes encoding for resistance to chloramphenicol (cat gene from pC194) 
and erythromycin (erm gene of Tn917), and a smaller 1.3 kb fragment that 
contains information essential for transposition (Perkins and Youngman, 
1984). pTVl^ g has been used as a Tn917 delivery vehicle (Youngman et al., 
1983). Nitrosoguanidine treatment of a population of cells containing 
pE194, a 3.7 kb erythromycin-resistance vehicle native to S. aureus 
(Horinouchî and Weisblum, 1982a), produced plasmid pE194ts (Youngman, 
1985). Chromosomal DNA isolated from ISPlOlO (control DNA for 
competent-cell transformation of S. aureus) was kindly provided by Dr. 
Peter A. Pattee. Cesium chloride purified pBR322 was generously provided 
by Dr. Kim Engwall. All of the strains used in this study are available 
from the ISP culture collection of Dr. Peter A. Pattee and/or the JBL 
culture collection of John B. Luchansky (Department of Microbiology, Iowa 
State University, Ames, Iowa). 
Several strains in this study contain chromosomal insertions of the 
transposable elements, Tn917. or Tn551. or Tn4001. Following the 
recommendations of Novick et al. (1976) and Campbell et al. (1979), the 
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Greek letter omega (w) , and the notation fChr: :TnXXXX1 followed by an 
isolation number, are used to denote silent insertions of Tn elements 
(e.g., w[Chr::Tn551]34). Insertions resulting in the inactivation of 
certain genes are identified by the gene symbol and allele number, followed 
by the notation ::Tn551 (e.g., uraB232::Tn551). Some strains carry a copy 
of Tn551 containing a mutation in the ermB gene that results in an 
erythromycin-sensitive phenotype (e.g., uraB232: :Tn551 ermB327'). A 
detailed description of the isolation of Em® mutants of Tn551 resulting 
from spontaneous point mutations within the ermB gene of this transposon 
has been provided (Pattee et al., 1983). 
Culture Media 
Except where noted, 1.5% (w/v) Bacto-agar (Difco Laboratories, 
Detroit, MI) was added to all of the commercially available dehydrated 
culture media used in this study to prepare both agar plates and slants 
[Brain Heart Infusion (BHI; Difco), and Trypticase Soy Broth (TSB; BEL, 
Cockeysville, MD)]. Trypticase Soy Agar (BBL) containing chloramphenicol 
was used to select and score for resistance to chloramphenicol. Oxoid 
Tryptone Soya Broth (Oxoid TSB; Oxoid Ltd., Basingstoke, Hants, England) 
was used for growing cells of S. aureus to competence. For protoplast 
plasmid transformation experiments, cells were grown to the proper density 
in antibiotic medium 3 (Penassay broth; Difco), and putative transformants 
were plated onto either DM3 medium or Regeneration (R) agar. DM3 was 
prepared essentially as described by Chang and Cohen (1979): 500 ml sodium 
succinate (Sigma Chemical Co., St. Louis, MO; 1 M; pH 7.3), 20 ml MgCl2 (1 
M), 5 ml Bovine Serum Albumin (BSA; Sigma; 2%), 25 ml of glucose (20%), 100 
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ml K2PO4/KH2PO4 solution (3.5% K2PO4 and 1.5% KH2PO4), 50 ml Bacto-yeast 
extract (yeast extract; Difco; 5%), and 100 ml casamino acids (Difco; 5%). 
The percent solutions for DM3 medium are listed on a weight per volume 
basis. All of the DM3 components were autoclaved separately, except for 
BSA (filter-sterilized) and sodium succinate [steam-sterilzed with 200 ml 
of H20-agar (8 g)]. R agar (Stahl and Pattee, 1983a) consisted of 273 g of 
sucrose (ultra pure ; Schwarz/Mann Inc., Spring Valley, NY), 30 g TSB, 0.5 g 
sodium citrate, 3.0 g soluble potato starch (Sigma), and 25 g of agar, all 
per liter of deionized water (dH20). The final pH was adjusted to 7.3 with 
1 N NaOH. 
All media for culturing strains of S. aureus were routinely 
supplemented with thymine (20 ug/ml), and adenine, cytosine, guanine, and 
uracil (5 ug sach/ml). Unless stated otherwise, all agar media were 
routinely supplemented with sodium citrate (Fisher Scientific Co., Fair 
Lawn, NJ) at 1 g per liter. All cultures of S. aureus and E. coll were 
stored at 4 C on BHI agar slants and Luria-Bertani (LB) agar slants, 
respectively. LB medium, modified from Maniatis et al. (1982), consisted 
of 10 g Bacto-tryptone (tryptone; Difco), 5 g yeast extract, and 5 g NaCl, 
all per liter of deionized water and adjusted to a pH of 7.3. Bacteria 
containing plasmids were maintained at the proper temperature in the 
presence of the appropriate antibiotic(s) (e.g., incubation at 30 C on BHI 
agar plates containing 3 ug/ml each of erythromycin and gentamicin and 1 
ug/ml of chloramphenicol for pPQ126-containing cells) to insure against 
loss of extrachromosomal elements. A second set of stock cultures were 
maintained at -70 C in GL broth plus 10% glycerol. GL broth consisted of 3 
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g each of casamino acids and yeast extract, 5.9 g NaCl, 3.3 ml of 60% 
sodium lactate, and 4 ml of 25% glycerol, all in 1000 ml deionized water 
adjusted to a final pH of 7.8 (Novick et al., 1979b). The composition of 
Complete Defined Synthetic (CDS) agar (Pattee and Neveln, 1975), used for 
selection and scoring of nutritional markers, is listed in Table 2. Table 
3 describes the precise formulations for the various media used in this 
study to select and score genetic markers, along with the phenotypes of 
these markers. 
Reagents and Buffers 
All antibiotics used in this study were purchased from Sigma, and 
stored at -10 C as stock solutions prepared at a concentration of 10 mg/ml, 
as follows: chloramphenicol and erythromycin were dissolved in 95% ethanol, 
and tetracycline, gentamicin, and ampicillin were dissolved in deionized 
water and filter sterilized. Lysostaphin (Sigma), for disrupting the 
integrity of S. aureus cell walls, was dissolved at 1 mg/ml in a solution 
containing 600 mg Tris(hydroxyraethyl)aminomethane (Tris; Sigma), 870 mg 
NaCl, and 100 ml deionized water, pH 7.5. Following positive-pressure 
filtration, 1-ml aliquots were stored at -10 C. Lysozyme (Sigma) was 
directly added at a concentration of 4 mg/ml to cells of E. coli in lysis 
buffer. The lysis buffer for both S. aureus and E. coli consisted of 200 g 
sucrose, 18.6 g ethylenediamine-tetraacetic acid [disodium salt] (EDTA; 
Fisher Scientific Co.), 3.95 g Tris(hydroxymethyl)aminomethane 
hydrochloride (Tris-HCl; Sigma): all 3 reagents were added to 800 ml 
deionized water, the pH was adjusted to 8.0, and the final volume was 
brought to 1 liter. The lysis buffer was dispensed in 150-ml portions and 
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Table 2. Composition of Complete Defined Synthetic (CDS) agar^  
Ingredient Amount^  Ingredient Amount^ 
glucose: 5 gm amino acids : 
L-glutamic acid 100 mg 
salts : L-serine 30 mg 
K2HPO4 7 gm L-methionine 10 mg 
KH2PO4 2 gm L-tyrosine 50 rag 
Nag citrate•2H2O 0 .4 gm L-alanine 60 mg 
MgS04 0 .05 gm L-lysine 50 mg 
(NH4)2S04 1 gm L-threonine 30 mg 
L-phenylalanine 40 rag 
vitamins : L-histidine 20 mg 
thiamine 1 mg glycine 50 mg 
niacin 1, ,2 mg L-tryptophan 10 rag 
biotin 0, ,005 mg L-isoleucine 30 rag 
Ca pantothentate 0, .25 mg L-valine 80 rag 
riboflavin^ 1 mg L-leucine 90 mg 
purines and pyrimidines: L-aspartic acid 90 gm 
adenine 5 mg L-arginine 50 gm 
guanine 5 mg L-proline 80 gm 
cytosine 5 mg L-cystine 20 gm 
uracil 5 mg 
thymine 20 mg Bacto-Agar (Difco) 15 gm 
deionized water 1000 ml 
S^ynthetic media were prepared by combining required volumes of each 
stock; these mixtures were filter-sterilized and combined with the agar, 
which had been previously autoclaved (121 C, 15 min) with the remaining 
water, and cooled to 50 C. 
F^inal concentration per liter of Complete Defined Synthetic (CDS) 
medium. 
Added only when needed. 
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Table 3. Selectable genetic markers, their phenotypes, and composition of 
media used for their selection and scoring 
Tn551 Em^ erythromycin resistance +1 ug/ml erythromycin 
for selection, or +10 
ug/ml for scoring of 
unselected markers in 
BHI agar 
ermB Em® erythromycin sensitive 
mutation of ermB in Tn551 
(see Tn551. above) 
Tn4001 Gm^  gentamicin resistance (see Tn551 above, but 
substitute gentamicin 
for erythromycin) 
Tn917 Em^ erythromycin resistance (see Tn551. above) 
am Ap^ ampicillin resistance +30 ug/ml ampicillin 
• for selection or +50 
ug/ml for scoring of 
unselected markers in 
LB agar 
cat Cm^  chloramphenicol 
resistance 
. +12.5 ug/ml chlor­
amphenicol for scoring 
of unselected markers 
in LB agar 
+3 or 10 ug/ml chlor­
amphenicol for 
selection in R agar 
tet Tc^ tetracycline resistance +25 ug/ml tetracycline 
for scoring of 
unselected markers in 
LB agar 
llv llv" isoleucine requirement -isoleucine and 
leucine 
from CDS agar; valine 
reduced to 20 ug/ml; 
+1% sodium pyruvate 
(Brown and Pattee, 
1980) . 
thr Thr' threonine requirement -threonine from CDS 
agar 
thv Thy" purine requirement -thymine from CDS agar 
trE Trp" uracil requirement -tryptophan from CDS 
agar 
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sterilzed in an autoclave, before being stored at 4 C for periods of up to 
4 months. 
S. aureus protoplasts were formed in sucrose-magnesium-tris buffer 
(SMTB) [0.8 M sucrose, 40 mM MgSO^ , and 100 mM Tris, at pH 7.6]. The MgSO^  
was added first, and allowed to dissolve before adding the remaining 
reagents. Tris-EDTA-NaCl buffer contained 0.1 M Tris, 0.15 M NaCl, and 0.1 
tl EDTA at pH 7.5. DNase-free RNase (Sigma) was dissolved in 0.15 M NaCl, 
pH 5.0. After boiling for 10 min, the pH was adjusted to 7.0, and 1.0-ml 
aliquots were stored at -10 C. Protease type XIV (Sigma) was dissolved at 
10 mg/ml in deionized water, and allowed to self-digest at 35 C for 1 h 
prior to use. The SLS-ethanol solution contained 5 g of sodium lauryl 
sulfate (SLS; Nutritional Biochemicals Corporation, Cleveland, OH) in 50 ml 
of 95% ethanol plus 50 ml of dH20. Standard saline citrate (SSC) for 
dissolving DNA consisted of 6.1 g NaCl, 4.4 g trisodium citrate, and 100 ml 
deionized water at pH 7.2. A modified SSC solution [designated SSC(2)] was 
required for DNA hybridization studies. SSC(2) consisted of 8.76 g (0.15 
M) NaCl, 4.4 g (0.015 M) sodium citrate, and 1000 ml deionized water at pH 
7.0. For denaturing proteins when extracting chromosomal DNA, phenol was 
distilled under N2, and was saturated with 0.01 M Tris on the day of use. 
The Tris-maleate buffer, used for competent-cell transformation of S. 
aureus. consisted of 0.1 M mono-Tris(hydroxymethyl)aminoethane maleate 
(Tris-maleate; Sigma) in deionized water at pH 7.0. 
Protoplast plasraid transformations were performed in SMMP, which 
consisted of 2X SMM combined with an equal volume of 4X Penassay broth. 
The SMM solution was composed of 0.5 M sucrose, 0.02 M maleic acid (Eastman 
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Kodak Co., Rochester, NY), and 0.02 M MgCl2, all at pH 6.5 in dH20. 
Polyethylene glycol (PEG) 40% (w/v) of molecular weight 6,000 was used in 
protoplast plasmid transformation experiments; the PEG solution was 
filter-sterilized, placed in 10-ml aliquots in 18 x 150-mra screw-capped 
test tubes, and stored at -70 C. An agar overlay (4 ml) was used to apply 
the selective agent to either DM3 medium or R agar for some experiments. 
The agar overlay, as modified from Novick (1963), consisted of 0,5 M sodium 
succinate, 0.02 M MgCl2, 0.08% BSA, 0.05 M beta-glycerol phosphate, 1.0% 
tryptone, 1.0% yeast extract, 0.5% NaCl, 0.5% glucose, 0.1% casamino acids, 
0.012% MgSO^, 20 ul trace metals, and 4 g agar per liter. The BSA was 
sterilized by filtration, and the beta-glycerol phosphate was sterilized in 
an autoclave; both were added separately to the other already sterilized 
components. The trace metals solution contained 0.5% (w/v) CuSO^, 0.5% 
(w/v) ZnS04, 0.5% (w/v) FeSOt, 0.2% (w/v) MnCl2, in 10% (v/v) HCl. 
For extracting plasmid DNA, the SLS-NaOH solution utilized to effect 
cell lysis consisted of 1% SLS in 0.2 N NaOH. The neutralizing solution of 
potassium acetate (KAc; 3 M potassium-5 M acetate) was prepared as follows; 
60 ml of 5 M KAc (Mallinckrodt Chemical Works, St. Louis, MO), 11.5 ml of 
glacial acetic acid, and 28.5 ml of deionized water were mixed, and the pH 
was adjusted to 4.8. Both of the above solutions were prepared fresh on 
the day of use; the SLS-NaOH solution was prepared from stock solutions of 
20% SLS (in deionized water) and 10 N NaOH. For the rapid preparation 
methods for isolating plasmid DNA, phenol was prepared and stored as 
described in Maniatis et al. (1982): phenol was distilled under N2, and 
8-Hydroxyquinoline (Fisher Scientific Co.) was added at a concentration of 
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0.1%. The mixture was extracted several times with equal volumes of 1.0 M 
Tris (pH 8.0), followed by 0.1 M Tris (pH 8.0) plus 0.2% 
beta-mercaptoethanol (Sigma). The phenol was stored for periods of up to 
one month at 4 C saturated in equilibration buffer. 
Restriction endonucleases were purchased from Bethesda Research 
Laboratories (BRL; Gaithersburg, MD). A molecular weight standard for 
estimating the concentration and size of DNA fragments following agarose 
gel electrophoresis, Hindlll-cut lambda DNA., was purchased from New England 
Biolabs, Beverly, MA. T4 deoxyribonucleic acid ligase (T4 DNA ligase), 
calf intestinal alkaline phosphatase (CIP), and dithiothreitol (DTT) were 
purchased from Sigma. Adenosine 5'-triphosphate [dipotassium salt] (ATP) 
and spermidine, generous gifts from Dr. Robert A. Andrews, were also 
purchased from Sigma. 
Plasmid DNAs were dissolved, diluted, and stored in TE buffer [10 mM 
Tris, 1 mM EDTA, pH 8.0]. Aliquots of 1-ml and/or 0.1-ml were placed in 
1.5 ml Eppendorf polypropylene micro test tubes (Eppendorf tubes; Brinkman 
Instruments Co., Westbury, NY), and held at either -70 C for long-term 
storage (periods exceeding three months), or at 4 C for short-term storage. 
For purification and/or concentration, plasmid DNAs were precipitated as 
follows: the volume of DNA was estimated, and the concentration of 
monovalent cations was adjusted by the addition of sufficient 3 M sodium 
acetate to attain a final concentration of about 0.25 M. To provide a 
matrix to aid in the precipitation of DNA, 1 ul of a tRNA solution (Sigma; 
10 mg/ml in dH20) was added per ml of DNA dissolved in TE buffer. For 
small volumes (less than 1.5 ml), it was most convenient to perform the 
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entire procedure in a single Eppendorf tube. For larger volumes, the 
precipitation was performed in 50-ml centrifuge tubes (Nalge Company, 
Rochester, NY). After the addition of a 2X volume of cold (-20 C) 95% 
ethanol, the solution was mixed thoroughly, and placed at -20 C for 45 min, 
followed by an additional 15 min incubation at -70 C. Alternatively, the 
solution was held at -20 C overnight. The DNA was harvested by 
centrifugation for at least 30 min at 4 C in either a Micro-Centaur micro 
centrifuge (maximum speed - 11,600 x g; MSE Scientific Instruments, Suffex, 
England), or a Beckman Model J2-21 centrifuge (10,000 x g; Beckman 
Instruments, Inc., Palo Alto, CA). The resulting pellet was washed once in 
1 to 5 ml of cold (4 C) 70% ethanol, and the residual ethanol was removed 
by evaporation on a Savant Speed Vac Concentrator (Model SVC-IOOH, Savant 
Instruments Inc., Hicksville, L.I., NY). The DNA was resuspended in a 
minimal (about one-tenth original volume) amount of TE buffer, held at 35 C 
for about 10 min to assist in dissolving the pellet, and stored as 
described above. 
Plasmid and phage lambda DNAs were analyzed via agarose-gel 
electrophoresis by using either a horizontal-bed Wide Mini-Sub Cell 
(mini-gel, 15 x 10 cm tray), or a horizontal-bed DNA Sub-Cell (medium gel, 
15 X 20 cm tray; or long gel, 15 x 25 cm tray) electrophoresis system with 
1.5 mm-wide 10, 15, or 20 well combs, or a 2-well prep comb. All 
electrophoresis equipment was purchased from Bio-Rad Laboratories, 
Richmond, CA. DNA samples (5 to 500 ul) were applied to gels of 0.7 to 
1.2% (w/v) Seakem HGT agarose (FMC Corporation, Rockland, ME) or Bio-Rad 
Ultra Pure DNA Grade agarose (Bio-Rad Laboratories), and fractionated by 
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electrophoresis in Tris-borate electrophoresis running buffer (TBERB: 89 niM 
Tris, 89 mM Boric acid, 2.5 mM EDTA) at 3 to 8 volts per cm (constant 
voltage). To facilitate the loading and to approximate the migration of 
DNA samples for electrophoresis, a 0.25 volume of tracking dye (0.1% 
Brom-phenol-blue in 33% glycerol, and 66% TBERB) was added to each sample. 
After electrophoresis, the gels were stained for approximately 25 min in 
TBERB containing ethidium bromide (EtBr; Calbiochem-Behring Corp., La 
Jolla, CA; 1 ug/ml in dH20). The DNA bands were visualized on a short-wave 
UV transilluminator (Model LJS-671-500FG, La Jolla Scientific Co. Inc., La 
Jolla, CA), and photographed with a Polaroid MP-4 Land Camera (Polaroid 
Corporation, Cambridge, MA), using either Polaroid type 55 P/N or type 57 
film and a Wratten #29 gelatin filter (Eastman Kodak Co.). Some gels were 
also photographed by using 35 mm Plus-X Pan Film (Eastman Kodak Co.) and a 
Pentax KlOOO SE camera (Asahi Optical Co., Japan) fitted with a Wratten #29 
gelatin filter. 
The customized molecular cloning buffers described below were 
prepared, with minor modifications, as described in Maniatis et al. (1982). 
All buffers were prepared at lOX concentration in deionized water, and 
stored in aliquots of 100 and/or 1000 ul at -20 C for long-term storage 
(periods exceeding one month), or at 4 C for short-term storage. For 
digesting DNA with restriction endonucleases, the following restriction 
endonuclease buffers (REB) were prepared: high-salt REB solution (10 mM 
DTT, 60 mM MgCl2, 600 mM NaCl, and 1 M Tris-HCl, all at pH 7.5), and 
medium-salt REB solution (10 mM DTT, 60 mM MgCl2, 600 mM NaCl, and 60 mM 
Tris-HCl, pH 7.4). In later experiments, DNAs were digested in REB buffer 
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provided by the supplier of the restriction enzyme (BRL). Two buffers, CIP 
and STE, were required for dephosphorylating (with calf intestinal alkaline 
phosphatase) the 5' terminal phosphates from restriction endonuclease 
digested vector DNA to preclude intra-molecular reannealing. Ammonium 
sulfate was removed from CIP by centrifugation (11,000 x g, 1 min, 4 C); 
CIP was redissolved in sterile dH20 and stored at 4 C for up to one month. 
The CIP buffer used in this study contained 1 mM ZnCl2, 10 mM MgCl2, 10 mM 
spermidine, and 500 mM Tris-HCl, with the pH adjusted to 9.0. The ZnCl2 
and spermidine were prepared fresh at concentrations of 10 mM and 100 mM, 
respectively, and were diluted for use by addition to the other CIP-buffer 
reagents. The formulation for STE buffer was 0.01 M EDTA, 0.1 M Tris-HCl 
and 1 M NaCl, pH 8.0, The ligation buffer used in this study consisted of 
7,5 ul of ATP (1,5 mM), 7.5 ul DTT (50 mM), 11.5 ul of sterile dH20, and 
22.5 ul of a solution containing Tris-HCl (0.23 M), MgCl2(30 mM), and BSA 
(500 ug/ml; filter sterilized)." 
Plasmid DNA Extraction 
Extraction of E. coli plasmid DNA 
Plasmid DNAs were extracted from E. coli by using a procedure modified 
from Maniatis et al. (1982). A 100-ml volume of LB medium in a 300-ml 
flask was inoculated with a loopful of cells from a fresh 18 x 150 mm BHI 
agar slant culture of an E. coli strain containing pJHlOl, or a derivative 
of pJHlOl. After overnight incubation in the presence of 30 ug of 
ampicillin per ml at 35 C with shaking (110 cycles/min, 3.8-cm strokes), 
each culture was harvested by centrifugation (10,000 x g, 30 min, 4 C), and 
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washed once with IX STE (20 ml). The resulting pellet was resuspended in 
lysis buffer (10 ml). At this point, it was often more convenient to store 
the cells in lysis buffer at -20 C (in a sterile 18 x 150 mm screw-capped 
test tube), and continue with the protocol at a later time. If frozen, the 
cells were thawed at room temperature, lysozyme (4 mg/ml) was added, and 
the mixture was held at room temperature for 10 min. Following transfer to 
a 50-ml beaker containing a 1/2-inch magnetic stir-bar, a 20-ml volume of 
SLS-NaOH solution was added gradually over a period of about 2 min with 
gentle stirring, and the mixture was allowed to incubate for 10 min on ice. 
While stirring, cold (4 C) KAc solution (15 ml) was added, and the mixture 
was placed on ice for an additional 10 min Incubation. This neutralized 
lysis mixture was transferred to one or more 50-ml screw-capped plastic 
centrifuge tubes, and pelleted at 50,000 x g for 45 min at 4 C. The 
supernatant was carefully removed and placed into 50-ml screw-capped 
plastic centrifuge tubes, to which a 0.6-ml volume of room temperature 
isopropanol was added. The tubes were gently inverted several times, and 
held at room temperature for 15 min before the DNA was harvested (10,000 x 
g, 45 min, room temperature). The pellet was washed once with 5 ml cold 
(-20 C) 70% ethanol and dried under vacuum (about 10 min). After the 
addition of 5 ml TE buffer, and a 15 min incubation at 35 C to assist in 
dissolving the pellet, the plasmid DNA was further purified by CsCl 
gradient centrifugation as described below. 
Extraction of S. aureus plasmid DNA 
Plasmid DNA was extracted from protoplasts of S. aureus by a 
modification of the Birnboim and Doly (1979) lysis by alkali procedure. A 
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100-ml volume of GL broth, plus appropriate antibiotics, was inoculated 
with cells from the strain of S. aureus from which DNA was to be extracted. 
The cells were incubated overnight with shaking as described above for an 
E. coll DNA-extraction starter-culture. For plasmid pI258, and other 
temperature-sensitive plasmids, this starter culture was incubated at 30 C 
overnight to preclude loss of the plasmid. The cells were harvested, 
washed once in 10 ml of sterile saline (3% NaCl), and the resulting pellet 
was resuspended in 10 ml SMTB. Following transfer to a 50-ml screw-capped 
Erlenmeyer flask, protoplasts were prepared as follows: a 0.45-ml volume of 
lysostaphin (1 rag/ml) was added, and the flask was extracted on a Kraft 
RD-30-18 rotor (Kraft Apparatus Inc., Mineola, NY) for 35 min at 35 C. The 
contents of the flask were harvested (2,000 x g, 10 min, room temperature) 
and the supernatant was carefully decanted, and then the protoplasts were 
gently dislodged from the walls of the.tube with the aid of a pipette while 
immersed in lysis buffer (10 ml). After transfer to a 50-ml screw-capped 
Erlenmeyer flask, a 1-ml volume of protease solution (10 mg/ml) was 
introduced, and the flask was roller extracted for 35 min at 35 C. 
Following transfer to a 50-ml beaker with a 1/2-inch magnetic stir-bar, the 
SLS-NaOH and KAc solutions were added as described above. The mixture was 
harvested (50,000 x g, 45 min, 4 C), and the supernatant was carefully 
decanted in two equal portions into 50-ml plastic centrifuge tubes. A 
0.6-ml volume of room temperature isopropanol was added to each tube, and 
the tubes were gently inverted several times and held at room temperature 
for 15 min. After harvesting the DNA by centrifugation (10,000 x g, 45 
min, room temperature), the pellets were washed once in 5-ml cold (-20 C) 
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70% ethanol. The supernatant was discarded, and the pellets were dried 
under vacuum to remove residual ethanol. The DNA was dissolved in 5 ml 
sterile TE, and then further purified by CsCl gradient centrifugation (see 
below). 
Rapid preparation of plasmid DNA from E. coli and/or S. aureus 
The following procedure, modified from Birnboim and Doly (1979) and 
described in Maniatis et al. (1982), was utilized for the detection and 
preliminary characterization of plasmid DNA from E. coli and/or S. aureus. 
It should be noted that this protocol does not yield a highly concentrated 
nor highly purified preparation of plasmid DNA; however, the DNA obtained 
can be analyzed by restriction-enzyme digestion. A loopful of cells from a 
fresh culture of each strain to be analyzed was used to inoculate 5 ml of 
LB broth (for E. coli) or 10 ml of BHI (for S^ . aureus) in an 18 x 150 mm 
screw-capped test tube. Following overnight incubation at the appropriate 
temperature in the presence of the desired selective agent(s), a 1.5-ml 
sample of each strain was transferred into an Eppendorf tube and the cells 
were sedimented (11,600 x g, 3 min, room temperature). The resulting 
pellet was resuspended in 100 ul of cold (4 C) lysis buffer containing 
either 4 mg/ml of lysozyme (E. coli). or 40 ul of lysostaphin solution (S. 
aureus). Following 60 min of incubation at room temperature to effect cell 
wall removal, 200 ul of the SLS-NaOH solution was added; the Eppendorf tube 
was inverted several times and then was placed on ice for 10 min. A 150 ul 
volume of cold (4 C) KAc solution was added, and the solution was agitated 
briefly on a vortex mixer, and returned to ice for an additional 10-min 
incubation. Cellular debris and chromosomal DNA were sedimented by 
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centrifugation (11,600 x g, 10 min, 4 C), and the plasmid-containing 
cleared-lysate (about 425 ul) was transferred to a sterile Eppendorf tube. 
A 0.5-ml volume of a 1:1 mixture of phenol and chloroform-isoamyl alcohol 
(24:1 mixture of chloroform and isoamyl alcohol) was added. After gentle 
mixing, the phases were separated by centrifugation (11,600 x g, 3 min, 
room temperature). The upper, plasmid-containing phase was transferred to 
a sterile Eppendorf tube. The DNA was precipitated with ethanol as 
described previously. The final pellet was dissolved in about 32 ul of TE 
and stored at 4 C until analyzed. 
Chromosomal DNA extraction from S. aureus protoplasts 
The protocol outlined below is a modification (Luchansky and Pattee, 
1984) of the procedure described by Stahl and Pattee (1983b) for isolating 
DNA of high molecular weight from protoplasts of S. aureus. A plate 
(containing 3 ug/ml each of gentamicin and erythromycin and 1 ug/ml of 
chloramphenicol) was streaked with a strain harboring pPQ126 and incubated 
at 30 C overnight. The growth was resuspended in 5 ml of sterile saline. 
Serial 5-fold dilutions of this suspension were made in saline, and 0.1 or 
0.25 ml aliquots of these dilutions were used to inoculate duplicate 150-ml 
volumes of BHI (containing the above concentrations of antibiotics) in 
300-ml flasks. The flasks were incubated with gentle shaking at 42 C for 
about 16 h, and the cells were harvested (10,000 x g, 25 min, 4 C) from 
flasks of the two highest dilutions exhibiting confluent growth; each 
pellet was washed once in 10 ml of saline (3.0%). The resulting pellets 
were resuspended in 5 ml SMTB, duplicate cell suspensions were combined, 
and protoplasts were prepared as described above (see extraction of S. 
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aureus plasmid DNA). A 5-ml volume of Tris-EDTA-NaCl was added, and the 
pellet was gently dislodged from the wall of the tube with a pipette. The 
protoplast mixture was transferred to a 50-ml screw-capped Erlenmeyer 
flask. Following the addition of 0.5 ml of DNase-free RNase, the 
suspension was incubated at 35 C without shaking for 60 min. Protease (1 
ml) was added, and the flask was placed at 35 C for an additional 60 min 
without shaking. The flask received 0.6 ml SLS-ethanol, and the mixture 
was shaken vigorously by hand for 1.5 min. Following the introduction of 6 
ml of phenol, the contents of the flask were swirled gently, and the 
mixture was roller extracted for 5 min at room temperature. The phases 
were separated by centrifugation (10,000 x g, 45 min, 4 C), and the upper 
DNA-containing phase was transferred to a 50-ml screw-capped Erlenmeyer 
flask1 The DNA was precipitated by the addition of two volumes of cold 
(-20 C) 95% ethanol, plus sufficient 3 M sodium acetate to attain a final 
concentration of 0.25 M. The DNA was then spooled onto a glass rod, placed 
in fresh cold (4 C) 95% ethanol, and held at 4 C overnight. The DNA was 
aseptically transferred to a test tube containing 3.5 ml of sterile SSC, 
and stored at 4 C for at least 72 h prior to use. 
CsCl Equilibrium Density Centrifugation 
Plasmid DNA was separated from contaminating chromosomal DNA and 
cellular debris by cesium chloride (CsCl) equilibrium density 
centrifugation, essentially as described in Maniatis et al. (1982). 4.5 
grams of solid CsCl (Boehringer Mannheim GmbH, West Germany) and 425 ul of 
ethidium bromide 10 mg/ml in H2O were added to 4.5 ml of a 
plasmid-containing lysate. The mixture was placed in polyallomer 
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quick-seal centrifuge tubes (13 x 51 mm; Beckman Instruments, Inc.) in a 
VTi65 rotor. After centrifugation at 45,000 rpm for 24 h at 25 C in a 
Beckman Model LB-70 (Beckman Instruments Inc.) ultracentrifuge, the maximum 
density of the cesium gradient was about 1.55 g/ml. Following 
centrifugation, DNA bands were visualized under short-wave UV light, and 
removed by using a syringe fitted with an 18-gauge needle. EtBr was 
removed from the DNA by several extractions with either room temperature 
isopropanol saturated with 5 M NaCl or a room temperature mixture (1:1) of 
1-butanol and water. CsCl was removed by dialysis against four 2-liter 
changes of TE buffer over 30 h at 4 C. Plasmid DNA was concentrated by 
ethanol precipitation. The resulting pellet was resuspended in sterile TE 
buffer and stored as described previously. 
Molecular Cloning 
Restriction endonuclease digestion of DNA 
DNAs were digested with restriction endonucleases essentially as 
described in Maniatis et al. (1982): a sample of DNA contained in 20 to 30 
ul of REB buffer was exposed to 5 to 10 units (U) of restriction 
endonuclease per ug of DNA to be digested, REB buffers were used at a 
sufficient volume to produce a final concentration of IX. Reaction 
mixtures were incubated at 37 C for approximately 1.5 h, before more (one-
half dose) enzyme was added. Following an additional 1.5 h incubation at 
37 C, the digestion was stopped by placing the reaction mixture at 67 C for 
about 9 min. The digested DNA samples were either loaded directly onto 
agarose gels or stored at 4 C until utilized. If stored at 4 C, the DNA 
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was incubated at 67 C for 10 min prior to analysis by agarose-gel 
electrophoresis. 
Dephosphorvlation of vector DNA with CIP 
The terminal 5' phosphates on the ends of restriction endonuclease-
digested vector DNA (e.g., pJHlOl or pTVl^ -g) were removed by treatment with 
calf intestinal phosphatase (CIP). The procedure was performed, with 
slight modification, as described in Maniatis et al. (1982). Between 1 and 
25 ug of digested vector DNA was precipitated with ethanol. The resulting 
pellet was resuspended in a nominal volume (10 to 30 ul) of 10 mM Tris-HCl 
(pH 8.0); 5 ul of lOX CIP buffer and sufficient sterile dH20 were added to 
bring the total volume to 50 ul. Approximately 0.01 units of CIP were then 
added per pmole of 5' ends of vector DNA, and the reaction mixture was 
incubated at 37 C for 30 min. A second aliquot of CIP was introduced, and 
the mixture was returned to 37 C for an additional 30 min incubation. 
After adding 40 ul of sterile dH20, 10 ul of lOX STE, and 5 ul of 10% SLS, 
the reaction was terminated by placing the mixture at 68 C for 15 min. The 
CIP-treated DNA was precipitated with ethanol, resuspended in TE buffer, 
and stored as previously described. 
Isolation of a restriction fragment from agarose bv electroelution 
Plasmid DNAs were digested with restriction endonuclease(s) as 
described above, and loaded onto a 1.0% agarose gel fitted with the prep 
comb. Following exposure to 80 volts constant current for 2.25 h, the gel 
was stained (see above), and the bands visualized under short-wave UV 
light. The fragment(s) of interest was excised from the gel with a 
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razor-blade and forceps. The gel slice was transferred into Spectraphor 
dialysis tubing (MW cutoff 12,000 to 14,000; Spectrum Medical Industries, 
Inc., Los Angeles, CA) containing a nominal volume of 0.IX TBERB, and the 
DNA was eluted from the agarose gel slice by applying a current of 250 
volts for 1.5 h. The polarity of the current was reversed for 
approximately 30 sec, and the fluid within the tubing was carefully 
transferred into a sterile Eppendorf tube containing siliconized glass 
wool. A small hole was made in the bottom of the tube, and the entire tube 
was placed inside a 17 x 100 mm Falcon tube (Falcon, Oxnard, CA). Residual 
chunks of agarose were removed by forcing the solution through the glass 
wool via centrifugation (2,000 x g, 4 min, room temperature). The eluate 
collected in the Falcon tube was transferred to a sterile Eppendorf tube, 
and the DNA was precipitated and stored as described above. 
Ligation of plasmid DNAs with T4 DNA ligase 
The ligation procedure utilized in this study was modified from a 
procedure described by Macrina et al. (1980). A 50-ul volume of 
restriction endonuclease-digested, CIP-treated vector DNA plus restriction 
endonuclease-digested passenger DNA was mixed with 50 ul of ligation 
buffer. The total concentration of DNA was approximately 1 ug, and the 
ratio of complementary ends of passenger DNA to ends of vector DNA was 
about 50 to 1. T4 DNA ligase (100 U/ml) was added, and the mixture was 
held at 15 C for 15 h. The DNA was precipitated with ethanol. The pellet 
was resuspended in SSC-CaCl2 (IX SSC plus 0.1 M CaCl2) or TE buffer, and 
used directly for transformation of either E. coli or S. aureus. 
respectively. 
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Transfer of DNA from agarose to nvlon membranes and detection of specific 
sequences via DNA hybridization 
Chromosomal and plasmid DNAs were purified by GsCl-gradient 
centrifugation, digested with a restriction endonuclease(s), and 
fractionated by agarose-gel electrophoresis. Lambda DNA was digested with 
Hindlll or PstI and included on all gels as a molecular weight standard and 
as a negative control for hybridizations. After the DNA was stained and 
photographed, the gel was incubated with gentle shaking at room temperature 
while submerged successively in depurination (0.25 M HCl), denaturation 
(0.5 M NaOH, 1.5 M NaCl), and neutralization (0.5 M Tris-HCl pH 8.0, 1.5 M 
NaCl) solutions for 8 min, 45 min, and 90 min, respectively. A sheet of 
Magnagraph (biochemically optimized nylon solid support membrane; Micron 
Separations Inc., Honeoye Falls, NY) was cut to the exact size of the gel, 
and both the membrane and gel were allowed to equilibrate for about 5 min 
in Tris-acetate buffer [(TAE); 0.04 M Tris -acetate, 0.002 M EDTA, pH 8.0]. 
The DNA was then transferred from agarose to Magnagraph using a Hoefer 
Scientific Instruments (HSI; San Francisco, CA) electroblot apparatus. 
Briefly, the membrane and gel were juxtaposed within a specialized cassette 
and placed into the HSI Transphor (TE 42) tank. Fragments of DNA were 
transferred from agarose to Magnagraph using TAE buffer (room temperature) 
at 400 milliamps (less than 10 volts) for 150 min. Upon completion of the 
transfer, the membrane was rinsed briefly in 2X SSC(2) and baked under 
vacuum at 80 C for 2 to 4 h. The baked membrane was stored at 4 C in a 
Micro-Seal sealable pouch (model 6011; Dazey Corporation, Industrial 
Airport, KS) until utilized. 
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DNA was labeled with alpha ^2[P]-dCTP by nick translation using a nick 
translation kit purchased from BRL. Labeled DNA was separated from 
unincorporated nucleotides by ethanol precipitation. Ethanol precipitation 
was performed as described previously, except one-half volume of 7,5 M 
ammonium acetate was substituted for sodium acetate. The labeled DNA was 
denatured by boiling for 10 min and added to the hybridization solution at 
a specific activity of about 10^ cpm/ug with a final probe concentration of 
25 to 50 ng/ml. 
The following solution (excluding probe) was used for both 
prehybridization and hybridization at 100 ul/cm^ membrane and 50 ul/cm^ 
membrane, respectively: 6X SSC(2), 50% deionized formamide, 0.2% bovine 
serum albumin, 0.2% ficoll (molecular weight 400,000), 0.2% polyvinyl-
pyrrolidine, 1.0% SLS, and 50 ug/ml of denatured salmon sperm DNA. The 
prehybridization solution was added to the Micro-Seal pouch and incubated 
at 42 C with constant agitation for at least 8 h. After prehybridization, 
the solution within the pouch was discarded, and hybridization solution and 
denatured radioactive probe were added and the mixture was incubated at 42 
C with constant agitation for an additional 16 to 30 h. Following 
hybridization, the solution was discarded and the membrane was washed 
successively in three different solutions to remove unbound and 
nonspecifically bound radioactive probe using an Omniblot processing system 
(American Bionetics Inc., Emeryville, CA). The wash solutions were: lOX 
SSC(2), 0.01% SLS (wash 1); IX SSC(2), 1% SLS (wash 2); and O.IX SSC(2), 
0.1% SLS (wash 3). Wash solution 2 was used at 37 C, and wash solutions 1 
and 3 were utilized at room temperature. The Omniblot system was operated 
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with a flowrate of about 50 ml/min, and each wash cycle was 5 to 10 rain in 
length (total volume of 250 to 500 ml for each wash solution). Following 
the wash regimen, the membrane was removed from the Omniblot bag and 
wrapped in plastic. DNA fragments that hybridized to the probe were 
visualized by autoradiography following exposure to Kodak X-Omat X-Ray film 
for 1 to 3 days. The film cassette was placed at -70 C because a Cronex 
intensifying screen (Dupont) was used to enhance the intensity of the 
autoradiogram and/or to minimize the time required for exposure. The X-Ray 
film was developed in Kodak GBX developer. 
Competent-Cell Transformations 
E. coll competent-cell transformation 
A modification of the procedure of Dagert and Ehrlich (1979) was used 
to transform E. coli with plasmid DNAs. The cells from an overnight BHI 
agar slant (18 x 150 mm) culture of the E. coli strain to be transformed 
were suspended in sterile saline; 2 ml of the cell suspension were used to 
inoculate a 100 ml-volume of LB broth. This flask was incubated with 
shaking at 35 C until an optical density at 540 nm [0.0.(540)] of 0.45 was 
attained. After being held on ice for 25 rain, the cells were harvested 
(10,000 X g, 30 rain, 4 C), and the resulting pellet was resuspended in 50 
ml of sterile 0.1 M MgCl2. The cells were sedimented again (10,000 x g, 15 
min, 4 C). The pellet was resuspended in 5 ml of sterile 0.1 M CaCl2 and 
held at 4 C for between 16 and 24 h. A 200-ul volume of competent cells 
was added to an Eppendorf tube containing either 100 ul (about 50 to 150 
ng) of plasmid DNA dissolved in SSC-CaCl2 (experimental), or 100 ul 
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SSC-CaCl2 (cell control tube). Following a brief heat-shock treatment (43 
C for 2 min), the tubes were returned to ice for 30 min. The contents of 
each tube were diluted to 1 ml with LB broth and placed at 37 C for 60 min. 
0.1-ml aliquots (with prior dilution) were plated onto selective media. 
Colony-forming units (cfu) were assayed by spreading diluted samples of the 
control tube onto duplicate LB agar plates. The reversion frequency was 
determined by plating 0.1-ml aliquots of the undiluted cell control onto 
selective media. All plates were incubated at 35 C for about 25 h. 
Colonies were counted, and plates with transformants were replicated onto 
appropriate media to score unselected markers. After incubation of the 
replica plates for about 30 h at 35 C, they were scored. 
S. aureus competent-cell transformation 
Recipient cells for competent-cell transformation of S. aureus were 
prepared essentially as described by Pattee and Neveln (1975) and Stahl and 
Pattee (1983b). Cells from an overnight BHI agar slant (18 x 150 mm) 
culture of the recipient strain were suspended in sterile saline (0.85%), 
and used to inoculate a 100-ml volume of Oxoid TSB to an O.D.(540) of 0.1. 
Ten ml of this suspension were added to each of six 300-ml nephelometer 
flasks, each containing 100 ml of Oxoid TSB plus 1 mM CaCl2. The flasks 
were incubated with gentle shaking at 35 C until an O.D.^g^Q) of 0.05 was 
attained. After the addition of 1 ml of normal rabbit serum (Pel-Freez 
Biologicals, Rogers, AZ) to each flask, the cells were returned to 35 C 
until an 0.0.(549) of 0.1 was reached. The cells from the six flasks were 
harvested (10,000 x g, 25 min, 4 C), and the resulti^ ? pellets were 
combined into 1.5 ml of TSB. TSB (0.5 ml), normal rabbit serum (1 ml), and 
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phage 55 (0.25 ml; titer — 1 to 2 x 10^^ pfu/ml) were added to the pooled 
cells. Following a 5-min incubation at 35 C with gentle shaking, the cells 
were harvested by centrifugation and washed in 9 ml of cold Tris-maleate 
buffer. The washed cells were resuspended in 6 ml of cold Tris-maleate 
buffer containing 0.1 M CaCl2, and 1-ml aliquots were added to tubes 
containing either 0.15 ml of transforming DNA (experimental) or 0.15 ml of 
SSC (control). The tubes were mixed gently and were held for 3 min at 4 C 
and then 3 min at 35 C with gentle shaking. The cells were harvested by 
centrifugation. The resulting pellets were resuspended in 3 ml of BHI 
containing 2 mM sodium citrate; the mixture was incubated for 1 h at 35 C 
with gentle shaking. When appropriate, 0.1 ug/ml of either erythromycin or 
chloramphenicol was added to a mixture to induce certain genes (e.g., erm 
of Tn917. or cat of pC194). The cells were harvested by centrifugation. 
Each pellet was resuspended in X ml of sterile saline (0.85%). 0.1-ml 
aliquots of the control and experimental suspensions (without prior 
dilution) were spread onto the appropriate selective media. Diluted 
samples (0.1 ml) of the control suspension were also spread in duplicate 
onto BHI agar plates to determine total cfu. After incubation of the 
plates at 35 C for approximately 40 h, colonies were counted and the 
transformants were replica-plated onto appropriate media to score for 
unselected markers. Replica plates were scored following 30 h of 
incubation at 35 C. 
Protoplast Plasmid Transformation 
The protoplast plasmid transformation protocol for S. aureus described 
below is a modification of the Chang and Cohen (1979) procedure for 
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transforming protoplasts of B. subtilis with plasmid DNA. Cells of a 
recipient strain, grown overnight on an 18 x 150 mm BHI agar slant culture 
at 35 C, were uniformly suspended in 5 ml of sterile saline. A sufficient 
volume of this suspension was used to inoculate a 300-ml nephelometer flask 
containing 100 ml of Penassay broth to an 0.0.(540) of 0.04. The flask was 
incubated at 35 C with shaking until an 0.0.(540) of 0.62 was attained. 
The cells were harvested by centrifugation (10,000 x g, 25 min, 4 C), and 
the pellet was washed once with 10 ml of 3% NaCl. A 10-ml volume of SMTB 
was added to resuspend the resulting pellet, and the suspension was 
transferred to a 50-ml screw-capped Erlenmeyer flask. Following the 
addition of 0.45 ml of lysostaphin solution, the mixture was extracted on a 
roller apparatus for 45 min at 35 C. The mixture was transferred to a 
50-ml plastic centrifuge tube, and the protoplasts were pelleted by 
centrifugation (2,000 x g, 15 min, 4 C). SMMP (5 ml) was added, and the 
pellets were gently dislodged from the walls of the tube with the aid of a 
pipette. The protoplasts were again sedimented by centrifugation (1,000 x 
g, 6 min, 4 C). The pellet was resuspended in 2 ml of SMMP. An aliquot of 
the protoplast suspension was diluted in SMMP. Various dilutions were 
plated in duplicate onto TSA and 0M3 and/or R agar to determine 
non-protoplasted units and regeneration frequency, respectively. 
Plasmid DNA (0.5 to 2 ug, usually in a volume of 100 ul) was mixed 
with an equal volume of 2X SMM in a sterile 50-ml plastic centrifuge tube 
(experimental). A control tube, containing 2X SMM and an equal volume of 
TE buffer, was also prepared. A 0.5-ml volume of the protoplast suspension 
was added to each tube, usually followed immediately by the addition of 1.5 
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ml of PEG. In some experiments, the protoplasts were incubated at 56 C for 
45 seconds before addition to the DNA/SMM solution. The tubes were slowly 
inverted for 3 to 4 min, and then 5 ml of SMMP were added to each tube. 
After inverting the tube 2 or 3 times, the solution was harvested (1,000 x 
g, 6 min, 4 C), The resulting pellets were carefully removed from the 
walls of the tube with the aid of a pipette while immersed in SMMP (1 ml). 
The protoplast-DNA mixture was either plated immediately (plating method 
1), or allowed to incubate for 3.5 h at 30 C without shaking before plating 
(plating method 2). The protoplast-DNA mixture was plated onto DM3 medium 
or R agar that either directly contained the selective agent, or was 
supplied with the selective agent via an agar overlay. In some 
experiments, the protoplast-DNA mixture was incubated in the presence of 
low levels of the selective agent (0.1 ug/ml) during thé 3.5-h incubation 
at 30 C, to induce enzyme formation. Protoplasts were plated with and 
without dilution onto selective media, and were incubated at high humidity 
for 5 to 10 days at 30 C. Selective levels of antibiotics were 3 or 10 
ug/ml for chloramphenicol, and 1 or 1.5 ug/ml for erythromycin. The 
presence of plasmid-containing transformants was verified by their 
resistance to higher concentrations of antibiotic, and by the subsequent 
isolation of plasmid DNA via rapid preparation methods. 
Transduction 
The phage phill lysate used for all transduction experiments was 
prepared as described previously (Schroeder and Pattee, 1984). 
Transductions were performed by using the procedure described by Kasatiya 
and Baldwin (1967), as modified by Schroeder and Pattee (1984), Cells from 
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an overnight BHI agar slant (18 x 150 mm) culture of the recipient strain 
were harvested into 1 ml of TSB. Aliquots of 0.5 ml (between 1 and 5 x 
lO^ O cfu) were transferred to two 15-ml Corex centrifuge tubes. Sufficient 
transducing lysate (usually 0.25 to 0.5 ml) was added to the experimental 
tube to obtain a multiplicity of infection (moi) of one. The volumes of 
the experimental and control tubes were brought to 2 ml with TSB containing 
5 mM CaCl2. The contents of the tubes were separately mixed and incubated 
with vigorous shaking at 30 C for 20 min. After the addition of 1 ml of 
cold (4 C) 20 mM sodium citrate to each tube, the cells were harvested by 
centrifugation. Each pellet was resuspended in 1 ml of cold (4 C) 20 mM 
sodium citrate. Aliquots (0.1 ml) were spread onto the appropriate 
selective media. Diluted samples (0.1 ml) from the control suspension were 
spread in duplicate onto BHI agar plates to determine total cfu. All 
plates were incubated at 30 C for 40 h before colonies were counted, and 
transductants were replica plated onto appropriate media to score for 
unselected markers. After incubating for approximately 30 h at 30 C, the 
replica plates were scored. 
Flasmid Elimination Experiment 
Bacteria carrying a temperature-sensitive plasmid were incubated on 
agar plates with appropriate selection for about 30 h at 30 C. A 5-ml 
volume of sterile saline (0.85%) was poured onto the plates, and the cells 
were removed from the surface of the plates by using a glass spreader 
(usually 1 to 5 X 10^® cfu/ml). After brief mixing, serial 10-fold 
dilutions were made in saline, and the cells were plated onto agar plates 
with and without antibiotics. Duplicate plates of each dilution were 
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Incubated at 30 C and 39 and/or 43 C. Several isolates from plates 
incubated at each temperature were analyzed for the presence or absence of 
plasmid DNA by scoring for unselected plasmid markers, and by the isolation 
of plasmid DNA with the rapid preparation method. 
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RESULTS 
Preliminary Observations 
The aim of this project was to construct and employ an integrable 
plasmid to facilitate the genomic analysis of S. aureus NCTC 8325. Because 
several well-characterized B. subtilis insertion vehicles were already 
available (Ferrari et al., 1983; Haldenwang et al., 1980; Niaudet et al., 
1982; Saunders et al., 1984a), attempts were made to adapt an established 
Gram-positive insertion vector (pJHlOl) for use in S. aureus. A portion of 
Tn551 was cloned onto pJHlOl (-plasmid pLUCH3) to extend the utility of 
this vector: plasmid integration directed into any region of the chromosome 
containing an insertion of Tn551. For several reasons, most notably the 
reliance on resistance to chloramphenicol to select for plasmid 
integration, it was not possible to recover chromosomal insertions of 
pLUCH3 in S. aureus. The efforts to adapt pLUCH3 for use in S. aureus are 
summarized below, because many of these early results contributed to the 
strategy used to construct a novel S. aureus plasmid insertion vector, 
pPQ126. 
Restriction endonuclease characterization of pJHlOl and t)I258 
Before using pJHlOl and pI258 in molecular cloning experiments, it was 
necessary to digest both plasmids with restriction enzymes to verify the 
presence of certain cleavage sites. Figure 6 contains the EcoRI and 
HindiII restriction endonuclease analyses of pJHlOl and pI258. Lanes 1 and 
2 contain pJHlOl linearized with EcoRI and Hindlll. respectively: the 
single band in each lane was the expected result for EcoRI or 
Figure 6. EcoRI and HindiII restriction analyses of CsCl-purified 
plasmids pJHlOl and pI258 
Lane 1, EçoRI-digested pJHlOl; lane 2, HindIII-disested 
pJHlOl; lane 3, HindIII-digested lambda standard (0.35 ug 
total); lane 4, HindIII-digested pI258; lane 5, EçoRI-digested 
pI258. 
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HindIII-digested pJHlOl based on the restriction map for pJHlOl published 
by Ferrari et al. (1983). The four distinct bands visible in lane 5 
following digestion of plasmid pI258 with EcoRI compare exactly with the 
EcoRI-digestion pattern for pI258 published by Novick et al. (1979b). The 
HindiII restriction endonuclease analysis of pI258 (lane 4) shows the 
presence of 13 distinct bands, and perhaps an additional fragment faintly 
visible below the 0.6 kb band of HindllI-digested lambda DNA. Wilson and 
Baldwin (1978) reported a total of 11 fragments following digestion of 
plasmid pI258 with HindiII. The pattern of the first 11 fragments (HinA to 
HinK) compares favorably with the HinA through HinK fragments published by 
Wilson and Baldwin (1978). Two plausible explanations could account for 
the absence of the HinL. M, and N fragments from the work of Wilson and 
Baldwin; 1) not enough DNA was loaded onto the gel for these bands to be 
visualized; and/or 2) plasmid pI258 was not completely digested, and the 
three smaller bands remained associated with higher molecular weight DNA. 
Either or both of the above possibilities could account for the 
discrepancy. 
Molecular cloning of the ervthromvcin-resistance determinant from plasmid 
91258 into the Hindlll site of pJHlOl 
The ermB determinant (of transposon Tn551) was reported to reside on a 
2.8-md fragment of Hindlll-digested pI258 (Wilson and Baldwin, 1978). One 
objective of this study was to clone the erythromycin resistance 
determinant of pI258 onto an insertion vector. The results of two 
different approaches to accomplish this goal are described below. 
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The first approach was to "shotgun" clone the erythromycin resistance 
determinant of pI258 onto the insertion plasmid pJHlOl. Both pI258 and 
pJHlOl were digested with Hindlll: the resulting fragments were ligated and 
transformed into competent cells of E. coli strain HBlOl, as described 
previously. Among the ampicillin-resistant transformants generated in this 
manner, it seemed probable that the 2.8-md HinB fragment would be present 
in at least one clone. Several phenotypic (Am^ Cm^ Tc®) insert-containing 
clones were obtained (data not shown). Each isolate was streaked for 
isolation, and a single colony of each was retained for further study. 
Plasmid DNA was extracted from each isolate by the rapid preparation 
method, digested with Hindlll. and subjected to electrophoretic analysis. 
Of all the presumptive insert-containing isolates tested (data not shown), 
only one isolate (JBL6) contained a segment of S. aureus passenger DNA. 
Analysis of DNA isolated from JBL6 confirmed the presence of a recombinant 
plasmid, pL'UCH4, harboring the HlnG fragment of plasmid pI258 (see below). 
The "shotgun" approach to cloning the HinB fragment of pI258 was not 
successful. 
Next, the 2.8-md fragment of Hindlll-digested pI258 was isolated 
directly from agarose and ligated to pJHlOl to increase the probability of 
obtaining a recombinant plasmid containing the ermB gene from plasmid 
pI258. The ligation mixture of CIP-treated, Hindlll-digested pJHlOl plus 
the HinB fragment of pI258 was used to transform E. coli strain HBIOI. 
Transformants were selected for resistance to ampicillin, and then scored 
for resistance to chloramphenicol and for tetracycline sensitivity. 
Approximately 7% (7 of 105 total) of the Ap^ transformants recovered were 
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also Cm  ^and Tc®; however, two of the 7 Am^ Cm^ Tc® clones were also 
resistant to 300 ug of erythromycin per ml (data not shown). After 
selecting a single colony from each Tc® transformant from streak plates, 
all 7 Am^ Cm^ Tc® putative insert-containing clones were retained for further 
study. 
To determine if any of the AmfCm^ TcS isolates contained recombinant 
molecules, plasmid DNA was extracted from each clone. Following digestion 
of the CsCl-purified plasmid DNA with Hindlll. each of the isolates, along 
with Hindlll-cut pI258 and pJHlOl, were analyzed by agarose-gel 
electrophoresis (data not shown). Of the 7 Am^ Cm^ Tc® clones tested, only 
the two clones that were also resistant to erythromycin contained pJHlOl 
plus S. aureus passenger DNA. Figure 7 presents evidence that the 2.8 md 
HinB fragment from plasmid pI258 was cloned into the Hindlll site of 
pJHlOl. pLUCH2 (lane 9) and pLUCH3 (lane 10) each display 2 distinct bands 
following digestion with Hindlll. The larger fragment migrated to the same 
position as Hindlll-linearized pJHlOl (lane 11), and the smaller fragment 
to the same position as the HinB (ermB determinant) of Hindlll-digested 
pI258 DNA (lane 7). Figure 7 also contains results of the "shotgun" 
cloning of the HinG fragment of pI258 onto pJHlOl (— pLUCH4). By comparing 
the Hindlll-digestion pattern of pLUCH4 (lane 8) to the Hindlll patterns 
for plasmids pI258 and pJHlOl (lanes 7 and 11, respectively), pLUCH4 was 
defined as pJHlOl plus the HinG fragment of pI258. Uncut pJHlOl, pLUCH4, 
pLUCHS, and pLUCH2 are shown in lanes 2, 3, 4, and 5, respectively. The 
migration patterns of the uncut plasmids were also consistent with the size 
of the passenger DNA in pLUCH2, pLUCH3, and pLUCH4. pJHlOl, the smallest 
Figure 7. Electrophoretic analysis of CsCl-purified preparations of uncut 
and Hindlll-digested plasmids pJHlOl, pLUCH4, pLUCH3, pLUCH2, 
and pI258 
Lane 1, Hindlll-digested lambda standard (0.32 ug total); 
lane 2, uncut pJHlOl; lane 3, uncut pLUCH4; lane 4, uncut 
pLUCH3; lane 5, uncut pLUCH2; lane 6, Hindlll-digested lambda 
standard (0.32 ug total); lane 7, Hindlll-digested pI258; lane 
8, Hindlll- digested pLUCH4; lane 9, Hindlll-digested pLUCH3; 
lane 10, Hindlll-digested pLUCH2; lane 11, Hindlll-digested 
pJHlOl; lane 12, HindlIl-digested lambda standard (0.32 ug 
total). 
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plasmid, migrated farther than the next largest plasmid, pLUCH4, that 
migrated farther than pLUCH2 and pLUCH3. 
From the results presented in Figure 7, two isolates were verified to 
contain the 2.8-md fragment of plasmid pI258 cloned into the HindiII site 
of pJHlOl: JBLA contained pLUCH2 (lane 10), and JBL7 contained pLUCH3 (lane 
9). It is not precisely known why 5 of the 7 presumptive clones 
(Am^ Cm^ Tc®) did not contain inserts of S. aureus passenger DNA. Efforts 
were directed to determine the precise orientation of the HinB fragment in 
pLUCH2 and pLUCH3. Ferrari et al. (1983) determined that pJHlOl contained 
a single cleavage site for the restriction endonuclease PstI. Wilson and 
Baldwin (1978) reported that the HinB fragment from plasmid pI258 contained 
a single PstI site, positioned very near one end of the fragment. The 
digestion of pLUCH2 and pLUCH3 with PstI would be expected to yield 2 
distinct fragments for each plasmid (one PstI site each in the vector and 
passenger segments of these plasmids). Furthermore, if the HinB fragment 
were present in the same orientation in both pLUCH2 and pLUCH3, then the 
PstI restriction pattern would be identical for these two plasmids. 
Restriction endonuclease digestion of pLUGH2 and pLUGH3 with PstI generated 
the expected two fragments from each plasmid: the migration patterns were 
identical (data not presented). Because pLUCH2 and pLUCH3 both contained 
the HinB fragment in the same orientation, pLUCH3 was chosen arbitrarily 
for further study. 
Presentation of PLUCH3 to competent cells of S. aureus 
Competent cell transformation was the approach initially used in 
attempts to introduce pLUCH3 into aureus. As shown in Table 4, 
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Table 4. Transformation of strain ISP130 with chromosomal DNA from 
strain ISPlOlO and plasmid DNA from strains ISP479, ISP1213, 
JBL7, and ISP856® 
Selection for: 
Frequency" of: 
Em^ Cm^ 
Transformation 
Reversion 
197 
6 
QC 
OC 
Relevant markers 
Donors : 
Recipient: 
Em 
R 
S 
Cm 
S 
S 
Analysis of phenotypes 
of transformants: 
ISPlOlO 
Of 55 Em^ transformants 
55 (100%) R S 
Of the Cm^  transformants*^  
14 R .S 
&ISP130 8325-4 w[pI258 blaI443 asa-33 ermB20 repAl81500 pig-131 
ISPlOlO 8325 mec-4916 nov-142 troEBS ribl27 tmn3106 
uraB232::Tn551 ermB321 
ISP479 8325-4 pig-131 (pI258) 
ISP1213 E. coli MM294 (pJHlOl) 
JBL7 E. coli HBlOl (pUJCHS) 
ISP856 8325-4 (pC194). 
E^xpressed for ISPlOlO DNA as colonies recovered per 10^ cfu; 1.88 x 
10^  cfu per ml of the transformation suspension and excess ISPlOlO DNA 
were used. 
*^Lawn of cells present due to basal-level resistance of ISP130 to 
approximately 4 ug of chloramphenicol per ml. 
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Table 4 (Continued) 
Relevant markers 
Em Cm 
Donors : 
pI258 
pJHlOl 
pLUCH3 
pC194 
Recipient: 
Analysis of phenotypes 
of transformants: 
pI258d 
Of 2 Em^ transformants 
2 (100%) 
Of the Cm^  transformants^ 
1 
pJHlOld 
Of 3 Em^ transformants 
3 (100%) 
Of the Cm^  transformants^ 
2 
pLUCH3^  
Of 1 Em^ transformant 
1 (100%) 
Of the Cm^  transformants^ 
2 
pC194^  
Of 2 Em^ transformants 
2 (100%) 
Of the Cm^  transformants^ 
7 
R 
S 
R 
S 
S 
R 
S 
R 
R 
R 
S 
R 
^Approximately 10 ug of non-CsCl purified plasmid DNA was used. 
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competent cells of ISP130 were transformed with the following plasmids: 
pC194, pJHlOl, pI258, and pLUCH3. When selection was made for resistance 
to erythromycin by using chromosomal DNA (ISPlOlO), Em^ Cm® transformants 
were recovered at a frequency of 197 per 10^ cfu. The recovery of Em^ 
transformants with ISPlOlO DNA indicated that ISP130 was indeed competent 
for DNA uptake. As expected, however, it was not possible to recover any 
Cm^  transformants using ISPlOlO DNA. It should be noted, that the strains 
of S. aureus used in this study had a basal-level resistance to about 4 ug 
per ml of chloramphenicol. Although higher selective levels of 
chloramphenicol lowered the amount of background growth observed, it was 
assumed that higher levels also reduced the number of Cm^ transformants ; 
therefore, Cm^  transformants were selected on media containing 4 ug of 
chloramphenicol per ml. The background lawn was distinguished from Cm^ 
transformants by scoring for resistance to 10 ug per ml of chloramphenicol. 
Fourteen Em^ isolates were obtained with ISPlOlO DNA when selection was 
made for resistance to chloramphenicol. These Em^ isolates probably 
represent reversion of the ermB20 mutation of ISP130. It was also possible 
that recombination between the two copies of ermB (ermB327 in ISPlOlO and 
ermB20 in ISP130) produced the Em^ transformants. 
For plasmid pI258, two Em^ Cm® transformants were obtained from 
erythromycin selection plates, and one Em^ transformant was recovered from 
chloramphenicol selection plates. These Em^ transformants are probably 
spontaneous revertants of the erythromycin-sensitive mutation (ermB20) of 
Tn551 in ISP130. As shown in Table 4, similar results were also obtained 
for pJHlOl, and pLUCH3. 
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As a positive control for the selection of Cm^ transformants, pCl94 
was presented to competent cells of ISP130; only seven Cm^ Em® isolates 
were recovered. Lofdahl et al. (1978a) reported a frequency of 1000 Cm^ 
resistant transformants per 1 ug of pC194 DNA introduced to competent cells 
of S. aureus. One explanation for the low recovery of pC194 transformants, 
was that the plasmid DNA utilized for this experiment was not purified on 
CsCl (see below). It is also possible that the higher frequency observed 
by Lofdahl et al. (1978a), was a consequence of the recipient strain. 
Because of the high number of cells present, it was not surprising to 
recover two Em^ Cm® isolates on the erythromycin selection plates. 
The results in Table 4 demonstrated that competent cells of ISP130 
were not amenable to transformation with plasmid DNA; plasmid pJHlOl, 
isolated from E. coli and lacking a Gram-positive origin of replication, 
—t 
yielded about the same low number of Em^ colonies as the other plasmids 
tested. Although several additional attempts were made to transform 
competent cells of various strains of S. aureus with plasmid DNA, these 
experiments were not successful (data not shown). 
Presentation of PLUCH3 to protoplasts of S. aureus 
From the results presented in Table 4, and similar data from several 
additional experiments, it was obvious that competent cells of S. aureus 
were recalcitrant to transformation by plasmid DNA. As an alternate method 
for introducing the insertion vector pLUCHS into S. aureus. attempts were 
made to transform protoplasts with plasmid DNA. The protocol was performed 
as described previously, with the following exceptions: plasmid DNAs were 
not purified by CsCl-gradient centrifugation, and protoplasts were not 
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heated prior to the addition of plasmid DNA. 
Table 5 contains data representative of results obtained for 
introducing plasmid DNA into S. aureus protoplasts. To better compare 
protoplast to competent-cell transformation, ISP130 was used as the 
recipient for the protoplast plasmid transformation experiment in Table 5. 
Because pLUCH3 contained two Gram-positive selectable markers, it was 
possible to select for erythromycin- or chloramphenicol-resistant 
transformants. Regardless of the antibiotic used for selection, however, 
no pLUCH3 transformants of ISP130 were obtained. 
Erythromycin-resistant transformants were obtained at low frequency 
(8.6 X 10® per ug of DNA) when protoplasts of ISP130 were transformed with 
plasmid pI258 DNA. Chloramphenicol-resistant transformants were recovered 
at a frequency of 1.18 x 10^ per ug when plasmid pC194 DNA was introduced 
to protoplasts of ISP130. Plasmid pI258 (28.2 kb) is considerably larger 
than pC194 (2.9 kb), and the size differential may account in part for the 
difference in recovery of these plasmids following transformation of ISP130 
protoplasts. Upon comparison of the data in Tables 4 and 5 it was apparent 
that S_. aureus was more amenable to plasmid uptake via protoplast plasmid 
transformation than by competent-cell transformation. Nevertheless, 
neither the protoplast nor the competent-cell transformation procedures 
were successful for transferring plasmid pLUCH3 from E. coll into S. 
aureus. Based on the results of the preliminary experiments, efforts were 
directed to improve the efficiency of plasmid DNA uptake via transformation 
of S. aureus protoplasts. 
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Table 5. Transformation of protoplasts of strain ISP130 with plasmid DNA 
from strains ISP856, ISP479, ISP1213, and JBL7® 
Frequency^  of: 
Selection for: 
1 ug/ml Em 3 ug/ml Cm 
pC194 0 1.18 X 10^ 
pI258 8. , 6 X IQO QC 
pJHlOl 0 QC 
pLUCH3 0 QC 
aiSP130 8325-4 wrpI258 blaI443 asa-•33 ermB20 reT3A181500 pie-131 
ISP856 8325-4 (pC194) 
ISP479 8325-4 Die-131 fpl258^ 
ISP1213 E. coli MM294 CpJHlOl") 
JBL7 E. coli HBlOl ('pLUCH31, 
E^xpressed as protoplast plasmid transformants recovered per 1 ug of 
plasmid DNA. 
L^awn of cells present due to basal-level resistance of ISP130 to 
approximately 4 ug of chloramphenicol per ml; the lawn was sensitive to 10 
ug per ml of both erythromycin and chloramphenicol. 
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Protoplast Plasmid Transformation 
As described in the previous section, protoplast.plasmid 
transformation was a more efficient method, compared to competent cell 
transformation, for introducing plasmid DNA into S,. aureus. Efforts were 
directed, therefore, to optimize the conditions for protoplast plasmid 
transformation to increase the frequency of plasmid uptake. The 
experimental parameters of the protoplast plasmid transformation procedure 
examined were: conditions for plating; regeneration media used for 
selection of plasmid-containing transformants; quality of plasmid DNA (CsCl 
purified vs non-CsCl purified DNA); induction of plasmid-borne inducible 
resistance determinants; and heat treatment of protoplasts prior to the 
addition of DNA. 
Lindberg vs Stahl and Pattee protocol for preparing 
and plating protoplasts 
The preparation of S. aureus protoplasts, plating conditions, and 
regeneration media, were investigated by using either the Lindberg (1981) 
and/or the Stahl and Pattee (1983a) methods for handling protoplasts. 
Several aspects of these procedures are variations of the Chang and Cohen 
(1979) protocol for transforming B. subtilis protoplasts with plasmid DNA. 
Parameters were compared between both methods to determine the combination 
resulting in the highest frequency for plasmid transformation. 
Several attempts were made to prepare protoplasts of S. aureus as 
described by Lindberg (1981), but these efforts were not successful. 
Colonies were obtained from control plates for total cfu, non-protoplasted 
units, and total protoplasts (on both DM3 and R-agar); however, plasmid 
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transformants were not recovered from the experimental plates when the 
Lindberg method was used for preparing protoplasts (data not shown). One 
explanation for the failure to recover transformants was the low efficiency 
of protoplast formation: of approximately 10^ cfu, only about 10^  
regenerated protoplasts were obtained from control plates (data not shown). 
The paucity of regenerated protoplasts precluded the recovery of protoplast 
plasmid transformants. Further attempts to increase the efficiency of 
protoplast formation with the Lindberg method were not attempted. For this 
reason, protoplasts were prepared by the method of Stahl and Pattee (1983a) 
in the experiments that follow. 
Table 6 presents results obtained from transforming protoplasts of 
ISP874 with plasmid pC194 DNA to determine the most efficient plating 
regimen, as well as the proper medium and selective conditions for 
recovering protoplast plasmid transformants. A concentration of 10 ug per 
ml of chloramphenicol was used for selection (compared to 4 ug per ml used 
in previous experiments) to eliminate the lawn of cells that appeared 
earlier on control and experimental plates due to the basal level of 
chloramphenicol resistance. More transformants were obtained when 
chloramphenicol was incorporated directly into DM3 media, as opposed to an 
agar overlay (compare columns A and B of Table 6). For R-agar, more 
transformants were recovered when an agar overlay was used, compared to 
direct incorporation of the antibiotic (columns C and D). With one 
exception (compare plating method 2 for column B vs D), R-agar yielded more 
transformants than DM3 agar, regardless of the conditions for plating or 
the manner in which the antibiotic was added. Table 6 also compares 
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Table 6. Transformation of protoplasts of strain ISP874 with plasmid DNA 
from ISP856^ 
Media^  
Plating^ 
A B C D 
1 3.2 X 104 6.8 X 10^  9.6 x 10^  7.8 x 10^ 
2 3.3 X 104 6.0 X 10% 6.0 x 10^ 1.9 x 10^  
*ISP874 8325-4 rl-r2-m31+m32+ tvrB282::Tn551 lvs-115 pig-131 
ISP856 8325-4 (pC194). 
P^rotoplast-DNA mixture was either plated directly (method 1), or 
allowed to express for 3.5 hour at 30 C (method 2), before plating onto 
selective media. 
•^ A - DM3 using chloramphenicol in an agar overlay; B = DM3 with 
direct incorporation of chloramphenicol; C - R-agar using chloramphenicol 
in an agar overlay; and D - R-agar with direct incorporation of 
chloramphenicol. Selection was made for resistance to 10 ug/ml of 
chloramphenicol. Frequencies are expressed as protoplast plasmid 
transformants recovered per ug of pC194 DNA. 
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plating the protoplast-DNA mixture immediately onto regeneration media 
(plating 1), with allowing a 3.5-hour expression period before plating 
(plating 2). Regardless of media and application of the selective agent, 
plating method 2 produced more pC194 transformants than plating method 1. 
From the data presented in Table 6, it was decided to plate putative 
plasmid-containing protoplasts following a 3.5-hour incubation at 30 C 
directly onto R-agar containing the selective agent. Furthermore, R-agar 
was considerably less complicated and less expensive to prepare than DM3 
agar, which are additional advantages of using R-agar. 
Effect of selective levels of antibiotic. CsCl purification of plasmid DNA. 
and induction for gene expression on the frequency of protoplast plasmid 
transformation 
A background lawn of cells was observed on control and experimental 
plates when selection was made on R-agar containing 4 ug per ml of 
chloramphenicol, because aureus exhibits a basal-level resistance to 
this antibiotic. The background growth was eliminated by exposure to 
higher selective levels of chloramphenicol. To determine if higher 
selective levels of chloramphenicol would affect the recovery of 
transformants, plasmid pC194 was presented to protoplasts of ISP1047, and 
the resulting mixture was plated onto R-agar containing either 3 or 10 ug 
per ml of chloramphenicol. As shown in Table 7, the transformation 
frequency for pCl94 was higher when selection was made for 10 ug per ml of 
chloramphenicol than when selection was made for 3 ug/ml. This higher 
frequency on R-agar plus 10 ug/ml of chloramphenicol was not affected 
either by antibiotic induction of the protoplast-DNA mixture or by CsCl 
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Table 7. Transformation of protoplasts of strain ISP1047 with plasmid DNA 
from strains ISP856 and ISP1578* 
Frequency^ of: 
pC194^ 
pC194® 
pCl94de 
Selection on: 
3 ug/ml Cm 
4.76 X 104 
5.99 X 104 
1.87 X 105 
10 ug/ml Cm 
2.09 X 105 
2.39 X 105 
3.08 X 105 
Selection on: 
pTVltgd 
pTVlcgde 
1 ug/ml Em 
7.72 X 104 
9.13 X 104 
I^SP1047 80CR3 nov-142 
ISP856 8325-4 (pC194) 
ISP1578 8325-4 pig-131 (pTVl^ s). 
^Expressed as protoplast plasmid transformants recovered per ug of 
plasmid DNA. 
^Background lawn of cells present due to basal-level resistance to 
chloramphenicol. Significantly less background growth when selection was 
made for resistance to 10 ug/ml of chloramphenicol compared to 3 ug/ml of 
chloramphenicol. 
dpiasmid DNA was purified by CsCl density-gradient centrifugation. 
^Transformation mixtures were incubated for 3.5 h at 30 C in the 
presence of 0.1 ug/ml of chloramphenicol (pCl94), or 0.1 ug/ml of 
erythromycin (pTVl^ -g) prior to plating onto R-agar. 
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purification of pC194 DNA. Because use of 3 ug/ml of chloramphenicol 
yielded fewer transformants and resulted in a significant amount of 
background growth, 10 ug per ml of chloramphenicol was used in subsequent 
experiments to select for protoplast plasmid transformants. 
Table 7 also presents data demonstrating that both CsCl-gradient 
purification of plasmid DNA and antibiotic induction for gene expression 
contributed to increased recovery of transformants. When selection was 
made on 3 ug/ml of chloramphenicol, almost 4 times as many transformants 
were obtained for the induced preparation, compared to the non-induced 
preparation of pC194 (1.87 x 10^ vs 4.76 x 10^ ). Non-CsCl purified pC194 
DNA that was induced yielded slightly more transformants than a preparation 
of CsCl-purified pC194 that was not induced (5.99 x 10^ vs 4.76 x 10^ ). An 
induced preparation of CsCl-purified pC194 DNA produced more transformants 
(1.87 X 10^) than non-CsCl purified and induced (5.99 x 10^ ), or 
CsGl-purified not induced (4.76 x 10^ ) preparations of pC194. This same 
trend was also observed when selection was made on R-agar containing 10 
ug/ml of chloramphenicol: pC194 CsCl-purified and induced (3.08 x 10^ ), 
yielded more transformants than pC194 non-CsCl-purified and induced (2.39 x 
10 )^, which in turn produced more transformants than pC194 CsCl-purified 
not induced (2.09 x 10^). 
Preparations of CsCl-purified plasmid pTVl^-g were also presented to 
protoplasts of ISP1047 to determine if induction with 0.1 ug/ml of 
erythromycin would result in increased recovery of plasmid transformants. 
As shown in Table 7, the values obtained for an induced preparation of 
pTVlj-g were higher than for a non-induced preparation of this same DNA 
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(9.13 X 10^  transformants per ug of pTVl^ -g DNA when induced, compared to 
7.22 X 10^  per ug when not induced). 
The data in Table 7 demonstrated that CsCl-purified plasmid DNA 
produced more transformants than non-CsCl purified plasmid DNA. 
Furthermore, more transformants were recovered from preparations induced 
for 3.5 h in the presence of the appropriate antibiotic, than from 
identical preparations of plasmid DNAs that were not induced. When 
selection was made for resistance to 10 ug/ml of chloramphenicol, the 
transformation frequency of an induced preparation of CsCl-purified pC194 
DNA (frequency of 3.08 x 10^ ) was significantly higher than CsCl-purified 
and induced pTVl^-g DNA (frequency of 9.13 x 10^ ). Plasmid pC194 (2.9 kb) 
is considerably smaller than pTVl^-g (12.4 kb), and small DNAs typically 
transform more efficiently than large DNAs. The data in Table 7 support 
this generalization. 
To determine if CsCl-purified DNA affected competent-cell 
transformation of E. coli. pJHlOl was transformed into competent cells of 
E. coli strain HBIOI. Ampicillin-resistant transformants were obtained at 
a frequency of 1.10 x 10^  per ug of CsCl-purified pJHlOl DNA, compared to a 
frequency of 1.35 x 10^  per ug of non-CsCl-purified pJHlOl DNA (data not 
shown). CsCl-purified plasmid DNA used in either protoplast plasmid 
transformation of S. aureus. or competent cell transformation of E. coll. 
resulted in higher frequencies of transformation than identical 
preparations of non-CsCl-purified plasmid DNAs. 
114 
Effect of heat treatment: of recipient protoplasts on homologous and 
heterologous protoplast plasmid transformation of S. aureus 
Sjostrom et al. (1979) reported that preheated restrictive strains of 
competent S. aureus were transformed with heterologous plasmid DNA at 
frequencies comparable to those for modified homologous DNA. For the 
purposes of this study, it was important to determine if similar results 
could be obtained for S. aureus protoplast plasmid transformation. As 
shown in Table 8, protoplasts of a restrictive strain (ISP990) were 
transformed with both homologous plasmid DNA (pTVl^ -s and pI258 isolated 
from S. aureus) and heterologous plasmid DNA (pTV20 isolated from B. 
subtilisé. Duplicate transformations were performed with each plasmid: one 
preparation of each plasmid was introduced to protoplasts of ISP990 that 
were incubated at 56 C for 45 seconds prior to the addition of plasmid DNA. 
For transformation using heterologous DNA (pTV20), transformants were not 
obtained from the non-heated preparation, whereas transformants were 
obtained at a frequency of 3.0 x 10^ when the protoplasts were heated. For 
transformation of ISP990 protoplasts with homologous DNA, the non-heated 
preparation of pTVl(.g produced transformants at a frequency of 2.8 x 10^ , 
compared to 2.0 x 10^  for the heated preparation. The slight difference in 
frequency between the non-heated and heated preparations of pTVlj-g could be 
explained by loss of protoplasts as a consequence of the elevated 
temperature. For plasmid pI258, the heated preparation produced 
transformants at a frequency about 3.5 times greater than the non-heated 
preparation: 9.8 x 10^  transformants per ug of pI258 DNA presented to 
heated protoplasts, compared to 2.8 x 10^  transformants per ug of pI258 DNA 
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Table 8. Transformation of protoplasts of strain ISP990 with plasmid DNA 
from strains ISP1769, ISP1578, and ISP479^ 
Frequency^ of: 
Em^ 
pTV20C 3. ,0 X 102 
pTV20 0 
PTVLCGC 2. ,0 X 105 
pTVlts 2. ,8 X 105 
pI258C 9, ,8 X 10^  
pI258 2, ,8 X 104 
^ISP990 8325 thrB106 tvrB282::Tn551 ermB321 trpE85 
tmn-3106 uraA141 nov-142 mec-4916 
ISP1769 B, subtilis BD170 (pTV20) 
ISP1578 8325-4 pig-131 (pTVl^ s) 
ISP479 8325-4 pig-131 (pI258). 
^Expressed as protoplast plasmid transformants recovered per ug of 
CsCl-purified plasmid DNA. Transformation mixtures were incubated for 3.5 
h at 30 C in the presence of 0.1 ug/ml of erythromycin prior to plating 
onto R-agar containing 1.5 ug/ml of erythromycin. 
^Protoplasts were heated for 45 seconds at 56 C before plasmid DNA 
was added. 
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presented to protoplasts that were not heated (Table 8). 
Plasmids pTV20 and pTVl^ g contain the same Gram-positive origin of 
replication, the pE194 origin, and are similar in size at 15.5 kb and 12.4 
kb, respectively. Although pTVl^s and pTV20 are similar, pTVl^ g 
transformed heated protoplasts at a frequency of 2.0 x 10^ per ug of DNA, 
compared to a frequency of 3.0 x 10^ per ug of pTV20. pTVlj-s transformed 
non-heated protoplasts at a frequency of 2,8 x 10^ per ug of DNA (see Table 
8). When protoplasts were not heated, transformants were not obtained with 
pTV20 DNA. The data in Table 8 provided evidence that the origin of DNA 
(B. subtilis vs S. aureus) largely determined the transformability of a 
particular plasmid. Restriction barriers were (partially) circumvented by 
heating S. aureus protoplasts just prior to the addition of DNA. 
The transfer frequency was significantly greater for pTVl^-g compared 
to pI258, regardless of whether or not the protoplasts were heated (see 
Table 8). Plasmid pI258 (28.2 kb) is more than twice as large as pTVl^ g 
(12.4 kb); therefore, it was not surprising that pTVl^ g transformed ISP990 
at a higher frequency than pI258. The transformation frequency for pI258 
was increased when protoplasts were heated, suggesting that heat treatment 
of S. aureus protoplasts may increase the permeability of the cell 
membrane, or inactivate a heat-sensitive nuclease, and allow for 
internalization of large plasmids. 
Protocol for maximum transformation frequencies of S. aureus protoplasts 
The following conditions consistently yielded the highest frequencies 
of plasmid transformants via protoplast plasmid transformation: 
CsCl-purified plasmid DNA was presented to protoplasts prepared via the 
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Stahl and Pattee protocol and maintained at 56 C for 45 seconds, and the 
resulting mixture was plated (following a 3.5-hour incubation at 30 C, in 
the presence of inducing levels of antibiotics if appropriate, to allow for 
gene expression) onto R-agar containing either 10 ug per ml of 
chloramphenicol or 1.5 ug per ml of erythromycin. Following an incubation 
at 30 C at high humidity for approximately 5 days, regenerated colonies 
were counted and replica-plated onto appropriate media to score for 
unselected plasmid markers. After incubation for approximately 30 h at 30 
C, the replica plates were scored. 
By utilizing the optimized protoplast transformation procedure 
detailed above, several additional attempts were made to transform pLUCH3 
into protoplasts of different recipient strains of S. aureus : as with 
earlier efforts to introduce this vector into S. aureus. these experiments 
were not successful (data not shown). Although much useful information 
concerning the ideal conditions for introducing plasmid DNA into S. aureus 
was accumulated, it was not possible to introduce the integrable vector 
pLUCH3 into this organism. Based on information obtained from efforts to 
transform pLUCH3 into S. aureus protoplasts, a novel insertion vector, 
pPQ126, was constucted that was amenable for use in S. aureus (see below). 
Characterization of pTVlj-s 
As described in the previous section, attempts to utilize an 
established integrable plasmid in S. aureus. a pJHlOl-based vector, were 
not successful. Because insertion plasmids do not replicate autonomously 
prior to integration, it was important to determine if pLUCH3 entered the 
cell and circumvented restriction barriers or if a problem existed at the 
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level of integration (reliance on selection for resistance to 
chloramphenicol to recover integrated plasmids). To gain insight into this 
problem, a temperature-sensitive insertion vector was introduced and 
established at the permissive temperature before selecting for integration 
into the host chromosome by shifting to the non-permissive temperature. 
Plasmid pTVl s^ (12.4 kb) encodes for resistance to chloramphenicol (cat 
gene from S,. aureus plasmid pC194) and erythromycin (Tn917). More 
importantly, this vector also harbors a mutated origin of replication, 
responsible for an abrupt block in plasmid replication at 38 C. 
The effect of using chloramphenicol to select for transfer of pTVl^-g into 
S. aureus via protoplast plasmid transformation 
In previous experiments, pTVl^s was utilized to define conditions for 
obtaining higher frequencies for protoplast plasmid transformation, and 
erythromycin was used to select for pTVl^g-containing transformants' (see 
Tables 7 and 8). It was necessary, therefore, to determine the effect of 
selection for resistance to chloramphenicol on the recovery of pTVl^ g 
transformants. The results comparing erythromycin to chloramphenicol for 
selection of pTVl^ s transformants via protoplast plasmid transformation are 
shown in Table 9. Plasmids pC194 and pE194tg were utilized as control 
DNAs. Both pE194ts and pC194 transformed at good efficiency, but pE194tg 
transformed ISP990 about 1.5 times better than pC194 (3.96 x 10^ 
transformants per ug of pE194tg DNA compared to 2.35 x 10^  transformants 
per ug of pC194 DNA). Although somewhat similar in size, pC194 (2.9 kb) is 
about 800 base pairs smaller than pE194tg (3.7 kb). For this reason, one 
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Table 9. Transformation of protoplasts of strain ISP990 with plasmid DNA 
from strains ISP856, ISP1574, and ISP1578& 
Frequency^ of : 
Em? Cm^ 
PE194TS 3.96 X 105 NDC 
pC194 NDC 2.35 X 105 
PTVLTS 1.56 X 104 6.60 X 10^ 
aiSP990 8325 thrB106 tyrB282:;Tn551 ermB321 trpE85 
tmn-3106 uraA141 nov-142 mec-4916 
ISP856 8325-4 (pC194) 
ISP1574 8325-4 pig-131 (pE194cg) 
ISP1578 8325-4 pig-131 (pTVlfg). 
E^xpressed as protoplast plasmid transformants recovered per ug of 
CsCl-purified plasmid DNA. Transformation mixutres were incubated for 3.5 
h at 30 C in the presence of 0.1 ug/ml of either erythromycin (pTVl^ s and 
pE194tg) or chloramphenicol (pTVl^s and pC194) prior to plating onto 
R-agar containing either 1.5 ug/ml of erythromycin or 10 ug/ml of 
chloramphenicol. Protoplasts of ISP990 were not heated prior to the 
addition of plasmid DNA. 
•^ ND = not determined. 
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would expect pC194 might transform S. aureus protoplasts more efficiently 
than pE194ts. The observed difference in transformation frequency between 
pE194ts and pC194 may have resulted from loss of viable protoplasts because 
chloramphenicol may be more stressful than erythromycin on regenerating 
protoplasts. 
When selection was made on R-agar containing 1.5 ug/ml of 
erythromycin, pTVlj-g-containing transformants were recovered at a frequency 
of 1.56 X 10^ per ug of DNA. In comparison, protoplasts of ISP990 were 
transformed with pE194tg DNA at a frequency about 25 times greater than the 
frequency reported in Table 9 for pTVl^-g (3.96 x 10^  pE194tg transformants 
vs 1.56 X 10^  pTVl^ g transformants). An explanation for the difference 
between the recovery of pE194cg and pTVl^ g transformants on R-agar plus 1.5 
ug/ml of erythromycin was the considerable size differential between these 
two plasmids (pE194ts is 3.7 kb and pTVl^ g is 12.4 kb). 
pTVl^ g transformants were obtained at a frequency of 6.6 x 10^  when 
the transformation mixture was plated on R-agar containing 10 ug/ml of 
chloramphenicol. The value 6.6 x 10^  represents a significant reduction in 
pTVl^-g transformants compared to the value of 1.56 x 10^  obtained on R-agar 
plus 1.5 ug/ml of erythromycin. It was not clear, however, why 
chloramphenicol selection resulted in a decreased transformation frequency, 
because pC194 transformed protoplasts of ISP990 at good efficiency (2.35 x 
10^ transformants per ug of DNA), and because transformation of pTVl^-g 
occurred at good efficiency on R-agar plus 1.5 ug/ml of erythromycin (1.56 
X 104). 
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Phenotypic and molecular confirmation of pTVl^ g deletions resulting from 
selection for chloramphenicol-resistant transformants via protoplast 
plasmid transformation 
Representative transformants recovered for each of the plasmids 
transformed into ISP990 (see Table 9) were screened for resistance to 
chloramphenicol and erythromycin: isolates were replica-plated onto media 
containing chloramphenicol at concentrations of 4, 10, 15, 20, and 50 
ug/ml, and erythromycin at concentrations of 10 and 25 ug/ml. The 
recipient for this experiment, ISP990, was resistant to about 4 ug/ml of 
chloramphenicol, but sensitive to 10 ug/ml each of chloramphenicol and 
erythromycin (data not shown). All 258 transformants of ISP990 containing 
pE194ts were resistant to 25 ug/ml of erythromycin, but sensitive to 10 
ug/ml of chloramphenicol (data not shown). All 78 transformants that 
contained pC194 were resistant to 50 ug/ml of chloramphenicol, but 
sensitive to 10 ug/ml of erythromycin (data not shown). 
All 87 pTVl^ s transformants recovered from R-agar plus 1.5 ug/ml of 
erythromycin were resistant to about 15 ug per ml of chloramphenicol and 25 
ug per ml of erythromycin (data not shown). Although basal-level 
resistance to chloramphenicol for ISP990 was about 4 ug/ml, transformants 
harboring pTVl^-g were resistant to about 15 ug/ml of chloramphenicol. 
Thirty-one pTVlj-s*containing transformants of ISP990 obtained using 
chloramphenicol selection were also screened for resistance to erythromycin 
and chloramphenicol. As shown in Table 10, the 31 transformants comprised 
three distinct phenotypic classes: class I isolates (64.5%) were resistant 
to 50 ug/ml of chloramphenicol, but sensitive to 10 ug/ml of erythromycin; 
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Table 10. Phenotypic distribution of pTVl^ s-containing transformants from 
protoplast plasmid transformation of ISP990& 
Analysis of Antibiotic concentration (ug/ml)^  Class 
pheno types Cm Em 
4 15 20 50 10 
Of 31 Cm^  transformants 
64.5%(20) r r r r s I 
19.4%( 6) r r +/- s s II 
16.1%( 5) r +/- s s r III 
P^rotoplasts of ISP990 were transformed with pTVl^s and plated onto 
R-agar plus 10 ug/ml of chloramphenicol. Transformants were recovered at 
a frequency of 6.6 x 10^  per ug of pTVl^ g DNA (Table 10). 
T^ransformants were replica-plated onto media containing different 
concentrations of either chloramphenicol or erythromycin. Following a 30 
h incubation at 30 C, the plates were scored for growth (r — resistant), 
no growth (s - sensitive), or poor growth (+/") of the transformants. 
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class II Isolates (19.4%) were resistant to at least 15 ug/ml of 
chloramphenicol, but sensitive to 10 ug/ml of erythromycin; and class III 
isolates (16.1%) were resistant to about 15 ug per ml of chloramphenicol, 
and at least 10 ug/ml of erythromycin. From the data presented in Tables 9 
and 10 for pTVl^g, it was apparent that selection for chloramphenicol 
resistance resulted in reduction of the total number of transformants, and 
phenotypic variation was present among the transformants that were 
recovered. The most obvious explanation for the different phenotypes was 
that classes I and II from Table 10 contained forms of pTVl^-g that 
contained deletions. The erythromycin-sensitive phenotype of classes I and 
II was attributed to loss (deletion) of all or part of the erm gene of 
pTVl^ g. Class III isolates were of the same phenotype of pTVl^ g 
transformants recovered by using selectioù for resistance to erythromycin, 
and were thought to contain an intact copy of pTVl^ s• 
To determine if any or all classes described above contained deleted 
forms of pTVl^si plasmid DNA was extracted from representative isolates and 
analyzed by agarose-gel electrophoresis. All isolates from a particular 
class displayed the same migration pattern (data not shown); therefore, 
Figure 8 includes data for one member of each class. The results shown in 
Figure 8 confirmed that deleted forms of pTVl^ -g were present in classes I 
and II, and verified the presence of intact copies of pTVlj-g in class III 
and the erythromycin-selected transformants (see below). Lane 2 contains a 
class III transformant (JBL14a; pTVl^ -g), and lane 5 contains a transformant 
obtained via selection for resistance to erythromycin (JBL14b; pTVl^g); the 
migration pattern of the plasmid DNA in lanes 2 and 5 are identical. 
Figure 8. Analysis of pTVl^ g deletion derivatives obtained from 
protoplast plasraid transformation of ISP990 with selection for 
resistance to 10 ug/ral of chloramphenicol 
Lane 1, Hindlll-digested lambda standard (0.30 ug total); 
lane 2, pTVl^ -g isolated from JBL14a; lane 3, pLUCHll isolated 
from JBLll; lane 4, pLUCHlO isolated from JBLIO; lane 5, pTVl^ s 
isolated form JBL14b; lane 6, Hindlll-digested lambda standard 
(0.30 ug total). 
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JBLl4a and JBL14b share the same phenotype and plasmid profile, and 
represent successful protoplast plasmid transformation of pTVl^s into 
ISP990. As shown in lane 4 of Figure 8, plasmid pLUCHlO (JBLlO) was the 
product of a major deletion of pTVl^g; compare pLUCHlO in lane 4 to an 
intact copy of pTVl^ g in lanes 2 and 5. Plasmid pLUCHll (JBLll, lane 3) 
also suffered a deletion, but the deletion in pLUCHll was not as extensive 
as the deletion in pLUCHlO. Therefore, these data support the hypothesis 
that transformants JBLIO and JBLll (class I and class II, respectively) are 
erythromycin sensitive as a consequence of deletion. Deletions may also 
explain why JBLlO and JBLll were more resistant than transformants 
containing parental pTVl^ g (e.g., JBL14a and JBL14b) to higher levels of 
chloramphenicol. Smaller plasmids typically exist in higher copy number 
than larger plasmids, and increased copy number also results in increased 
production of plasmid-encoded products (e.g., chloramphenicol acetyl 
transferase). The smallest deletion derivative (pLUCHlO; 50 ug/ml) was 
resistant to higher levels of chloramphenicol than the next largest 
deletion derivative (pLUCHll; between 15 and 20 ug/ml), which was resistant 
to slightly higher levels of chloramphenicol than the parental plasmid 
(pTVlts; 15 ug/ml). 
Construction of pPQ126 
To adapt pTVl^g for use as an insertion plasmid, it was necessary to 
inactivate Tn917 transposition functions and add a readily selectable 
marker. Digestion of pTVl with HindiII produces fragments 11.1 and 1.3 kb 
in length; the smaller 1.3-kb fragment contains the information required 
for transposition of Tn917 (Perkins and Youngman, 1984). The strategy for 
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modifying pTVl^ s was to remove the 1.3-kb fragment and replace it with 
another HindiII fragment containing a readily selectable marker. The 
gentamicin-resistance determinant of Tn4001 was chosen because it was known 
to reside on a 2.5-kb HindiII fragment, and it was readily selectable in S. 
aureus (Lyon et al., 1984; Tennent et al., 1985). 
To facilitate the cloning of the gentamicin-resistant determinant, an 
insertion of Tn4001 was obtained in plasmid pPQ58. Figure 9 shows the 
EcoRI and HindiII restriction analyses of plasmid pPQ58. To avoid possible 
confusion, it should be mentioned that plasmid pPQ58 is plasmid pI258 plus 
an insertion of Tn4001. The EcoRI-digestion patterns of pPQ58 and pI258 in 
Figure 9 (lanes 1 and 3, respectively) are similar; however, the EcoA 
fragment of pPQ58 is larger (migrates slower) than the EcoA fragment of 
pI258. Plasmids pI258 and pPQ58 were digested with EcoRI. and the EcoA 
fragments for each plasmid were isolated from agarose. Lanes 2 and 4 of 
Figure 9 contain the isolated EcoA fragments of plasmids pI258 and pPQ58, 
respectively. By comparing lanes 1 and 2 to lanes 3 and 4, it was 
concluded that Tn4001 resides on the largest (EcoA) fragment of EcoRI-
digested pPQ58. Lanes 7 and 8 contain the HindiII restriction analysis of 
the EcoA fragments only for plasmids pI258 (lane 7) and pPQ58 (lane 8). 
For plasmid pTVl^si two fragments were visible following digestion with 
Hindlll: an 11.1-kb fragment (A, Figure 9), and a 1.3-kb fragment (E, 
Figure 9). Compared with the HindiII pattern of pI258 (lane 6), 2 
additional fragments were observed (labeled C and D) and one original 
fragment, the HlnB fragment, was absent from pPQ58 (lane 9). The 2.8-md 
HinB fragment of pI258 contains the ermB gene of Tn551 and, therefore, the 
Figure 9. Restriction characterization of plasmids pI258, pPQ58, and 
pTVl|-s, and HindIII-digestion of the EcoA fragments only of 
plasmids pI258 and pPQ58 
Lane 1, EcoRI-digested pI258; lane 2, EcoA fragment of 
pI258; lane 3, EcoRI-digested pPQ58; lane 4, EcoA fragment of 
pPQ58; lane 5, Hindlll-digested lambda standard (0.30 ug 
total); lane 6, Hindlll-digested pI258; lane 7, Hindlll-
digested pI258 EcoA fragment; lane 8, Hindlll-digested pPQ58 
EcoA fragment; lane 9, Hindlll-digested pPQ58; lane 10, 
Hindlll-digested pTVl^g; lane 11, Hindlll-digested lambda 
standard (0.30 ug total). 
A - 11.1 kb Hindlll fragment of pTVl^g; B = doublet 
consisting of the HinA fragment of pPQ58 (5.1 kb; the HinB 
fragment of pI258 containing a portion of Tn4001) and the HinB 
fragment of pPQ58 (4.9 kb; the HinA fragment of pI258); C = 2.5 
kb Hindlll fragment of pPQ58 that encodes for gentamicin 
resistance; D - approximately 1.5 kb HinH fragment of pPQ58 
(Tn4001 DNA) ; E - 1.3 kb Hindlll fragment of pTVl^-g (contains 
information required for transposition of Tn917). 
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HlnB fragment is a component of the EcoA fragment of pI258. By comparing 
the migration patterns of the Hindlll-digested EcoA fragments of pI258 
(lane 7) and pPQ58 (lane 8), it was apparent that the largest Hin fragment 
of pPQ58 (labeled B in Figure 9) was actually a doublet, consisting of the 
HinA fragment of pPQ58 (approximately 5.1 kb; the HinB fragment of pI258 
containing a portion of Tn4001), and the HlnB fragment of pPQ58 
(approximately 4.9 kb; the HinA fragment of pI258). From the HindiII and 
EcoRI analysis of plasmids pI258 and pPQ58 presented in Figure 9, it was 
concluded that Tn4001 had inserted onto the EcoA fragment of plasmid pI258 
in close proximity to the Hindi 11 site on the em-distal end of the 2.8 md 
HinB fragment, producing plasmid pPQ58. The band in lanes 8 and 9 labelled 
C is the 2.5-kb HindiII fragment containing the gentamicin-resistance 
determinant of Tn4001. Figure 10 more clearly defines the location of 
Tn4001 on plasmid pPQ58 relative to other markers. 
Cloning the 2.5 kb Hindlll fragment of pPQ58 onto pTVl^s 
Plasmid pPQ58 was digested with Hindlll. The resulting fragments were 
ligated to Hindlll-digested, CIP-treated pTVl^-g. This ligation mixture was 
used to transfom protoplasts of a restrictionless recipient strain of S. 
aureus (ISP1658) under conditions determined previously as optimum for 
protoplast plasmid transformation. Of 8 erythromycin-resistant 
transformants, only one was also resistant to 10 ug/ml of gentamicin and 10 
ug/ml of chloramphenicol (data not presented). The EmfCmfCm^  transformant 
was streaked for isolation and a single colony was retained for further 
study as ISP1844. Plasmid DNA was extracted from ISP1844, purified by CsCl 
centrifugation, and digested with Hindlll for molecular identification (see 
Figure 10. Genetic and physical map of pPQ58 showing the approximate 
location of Tn4001 
Numbers are kilobase coordinates reading clockwise from 
the BamHI site at 8 o'clock. Heavy lines represent probable 
direction of transcription for the mer and asa opérons. 
Symbols represent restriction endonuclease sites; EcoRI. * ; 
MsJ, V : iiEal, O ; Bglll, o : xbal, # ; BamHI, • ; Hindi 11, H 
(modified from Novick et al., 1979c). 
9.7 
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Figure 11, lane 2). Lane 1 of Figure 11 contains Hindlll-digested pTVl^s^ 
both the 11.1-kb (labeled A), and the 1.3-kb (labeled C) fragments are 
clearly visible. Lanes 3 and 4 contain Hindlll-digested pPQ58 and pI258, 
respectively. Lane 2 of Figure 11 demonstrates that ISP1844 contains a 
plasmid, designated pPQ126, composed of the 11.1-kb Hindlll fragment of 
pTVlj-si plus the 2.5-kb Hindlll fragment of plasmid pPQ58. Plasmid pPQ125 
does not contain the 1.3-kb (labeled C) fragment of pTVl^s (the fragment 
essential for transposition of Tn917). A physical/genetic map of plasmid 
pPQ126 is given in Figure 12. 
Characterization of pPQ126 
Before pPQ126 was employed for use as an integrable plasmid in S. 
aureus. it was necessary to confirm that Tn917 and Tn4001 were 
transpositionally defective. Table 11 summarizes results of tests 
performed to investigate the ability of transposons Tn917. Tn551. and 
Tn4001 to transpose from various temperature-sensitive delivery vehicles. 
Youngman (1985) reported transposition frequencies of 5 x 10"^ to 5 x 10"^  
for Tn917 on plasmid pTVl in B. subtilis. Tn917 transposed at a frequency 
of 1.46 X 10"3 from pTVlj-g in £. aureus strain ISP1483 (see Table 11). The 
transposition frequency of 1.63 x 10'^ for Tn551 from plasmid pI258 (Table 
11), was in close agreement with already published results for 
transposition of Tn551 from this plasmid (Luchansky and Pattee, 1984; 
Novick et al., 1979b). 
A translocation frequency of about 10"^  has also been reported for 
Tn4001 (Lyon et al., 1984). As shown in Table 11, Tn4001 transposed from 
plasmid pPQ61 in a recombination-deficient background free": - ISP1801) at 
Figure 11. HindiII digestion of CsCl-purified preparations of plasmids 
pI258, pPQ58, pPQ126, and pTVlts 
Lane 1, Hindlll-digested pTVlts! lane 2, Hindlll-digested 
pPQl26; lane 3, Hindlll-digested pPQSS; lane 4, Hindlll-
digested pI258. 
A - 11.1 kb Hin fragment of plasmids pTVl^ -g and pPQ126 ; B 
=• 2.5 kb Hin fragment of plasmids pPQ126 and pPQSS; C = 1.3 kb 
Hin fragment of pTVl^ -g. 
The 2.5 kb Hindlll fragment contains the gentamicin 
resistance determinant from Tn4001. and the 1.3 kb Hindlll 
fragment contains information essential for transposition of 
Tnill. 
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2 3 4 
B 
Figure 12. Genetic and physical map of pPQ126 
Closed circles ( f) position TagI cleavage sites and open 
boxes CP) position SauIIKMbo) cleavage sites. The 
approximate region required for replication (from plasmid 
pE194tg) is indicated by "pE194 rep". erm = the ribosome 
methyltransferase gene of Tn917. amp - the beta-lactamase gene 
of pBR322, cat =• the chloramphenicol acetyl transferase gene of 
pC194, Gm = the 2.5 kb HindiII fragment of pPQ58 containing the 
gentamicin-res is tance determinant of Tn4001. Arrows above 
antibiotic-resistance genes indicate direction of transcription 
(modified from Perkins and Youngman, 1984). 
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Table 11. Testing for transposition of Tn917, Tn551, and Tn400ia 
Antibiotic'- cfu Antibiotic^ cfu^ Transposition^ 
Strain Plasmid Transposon 30 C 39/43 C frequency 
ISP1483 pTVlts Tn917 2.02 X lOlO 3.05 X 10^ 1.46 X 10-3 
ISP479 pI258 Tn551 1.31 X lOlO 2.14 X 106 1.63 X 10-4 
ISP1801 pPQ61 Tn4001 1.09 X lOlO 1.01 X 107 8.95 X 10-4 
ISP1504 pPQ58 Tn551 2.02 X lOlO 9.85 X 106 3.59 X 10-4 
ISP1504 pPQ58 Tn4001 1.99 X lOlO 2.17 X 106 NOd 
ISP1844 pPQl26 Tn917 8.50 X 109 1.50 X 104 ND 
ISP1844 pPQl26 Tn4001 1.10 X LOLO 1.00 X 104,e ND 
^Cells from a fresh streak plate of each culture to be tested, previously grown at 30 C with 
selection, were harvested into 5 ml sterile saline, and serial dilutions were plated onto selective 
media as follows: BHI plus 10 ug/ml erythromycin for testing Tn917 and Tn551, and BHI plus 10 ug/ml 
gentamicin for testing TnAOOl. Duplicate plates of each dilution were incubated at each temperature. 
^Strains containing pPQ126 were incubated at 39 C, and strains containing plasmids pTVl^g» pI258, 
pPQ58, and pPQ61 were incubated at 43 C. 
A^ntibiotic-resistant cfu at 39 or 43 C divided by antibiotic-resistant cfu at 30 C. The values 
listed were corrected to include only the percent of cells at the high temperature that were 
phenotypically confirmed as plasmid-free while retaining the transposon. 
^ND = not detected; less than the limits of detection. 
®The reported value was an estimated cfu, based on the recovery of only 1 or 2 colonies per plate 
at a 10*4 final dilution. 
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a frequency of 8.95 x 10'^ . Because the 2.5-kb gentamicin-resistance 
determinant of plasmid pPQ126 was originally harbored on plasmid DNA from 
ISP1504, the transpositional capability of Tn4001 from the parental 
plasmid, pPQ58, was examined. It was also possible to test for 
transposition of Tn551 in the same experiment. Tn551 transposed from 
plasmid pPQ58 at a frequency of 3.59 x 10"^; however, it was not possible 
to detect transposition of Tn4001 from pPQ58. Efforts were not directed to 
determine why Tn4001 did not transpose from pPQ58 because only the 
gentamicin-resistance determinant from Tn4001 was essential to this study. 
Based on the behavior of Tn4001 on plasmid pPQ58, it was assumed that the 
2.5-kb gentamicin-resistance Hin fragment of pPQ126 was incapable of 
transposition; the results in Table 11 support this contention. When 
selection was made on BHI plus 10 ug per ml of gentamicin at 39 C, 
transposition of the 2.5-kb HindiII fragment of pPQ126 was not detected. 
Transposition of Tn917 from plasmid pPQ126 was not expected, because 
of the absence of the 1.3-kb HindiII fragment of Tn917 (Perkins and 
Youngman, 1984). As shown in Table 11, when cells of ISP1844 were plated 
on BHI plus 10 ug/ml of erythromycin and incubated at 39 C, it was not 
possible to detect transposition events of Tn917. For plasmid pPQl26 grown 
at 39 C on either erythromycin- or gentamicin-containing media and plated 
at a final dilution of 10"^, about 1 or 2 colonies were recovered along 
with a background haze of growth. These one or two colonies retained the 
phenotype of parental cells grown at 30 C (resistant to 10 ug/ml each of 
erythromycin and gentamicin, and 12 ug/ml chloramphenicol); however, the 
background haze was significantly diminished (data not shown). The 39 C 
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plates at the next highest dilution (10"^) did not contain bona fide 
colonies and exhibited a reduction in the amount of background haze; the 
background haze was further diminished upon replica-plating to higher 
concentrations of antibiotics (data not shown). The background haze at low 
dilution on the erythromycin and gentamicin plates at 39 C was attributed 
to the total number of cells present; insufficient cell divisions to dilute 
out pPQ126 and/or to overcome phenotypic lag. A similar phenomenon was 
also observed for ISP1504 when selection was made for gentamicin-resistance 
at 43 C. 
The results in Table 11 for ISP1844 also confirmed that pPQ126 
retained the temperature-sensitive replication defect. Regardless of 
selection, a 5 to 6 log difference was observed between 
antibiotic-resistant cfu at 39 C and 30 C: erythromycin selection at 39 C 
(1.5 X 10 )^ revealed a difference of 10^  compared to 30 C (8.5 x 10^ ); 
gentamicin selection at 39 C (1.0 x 10^) showed a difference of 10^  
compared to 30 C (1.1 x 10^®). More importantly, pTVl^ -g (ISP1483) at 43 C 
yielded erythromyc in-res is tant cfu at 3.05 x 10^ , compared to 1.5 x 10^  
erythromycin-resistant cfu for pPQ126 (ISP1844) at 39 C. The reported 
difference between pTVl^ g and pPQ126 was based on the recovery of only one 
or two colonies of ISP1844 per plate at a dilution of 10"^ ; therefore, the 
actual difference may be considerably greater. 
Transfer of pFQ126 into recipient strains that contain 
homologous chromosomal DNÀ 
The acquisition of pPQ126 from S. aureus (= ISP1844) enabled the use 
of transduction as the genetic transfer mechanism employed to move pPQ126 
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into recicpient strains that contained homologous chromosomal DNA (e.g., 
Tn4001 or Tn551). 
A phill lysate of ISP1844 (titer - 5.5 x 10^® pfu/ml) was prepared and 
used to transfer pPQ126 into various recipient strains. In the absence of 
chromosomal homology, pPQ126 was lost from a population of cells grown at 
39 C (Table 11, ISP1844), To determine if pPQ126 would integrate into the 
host chromosome, provided that a chromosomal target was available, pPQ126 
was transduced into ISP835 (- 8325-4 t>ig-131 tri3-159 : :Tn551 ermB312) and 
ISP1565 (- 8325 t)ig-131 w[Chr;:Tn4001]1210). pPQ126 was also transduced 
into a recipient containing a chromosomal copy of Tn4001 in a 
recombination-deficient background (— JBL122 8325-4 his-7 recAl tiig-131 
w[Chr::Tn4001]2000) to determine if integration of pPQ126 was dependent on 
recA"*" function. Gentamicin-resistant pPQ126 transductants were recovered 
(per 10^ cfu) at frequencies that ranged from 10 for pPQ126 transduced into 
ISP835 (- ISP1846), to 294 and 706 for pPQ126 transduced into ISP1565 (= 
JBL85) and JBL122 (- JBL177), respectively (data not presented). The 
results of experiments to test the behavior of pPQ126 in these genetic 
backgrounds are summarized below. 
Testing for integration of oP0126 in ISP1844 
In the absence of a chromosomal target (e.g., no chromosomal insertion 
of Tn551 or Tn4001), pPQ126 should be lost from a population of cells grown 
at elevated temperature. To test this hypothesis, pPQ126 was introduced 
into ISP1844, and a high-temperature, plasmid-elimination experiment was 
performed. 
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From the BHI plates without selection at 30 C, cfu were recovered at a 
frequency of 2.86 x 10^  per ml (Table 12). Of the 36 isolates screened, 2 
phenotypic classes were observed: about 6% (2) of the 36 isolates were 
resistant to only 6 ug/ml of chloramphenicol and 10 ug/ml each of 
erythromycin and gentamicin [Em^ Gm^ Cm^ (6 ug/ml)], and about 94% (34) of the 
isolates screened were resistant to 11 ug/ml of chloramphenicol and 10 
ug/ml each of erythromycin and gentamicin [Em^Gm^Cm'-(11 ug/ml)]. A 
representative member from each phenotypic class was retained for further 
analysis (JBL115 for resistance to only 6 ug/ml of chloramphenicol and 
JBL116 for resistance to 11 ug/ml of chloramphenicol). It was not clear 
why JBL115 was resistant to only 6 ug/ml of chloramphenicol. When BHI 
plates (without selection) were incubated at 39 C cfu were obtained at a 
frequency of 3.9 x 10® per ml. Of the 36 isolates screened, all displayed 
the Em®Gm®Cm^(6 ug/ml) phenotype. The integration frequency for plating on 
BHI (without selection) was reported as zero; no plasmid-containing cells, 
based on phenotype, were recovered at 39 C. 
The Em^ selection plates produced cfu at a frequency of 3.18 x 10® at 
30 C, and <1 x 10^  per ml at 39 C (see Table 12). The value <1 x 10'^ was 
an estimated cfu, based on a haze of growth (no bona fide colonies) present 
on plates of a 10"^  dilution. All 32 isolates screened from the 30 C 
erythromycin-selection plates displayed the pPQ126 phenotype [Em^ Gm^ Cm^ (ll 
ug/ml)]. The haze from the 39 C plate (10"^  dilution) was plasmid-free 
[Em®Gm®Cm^(6 ug/ml)]. A single isolate was retained from the 
erythromycin-selection plate at 30 G as JBL117. Although it was not 
possible to recover an isolated colony from the 39 C plate, a loopful of 
Table 12. Testing for integration of pPQ126 in ISP1844&'b 
Selection 
for cfu at 30 C 
PhenotypeC 
(no. scored) Strain^  cfu at 39 C 
Phenotype^  
(no. scored) Strain^ 
Integration 
frequency® 
None 2.8 X 109 36 A (2) 
C (34) 
JBL115 
JBL116 
3.9 X 109 36 B (all) JBL119 0 
Em^  3.2 X 109 32 C (all) JBL117 <1 X 104,F haze B JBL117(a) 0 
Gm^ 2.6 X 109 19 C (all) JBL118 4.0 X 106 80 D (all) JBL120 
JBL121 
0 
aiSP1844 = 8325-4 r" (pPQl26). 
bCells from a fresh streak plate of ISP1844, previously grown with selection at 30 C, were 
harvested into 5 ml sterile saline; serial dilutions were plated onto BHI + 10 ug/ml gentamicin or BHI 
+ 10 ug/ml of erythromycin, or BHI. Duplicate plates at each dilution were incubated at each 
temperature. 
= Em^Gm^Cm^(6ug/ml), B = Em®Gm®Cm^ (6ug/ml), C = Em^ Gm^ Cm^ (1lug/ml), D = Em®Gm^ Cm^ (6ug/ml). 
^Designation for representative member of each phenotype retained for further analysis. 
®cfu at 39 C divided by cfu at 30 C for each selection. The frequency was corrected to include 
only the percentage of cells recovered at 39 C that were confirmed phenotypically as plasmid free. 
^An estimated cfu; background haze of growth on plate of ICT^ dilution (no colonies). 
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growth was retained for further analysis as JBL117(a). The integration 
frequency for erythromycin selection was zero: pPQ126-containing cells 
(based on phenotype) were not detected at 39 C. 
A value of 2.6 x 10^  cfu per ml was observed for ISP1844 incubated at 
30 C on BHI medium containing 10 ug per ml of gentamicin. All 19 isolates 
screened from this plating displayed the phenotype for autonomous pPQ126 
[Em^ Gm'-Cm^ Cll ug/ml)]; one isolate, designated JBL118, was retained for 
further study. The gentamicin plates incubated at 39 C yielded cfu at a 
frequency of 4.0 x 10® (2 plates of dilution 10"^, with 53 and 27 colonies 
each). All 80 isolates recovered at 39 C were Em®Gm^ Cm^ (6 ug/ml), 
suggesting the absence of pPQ126 from these cultures. Two isolates, 
designated JBL120 and JBL121, were retained for further analysis. It was 
not clear why colonies were recovered on gentamicin-selection plates. In a 
previous experiment, 1 or 2 colonies per plate were recovered at a final 
dilution of 10"^  when cells of ISP1844 were plated on gentamicin and 
incubated at 39 C (see Table 11). Because all 80 isolates were Em® and 
resistant to only 6 ug/ml of chloramphenicol, the integration frequency was 
reported as zero. 
To screen for plasmid pPQ126, DNA was isolated from JBL115 through 
JBL121, digested with Hindlll. and analyzed by agarose gel electrophoresis. 
As discussed below, the agarose gel data (data not presented) coincided 
with the phenotypic data presented in Table 12. The Em^Gm^Cm^(ll ug/ml) 
isolates from Table 12 contained pPQ126, based on their Hindlll pattern 
(JBL116, JBL117, and JBL118). The Em^ Gm^ Cm'-(6 ug/ml) isolate (JBL115) 
produced 2 faint bands, corresponding to the Hindlll fragments of pPQ126. 
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The data suggest that pPQ126 was partially eliminated from JBL115 grown at 
30 C in the absence of selection; fewer copies of pPQ126 could also explain 
the lower level of resistance to chloramphenicol. The isolates 
phenotypically confirmed as missing pPQ126 [Em®Gm®Cm^ (6 ug/ml) or 
Em®Gm^ Cm^ (6 ug/ml)], were also shown by agarose gel analysis to lack this 
plasmid (JBL117(a), JBL119, JBL120, and JBL121). The phenotypic and 
molecular data demonstrated that in the absence of a chromosomal target 
(ISP1844), pPQ126 was lost from a population of cells under non-permissive 
conditions (39 C). Isolates missing pPQ126 were sensitive to 10 ug/ml each 
of erythromycin and gentamicin, and resistant to 6 ug/ml of 
chloramphenicol. 
Testing for integration of DP0126 in JBL85 
Plasmid pPQ126 was transduced into ISP1565 to generate JBL85: pPQ126 
in a recipient strain with a chromosomal target (w[Chr::Tn4001]1210). A 
high-temperature, plasmid-elimination experiment was performed with JBL85 
to test for integration of pPQ126 into the chromosomal Tn4001 target. 
Without selection, cfu were recovered at 7.25 x 10® per ml at 30 C, and 
2.45 X 10® per ml at 39 C (Table 13). All 60 isolates from the 30 C plates 
displayed the phenotype of autonomous pPQ126 [Em^Gm^Cm^(ll ug/ml)], and all 
36 isolates from the 39 C plates appeared to lack pPQ126 [Era®Gra^Cm^(6 
ug/ml)]. Two strains, JBLlOl and JBL108, were isolated from the 30 C and 
39 C plates, respectively, and retained for further analysis. Agarose gel 
electrophoresis of DNA extracted from JBLlOl demonstrated the presence of 
pPQ126, whereas DNA extracted from JBL108 did not reveal the presence of 
pPQ126 (see below). Based on the phenotypic and molecular data, the 
Table 13. Testing for integration of pPQl26 in JBL85®»^ 
Selection Phenotype^ 
Strain^ 
PhenotypeC Integration 
for cfu at 30 C (no. scored) cfu at 39 C (no. scored) StrainC frequency® 
None 7.2 X 108 60 A (all) JBLlOl 2.5 X 108 36 B (all) JBL108 0 
Em^ 7.6 X 108 85 A (all) JBL107 4.4 X 10? 53 A (all) JBL113 5.76 X 10-2 
JBL114 
ajBL85 = 8325 pig-131 w[Chr;;Tn4001]1210 (pPQ126). 
• bcells from a fresh streak plate of JBL85, previously grown with selection at 30 C, were 
harvested into 5 ml sterile saline; serial dilutions were plated onto BHI + 10 ug/ml of erythromycin, 
or BHI. Duplicate plates at each dilution were incubated at each temperature. 
= Em^ Gm^ Cm^ (1lug/ml), B = Em®Gm^Cm^(6ug/ml). 
^Designation for representative member of each phenotype retained for further analysis. 
®cfu at 39 C divided by cfu at 30 C for each selection. The frequency was corrected to include 
only the percentage of cells recovered at 39 C that were confirmed phenotypically as plasmid free. 
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integration frequency for pPQ126 in JBL85 (without selection) was nil. 
Em  ^cfu were obtained at a frequency of 7.55 x 10® per ml at 30 C, and 
at a frequency of 4.35 x 10^  per ml when plates were incubated at 39 C on 
BHI plus 10 ug/ml of erythromycin. Of 85 isolates grown at 30 C and 
examined for the presence of JBL85, all displayed the appropriate phenotype 
for cells containing autonomous pPQ126 [Em^ Gm^ Cm^ (ll ug/ml)]; an isolate, 
JBL107, was retained for further study. A total of 53 Em^ isolates from 
plates incubated at 39 C contained pPQ126, based on their Em^Gm^Cm^(ll 
ug/ml) phenotype. Two isolates, JBL113 and JBL114, were retained for 
electrophoretic analysis. DNA was isolated from JBLlOl, JBL107, JBL108, 
JBL113, and JBL114, and digested with Hlndlll. The 30 C isolates (JBLlOl 
and JBL107) contained autonomous pPQ126, and the 39 C isolates (JBL108 and 
JBL113 and JBL114) did not contain autonomous pPQ126 (see beldw). Because 
both Em  ^isolates from 39 C incubation (JBL113 and JBL114) displayed the 
pPQ126 phenotype but did not contain autonomous plasmid, the integration 
frequency for pPQ126 in JBL85 was reported as 5.76 x 10"^  for erythromycin 
selection. In the absence of selection at 39 C, pPQ126 was lost from 
JBL108, and the level of resistance to chloramphenicol dropped to 5 ug/ml. 
Testing for integration of PP0126 in JBL177 
After confirming that integration of pPQ126 occurred only in the 
presence of a chromosomal target, I decided to determine if integration was 
also dependent on host recombination function (rec"*") . pPQ126 was 
transduced into a rec" recipient that contained a chromosomal copy of 
Tn4001 (- JBL177), and a high-temperature, plasmid-elimination experiment 
was conducted. Table 14 lists results obtained to determine the effect of 
Table 14. Testing for integration of pPQ126 in JBL177^'^ 
Selection 
for cfu at 30 C 
PhenotypeC 
(no. scored) Strain^ ' cfu at 39 C 
Phenotype^ 
(no. scored) Strain^ 
Integration 
frequency® 
None 7.3 X 109 71 A (5) 
B (66) 
JBL200 
JBL201 
4.7 X 109 471 A (all) JBL205 0 
Em^  6.9 X 109 70 B (all) JBL204 8.4 X 104 90 C (all) JBL207 
JBL208 
1.2 X 10-5 
Gm^ 6.1 X 109 68 A (7) 
B (61) 
JBL202 
JBL203 
4.4 X 109 440 A (all) JBL206 0 
ajBL177 = 8325-4 his-7 recAl pig-131 w[Chr::Tn4001]2000 (pPQ126). 
''Cells from a fresh streak plate of JBL177, previously grown with selection at 30 C, were 
harvested into 5 ml sterile saline; serial dilutions were plated onto BHI + 10 ug/ml gentamicin, or 
BHI + 10 ug/ml of erythromycin, or BHI. Duplicate plates at each dilution were incubated at each 
temperature. 
= EmSGmfCmfCSug/ml), B = Em^ Gm^ Cm^ (14ug/ml), C = Em^ Gm^ Cm^ (lOug/ml). 
^Designation for representative member of each phenotype retained for further analysis. 
®cfu at 39 C divided by cfu at 30 C for each selection. The frequency was corrected to include 
only the percentage of cells recovered at 39 C that were confirmed phenotypically as plasmid free. 
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the rec" phenotype on the integration of pPQ126. 
Plates incubated at 30 C without selection yielded 7.3 x 10^ cfu per 
ml; about 7% (5 of 71) were Em^ Gm^Cm^CG ug/ml), and about 93% (66 of 71) 
were Em^ Gm^Cm^(14 ug/ml). One isolate, designated JBL200, was retained 
from the Em® class [Em^Gm^Cm'^Ce ug/ml)], and one isolate (JBL201) was 
retained from the Em^ class [Em^ Gm^ Cm^ (14 ug/ml)]. From plates incubated 
at 39 C in the absence of selection, cfu were recovered at a frequency of 
4.71 X 10^  per ml. All 471 isolates screened were of the same phenotype 
[Em®Gm C^m^(6 ug/ml)]; JBL205 was an isolate retained for further analysis. 
Based on phenotype, it was assumed that JBL200 and JBL205 had lost pPQ126, 
and that JBL201 retained this plasmid. 
The data for gentamicin-selection with JBL177 were similar to the data 
obtained without selection. At 30 G, 6.1 x 10^  cfu per ml were recovered. 
Of 68 gentamicin-resistant isolates tested, approximately 10% (7 of 68 
total) were Em® and resistant to only 6 ug/ml of chloramphenicol, and about 
90% (61 of 68 total) were Em^ and resistant to 14 ug/ml of chloramphenicol. 
JBL202 and JBL203 were retained to represent the Em® and Em^ classes, 
respectively. Gentamicin resistant cfu were recovered at a frequency of 
4.4 X 10^ per ml at 39 C. Of 440 isolates screened from 39 G masters, all 
were Em® and resistant to 6 ug/ml of chloramphenicol; JBL206 was the single 
isolate retained from this class. By using only phenotypic data, JBL202 
and JBL206 were assumed to lack pPQ126 and JBL203 was assumed to contain 
pPQ126. 
When erythromycin-selection was used, about a 5 log difference was 
obtained between the cfu recovered at 30 G (6.95 x 10^) compared to 39 G 
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(8.35 X 10^). A single phenotype [Em^ Gm^ Cm^ (14 ug/ml)] was displayed by 
all 70 isolates screened from 30 C masters (JBL204, Table 14, was 
representative of this class). Of 90 isolates screened from the 39 C 
masters, all displayed the phenotype Em^Gm^Cm^(10 ug/ml); two isolates, 
JBL207 and JBL208, were retained for further analysis. Compared to the Era® 
and low-level chloramphenicol resistance exhibited by both JBL205 and 
JBL206, JBL207 and JBL208 were Em^ and resistant to 10 ug/ml of 
chloramphenicol. The phenotype of JBL207 and JBL208 suggested that pPQ126 
had been retained in these two isolates. 
DNA was extracted from isolates JBL200 through JBL208 and digested 
with HindiII. The data in Figure 13 are in agreement with the predictions 
made from the phenotypic data for determining whether a given strain 
harbored pPQ126. Lanes 3 and 5 contained the 30 G Em® isolates JBL200 and 
JBL202; these lanes do not contain pPQ126. Lanes 4, 6, and 7 in Figure 13 
contained the 30 C Em^  isolates JBL201, JBL203, and JBL204, respectively; 
regardless of selection, these isolates contained pPQ126 (compare to lane 
2). Autonomous plasmid DNA was not evident in isolates JBL205, JBL206, 
JBL207, or JBL208 (lanes 8 to 11). JBL207 and JBL208, however, are 
EmfCmf(10 ug/ml), suggesting that pPQ126 is present as an integrated 
plasmid in these isolates. By using the phenotypic and molecular data, the 
integration frequency for pPQ126 in a rec" background was determined as 1.2 
X 10"5 (erythromycin selection). It was not possible to detect integration 
of pPQ126 at an observable frequency on BHI without selection, or BHI plus 
10 ug per ml of gentamicin. Although detectable, the integration of pPQ126 
in JBL177 (1.2 x 10"^) occurred at a frequency at least 3 orders of 
Figure 13. Analysis of isolates obtained following a high-temperature 
plasmid-elimination experiment with JBL177 
Lane 1, Hindlll-digested lambda standard (0.30 ug total); 
lane 2, Hindlll-digested JBL85 DNA (30 C, gee); lane 3, 
Hindlll-digested JBL200 DNA (30 C, no selection); lane 4, 
Hindlll-digested JBL201 DNA (30 C, no selection); lane 5, 
Hindlll-digested JBL202 DNA (30 C, g); lane 6, Hindlll-
digested JBL203 DNA (30 C, g); lane 7, Hindlll-digested JBL204 
DNA (30 C, e); lane 8, Hindlll-digested JBL205 DNA (39 G, no 
selection); lane 9, Hindlll-digested JBL206 DNA (39 C, g); lane 
10, Mndlll-digested JBL207 DNA (39 C, e); lane 11, Hindlll-
digested JBL208 DNA (39 C, e); lane 12, Hindlll-digested lambda 
standard (0.30 ug total). 
All DNAs were extracted via the rapid preparation method 
from cells grown overnight in 10 ml of BHI broth and incubated 
at the specified temperature without selection, or in the 
presence of 3 ug/ml of gentamicin (g) or 3 ug/ml of 
erythromycin (e), or 3 ug/ml each of gentamicin and 
erythromycin and 1 ug/ml of chloramphenicol (gee). 
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magnitude lower than the integration of pPQl26 in JBL85 (5.76 x 10"^ ); 
Table 13. The results obtained for JBL177 suggest that integration of 
pPQ126 is highly dependent upon host recombination functions. 
Testing for integration of PP0126 in ISP1846 
To determine the frequency of integration of pPQ126 into a chromosomal 
Tn551 target, pPQ126 was transduced into ISP835 [- ISP1846 8325-4 pig-131 
trp-159::Tn551 ermB317 (pPQ126)]. The results of a high-temperature, 
plasmid-elimination experiment using ISP1846 are presented in Table 15. 
Without selection, cfu were recovered at a frequency of 1.4 x 10^ ® and 1.51 
X 10^ 0 at 30 C and 39 C, respectively. From 30 C, approxmately 8% (11) of 
the 142 isolates tested were Em^Gm® and resistant to only 6 ug/ml of 
chloramphenicol (JBL301), and about 92% (131 of 142) were Em^ Gm^  and 
resistant to 12 ug/ml of chloramphenicol (JBL300). Of the 153 isolates 
screened from the 39 C plates, all displayed the Em®Gm®Cm^ (6 ug/ml) 
phenotype: one isolate, JBL302, was retained for further analysis. The 
phenotype of JBL301 and JBL302 suggested that pPQ126 was missing from these 
isolates. 
When selection was made for gentamicin resistance, isolates were 
recovered from 30 C plates at 1.29 x 10^® cfu per ml, and from 39 C plates 
at 4.2 X 10^ cfu per ml. The 30 C isolates were all Era^ Gm^ Cm^ (12 ug/ml); 2 
isolates, JBL310 and JBL311, were retained. All 84 isolates tested from 39 
C selection expressed the phenotype Em^ Gm^ Cra^ (10 ug/ml): 2 isolates were 
retained for further study (JBL314 and JBL315). 
When selection was made for erythromycin resistance, cfu were 
recovered at a frequency of 1.42 x 10^® from plates incubated at 30 C, and 
Table 15. Testing for integration of pPQ126 in ISP1846^»^ 
Selection PhenotypeC Phenotype^  Integration 
for cfu at 30 C (no. scored) Strain^ cfu at 39 C (no. scored) Strain^  frequency® 
None 1.4 X LOLO 142 A 
B 
(131) 
(11) 
JBL300 
JBL301 
1.5 X LOLO 153 B (all) JBL302 0 
Em^  1.4 X LOLO 113 A (all) JBL304 
JBL305 
3.1 X 108 297 C (all) JBL306 
JBL307 
2.2 X 10-2 
Gm^ 1.3 X LOLO 124 A (all) JBL310 
JBL311 
4.2 X 105 84 C (all) JBL314 
JBL315 
3.3 X 10-5 
aiSP1846 = 8325-4 pig-131 trp-159[Chr;;Tn551 ermB317] (pPQ126). 
^Cells from a fresh streak plate of ISP1846, previously grown with selection at 30 C, were 
harvested into 5 ml sterile saline; serial dilutions were plated onto BHI + 10 ug/ml gentamicin, or 
BHI + 10 ug/ml of erythromycin, or BHI. Duplicate plates at each dilution were incubated at each 
temperature. 
= BmfGmfCmr(12ug/ml), B = Em®Gm®Cm^ (6ug/ml), C = Em^ Gm^ Cm^ (10ug/ml). 
^Designation for representative member of each phenotype retained for further analysis. 
®cfu at 39 C divided by cfu at 30 C for each selection. The frequency was corrected to include 
only the percentage of cells recovered at 39 C that were confirmed phenotypically as plasmid free. 
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at a frequency of 3.13 x 10® cfu from plates incubated at 39 C. Two 
isolates each were retained from plates incubated at 30 C (JBL304 and 
JBL305) and 39 C (JBL306 and JBL307). All 113 isolates screened from 30 C 
plates were EmfGmfCmf(12 ug/ml), and all 297 isolates screened from 39 C 
plates were Em^Gm^Cm^(10 ug/ml). 
The 39 C phenotype for either gentamicin-resistant or 
erythromycin-resistant isolates [Em^Gm^Cm^(10 ug/ml)] was presumptive 
evidence for integration of pPQl26. BHI plates without selection at 39 C 
were Em®Gm® and resistant to only 6 ug/ml of chloramphenicol. To further 
test for the presence or absence of pPQ126, DNA was extracted from the 
following isolates: JBL300, JBL301, JBL302, JBL304, JBL305, JBL306, JBL307, 
JBL310, JBL311, JBL314, and JBL315. Following digestion of these 
preparations of DNA with HindiII, samples were analyzed by gel 
electrophoresis for the presence of pPQ126 fragments. Isolates presumed to 
contain integrated pPQ126, based on phenotype (JBL306, JBL307, JBL314, and 
JBL315), were also shown to be missing autonomous pPQ126 by electrophoretic 
analysis (data not shown). Although JBL302 was also missing pPQ126 (data 
not presented), the phenotype of this isolate [Em®Gm®Cm^(6 ug/ml)] 
suggested loss of pPQ126 rather than integration. The 30 C isolates that 
displayed the autonomous pPQ126 phenotype yielded pPQ126 Hindi11 fragments : 
JBL300, JBL304, JBL305, JBL310, and JBL311 (data not presented). 
Using both phenotypic data (Table 15) and molecular data, the 
integration frequency of pPQ126 in a Tn551 target was calculated to be 2.2 
X 10"2 for erythromycin selection, and 4.2 x 10"^  for gentamicin selection. 
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Testing for transposition of Tn917 in ISP1578 
For comparative purposes, a high-temperature, plasmid-elimination 
experiment was performed using ISP1578 to obtain phenotypic and gel 
electrophoretic evidence for transposition of Tn917. and elimination of 
pTVlts- The results of this experiment are presented in Table 16. Without 
selection, 1.06 x 10^ ® cfu per ml were recovered at 30 C, and 9.85 x 10^  
cfu per ml were recovered at 39 C. All 102 isolates screened from the 30 C 
plates displayed the phenotype for autonomous pTVl^s [EmfCm^ ClZ ug/ml)]. 
All 112 isolates screened from the 39 C plates displayed the pTVlj-g-minus 
phenotype [Em®Cm^ (6 ug/ml)]. JBL316 and JBL317 were retained to represent 
isolates obtained without selection at 30 C and 39 C, respectively; 
When selection was made for resistance to 10 ug/ml of erythromycin 
(see Table 16), 8.35 x 10^  cfu per ml were recovered at 30 C and 2.03 x 10^  
cfu per ml were recovered at 39 C. Of 84 Em^ isolates tested from 30 C 
masters, all were resistant to 10 ug/ml of erythromycin and 12 ug/ml of 
chloramphenicol; one isolate was retained (JBL319). Of 181 isolates 
screened from the 39 C erythromycin-selection plates, all were Em^Cra^(6 
ug/ml); a single isolate, designated JBL320, was retained. 
DNA was isolated from JBL316, JBL317, JBL319, and JBL320. Following 
digestion with Hindlll, the DNA was analyzed electrophoretically. The 30 C 
isolates (JBL316 and JBL319) contained pPQ126, whereas this plasmid was not 
present in the 39 C isolates (JBL317 and JBL320) [data not presented]. By 
using gel electrophoresis data and phenotypic data (Table 16), the 
transposition frequency of Tn917 in ISP1578 was determined as 2.43 x 10'^. 
Although this value is slightly higher than the published transposition 
Table 16. Testing for transposition of Tn917 in ISP1578^'^ 
Selection PhenotypeC 
Strain^  
PhenotypeC 
Strain^  
Integration 
for cfu at 30 C (no. scored) cfu at 39 C (no. scored) frequency® 
None 1.06 X lolo 102 A (all) JBL316 9.85 X 109 112 B (all) JBL317 0 
Em^  8.35 X 109 84 A (all) JBL319 2.03 X 10? 181 C (all) JBL320 2.43 X 10-3 
aiSP1578 = 8325-4 pig-131 (pTVlfg). 
bCells from a fresh streak plate of ISP1578, previously grown with selection at 30 C, were 
harvested into 5 ml sterile saline; serial dilutions were plated onto BHI + 10 ug/ml of erythromycin, 
or BHI. Duplicate plates at each dilution were incubated at each temperature. 
= Em^Cm^(12ug/ml), B = Em®Cm^(6ug/ml), C = Em^ Cm^ (6ug/ml). 
^Designation for representative member of each phenotype retained for further analysis. 
®cfu at 39 C divided by cfu at 30 C for each selection. The frequency was corrected to include 
only the percentage of cells recovered at 39 C that were confirmed phenotypically as plasmid free. 
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frequency for Tn917 (5 x 10"^ to 5 x 10"^ ; Youngman, 1985), it compares 
closely to the frequency of 1.46 x 10"^ for transposition of Tn917 in 
ISP1483 (Table 11). 
Table 17 summarizes results from the experiments testing for 
integration of pPQ126 in the presence of homologous chromosomal target 
sequences (e.g., ISP1846 and JBL85) and/or in a rec" background (JBL177). 
Table 17 also contains results from experiments testing a situation where 
pPQ126 should not integrate (ISP1844), and testing the transposition 
frequency of Tn917 from pTVl^ s (ISP1578). 
The use of high molecular weight DNA isolated from ISP1846 for the 
isolation and transfer of chromosomally integrated pPQ126 
Previous data demonstrated that growth of ISP1846 at 39 C, in the 
presence of either erythromycin or gentamicin, resulted in chromosomal 
integration of plasmid pPQ126 (see Table 15). To confirm that pPQ126 was 
integrated, high molecular weight DNA was prepared from cells of ISP1846 
grown at 43 C, and was used to transform competent cells of ISP5. As shown 
previously (Table 4), competent cells of S. aureus did not readily 
internalize plasmid molecules; therefore, Em^Gm^Cm^ transformants would 
only result from transfer of chromosomally integrated, not autonomous, 
pPQ126. As shown in Table 18, several Em^Gm^Cm^ transformants were 
recovered following transformation of ISP5 with DNA prepared from ISP1846: 
all incubations for this transformation were performed at 39 C. Of 33 Em^ 
transformants recovered, class A (12 of 33) and class H (1 of 33) 
demonstrated transfer of pPQ126 markers only [Em^Gm^Cm^(9 ug/ml)]. All 
other classes showed transfer of pPQ126 markers [Em^Gm^Cm^(9 ug/ml)], and 
Table 17. Summary of results from testing for integration of pPQ126 in different genetic backgrounds 
and testing for transposition of Tn917 from pTVlj-g^  
Strain 
Chromosomal 
target 
Selection 
for 
Antibiotic^ cfu 
30 C 
Antibiotic^ cfu 
39 C 
Integration 
frequency 
ISP1844 none Em^ 3.20 X 109 <1 X 104 0 
ISP1844 none Gm^  2.60 X 109 4.00 X 106 0 
JBL85 Tn4001 Em^  7.60 X o
 00
 
4.40 X 107 5.76 X 10-2 
ISP1846 Tn551 Em^  1.40 X LOLO 3.10 X 108 2.20 X 10-2 
ISP1846 Tn551 Gm^  1.30 X LOLO 4.20 X 105 3.30 X 10-5 
JBL177 Tn4001 Em^  6.90 X 109 8.40 X 104 1.20 X 10-5 
ISP1578 none Em^  8.35 X 109 2.03 X 10? 2.43 X 10-3.b 
&A11 data were obtained from Tables 14 through 18. 
T^ransposition frequency of Tn917, not an integration frequency for pTVl^g. 
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Table 18. Isolation of pPQ126 integration events by transforming ISP5 with 
DNA extracted from ISP1846 after growth at 43 C with selection^  
% recombinants in classFrequency^  of 
Phenotype A B C DEFGH Transfer- Rever-
(no. scored) mation sion 
Em^ (33) 36.4 21.2 12.1 9.0 6.1 6.1 6.1 3.0 50 0 
^ISP5 8325 thv-101 thrB106 ilv-129 pig-131 
ISP1846 8325-4 pig-131 trp-159::Tn551 ermB317 (pPQ126). 
^Classes: A, Em^ Gm^  Cm'- (9 ug/ml) Trp+ Thy" Thr" ; B, Em^ Gm® Gm^ (9 
ug/ml) Trp" Thy" Thr"; G, Em^ Gm^ Gm^ (9 ug/ml) Trp" Thy" Thr"; D, Em^ Gm^ 
Cm^  (9 ug/ml) Trp" Thy" Thr"*"; E, Em^ Gm^ Gm^ (9 ug/ml) Trp" Thy"^  Thr"; F, 
Em^ Gm^ Gm^  (9 ug/ml) Trp" Thy" Thr"*"; G, Em^ Gm^  Gm^ (9 ug/ml) Trp"*" Thy"*" 
Thr": H, Em^ Gm^  Gm^  (6 ug/ml) Trp+ Thy" Thr". 
GExpressed as colonies recovered per 10^  cfu of the transformation or 
control suspension spread onto the selective media; 0.66 x 10^ cfu per ml 
of the transformation suspension and excess DNA were used. The selective 
medium was BHI plus 1 ug/ml of erythromycin (Emf), and all incubations and 
platings were performed at 39 G. 
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chromosomal determinants (trp. or tvr. or thr) from ISP1846 to ISP5. To 
determine whether pPQ126 existed as an autonomous or integrated replicon in 
these transformants, DNA was extracted from one member of each class. 
Following digestion with HindiII and agarose-gel analysis, all classes 
demonstrated the absence of autonomous pPQ126 (data not presented). 
The effect of temperature on the stability of chromosomallv 
integrated PP0126 
It was important to confirm that pPQ126 was chromosomally integrated 
in isolates obtained following growth at elevated temperature in the 
presence of homologous chromosomal DNA. As described previously for JBL85, 
it was possible to recover isolates (e.g., JBL113 or JBL114) that displayed 
the pPQl26 phenotype following growth at 39 C [Em^Gm^Cm^(10 ug/ml)]. 
Furthermore, these isolates were shown by agarose-gel electrophoresis to be 
lacking autonomous pPQ126. Also recovered, were isolates from 30 C that 
contained autonomous pPQ126 [Em^ Gm^ Cm^ (14 ug/ml)], and isolates from 39 C 
that had lost pPQ126 [Em^Gm^Cm (^6 ug/ml)]. Assuming that pPQ126 was 
present as an integrated replicon in JBL113 or JBL114, only the elevated 
temperature (39 C) was responsible for assuring that pPQ126 was maintained 
in the integrated state. 
To test if lowered temperature would result in excision and autonomous 
replication of pPQ126, JBL113 was streaked for isolation onto two plates of 
BHI plus gentamicin (3 ug/ml), erythromycin (3 ug/ml), and chloramphenicol 
(1 ug/ml); one plate was incubated at 30 C and the other at 39 C. A 
loopful of cells from the 30 C streak plate was used to inoculate 10 ml of 
BHI (same selection) for overnight growth at 30 C, and a loopful of cells 
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from the 39 C streak plate was used to inoculate 10 ml of BHI (same 
selection) for overnight growth at 39 C. DNA was extracted from both 
preparations of JBL113, digested with Hindlll. and subjected to agarose-gel 
electrophoresis (Figure 14). For comparative purposes, DNA was also 
extracted from JBL85, JBLlOl, JBL107, JBL108, and ISP1565. Lane 3, the 
negative control, shows the absence of plasmid DNA in ISP1565. As a 
positive control, lane 5 contained the 11.1-kb and 2.5-kb Hindlll fragments 
of pPQ126 isolated from JBL85 (grown with selection at 30 C). JBLlOl and 
JBL107 displayed the pPQ126 phenotype at 30 C, and as expected, showed the 
pPQl26 Hindlll pattern in lanes 7 and 9, respectively. JBL108, which is of 
the pPQ126-minus phenotype, does not harbor pPQ126 DNA (see lane 11). As 
discussed previously, JBL113 grown at 39 C with selection displayed the 
phenotype for integrated pPQ126 [Em^Gm^Cm^(10 ug/ml)], and was shown by 
electrophoretic analysis to lack autonomous pPQ126: lane 15 further 
supports these earlier results. Following growth of JBL113 at 30 C with 
selection, however, pPQ126 appeared to excise imprecisely from the 
chromosome. As shown in lane 13, three Hindlll fragments are clearly 
visible following digestion of DNA extracted from JBL113 grown at 30 C. 
Two of the bands corresponded exactly to the two Hindlll fragments of 
pPQ126 (compare lane 13 to lane 5). The extra fragment (approximately 7 kb 
in length) is thought to be chromosomal DNA adjacent to the chromosomal 
insertion site of pPQ126 (see below). 
Figure 14. Analysis of isolates obtained following a high-temperature 
plasmid-elimination experiment with JBL85 
Lane 1, Hindlll-digested lambda standard (0.30 ug total); 
lane 2, uncut ISP1565 DNA (30 C, no selection); lane 3, 
Hindlll-digested ISP1565 DNA (30 C, no selection); lane 4, 
uncut JBL85 DNA (30 C, gee); lane 5, Hindlll-digested JBL85 DNA 
(30 C, gee); lane 6, uncut JBLlOl DNA (30 C, gee); lane 7, 
Hindlll-digested JBLlOl DNA (30 C, gee); lane 8, uncut JBL107 
DNA (30 C, gee); lane 9, Hindlll-digested JBL107 DNA (30 C, 
gee); lane 10, uncut JBL108 DNA (39 C, no selection); lane 11, 
Hindlll-digested JBL108 DNA (39 C, no selection); lane 12, 
uncut JBL113 DNA (30 C, gee); lane 13, Hindlll-digested JBL113 
DNA (30 C, gee); lane 14, uncut JBL113 DNA (39 C, gee); lane 
15, Hindlll-digested JBL113 DNA (39 C, gee). 
All DNAs were extracted via the rapid preparation method 
from cells grown overnight in 10 ml of BHI broth and incubated 
at the specified temperature without selection, or in the 
presence of 3 ug/ml each of gentamiein and erythromycin and 1 
ug/ml of chloramphenicol (gee). 
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Transformation of ISP5 with high molecular weight DNA 
extracted from JBL85 previously grown at 43 C 
High molecular weight DNA was extracted from a population of cells of 
JBL85 grown at 43 C, and was used to transform competent cells of ISP5. 
Selection was made for resistance to erythromycin. To determine if pPQ126 
would remain integrated following transformation under permissive 
conditions, all incubations were performed at 34 C. The results of this 
experiment are presented in Table 19. Although only 7 Em^  transformants 
were recovered, these transformants comprised three distinct phenotypic 
classes: class A (3 of 7) were Em^Gm^Cm^(12 ug/ml) Ilv-; class B (2 of 7) 
were Era^ Gm®Cm^ (12 ug/ml) Ilv-; and class C (2 of 7) were Em'-Gm^Cm'-(12 
ug/ml) Ilv"^ , A single member from each class was retained for further 
analysis: JBL89, class A; JBLSB, class B; JBL87, class C. All three 
classes were resistant to erythromycin and chloramphenicol, and JBL87 and 
JBL89 were also resistant to gentamicin. It was assumed that some form of 
autonomous plasmid DNA was present because each isolate was resistant to 12 
ug/ml of chloramphenicol. In addition, JBL87 transferred a chromosomal 
determinant from JBL85 to ISP5 (Ilv"*"). 
Following extraction and subsequent digestion of DNA isolated from 
JBL89, JBL88, and JBL87, the DNA preparations were analyzed by agarose-gel 
electrophoresis (Figure 15). As described below, all 3 isolates harbored 
at least one fragment of pPQ126 DNA. Lane 7 contains Hindlll-cut DNA 
isolated from ISP5 to show that plasmid DNA was not present prior to 
transformation with JBL85 DNA. JBL89 DNA (lane 9) contained the 2.5 kb Hin 
fragment of pPQ126, and 3 additional bands approximately 8.5 kb, 7.5 kb, 
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Table 19. Isolation and analysis of transformants obtained by transforming 
ISP5 with DNA extracted from JBL85 after growth at 43 C with 
selection^  
% recombinants in classFrequency^ of: 
Phenotype ABC Transfor- Rever-
(no. scored) mation sion 
Emr (7) 42.86 28.57 28.57 10 0 
aiSPS 8325 thy-101 thrB106 ilv-129 pig-131 
JBL85 8325 pig-131 w[Chr;;Tn4001]1210 (pPQ126). 
^Classes: A, Em^ Gm^ Cm^ (12 ug/ml) Ilv"; B, Em^ Gm® Cm^ (12 ug/ml) 
Ilv"; C, Em^ Gm^ Cm^  (12 ug/ml) Ilv+. 
E^xpressed as colonies recovered per 10^  cfu of the transformation or 
control suspension spread onto the selective medium; 0.88 x 10^  cfu per ml 
of the transformation suspension and excess DNA were used. The selective 
media was BHI plus 1 ug/ml of erythromycin (Em^), and all incubations and 
platings were performed at 34 G. 
Figure 15. Analysis of transformants obtained from transformation of ISP5 
with DNA extracted from JBL85 previously grown with selection 
at 43 C 
Lane 1, Hindlll-digested lambda standard (0.30 ug total); 
lane 2, uncut ISP1565 DNA (g); lane 3, Hindlll-digested ISP1565 
DNA (g); lane 4, uncut JBL85 DNA (gee); lane 5, Hindlll-
digested JBL85 DNA (gee); lane 6, uncut ISP5 DNA (no 
selection); lane 7, Hindlll-digested ISP5 DNA (no selection); 
lane 8, uncut JBL89 DNA (gee); lane 9, Hindlll-digested JBL89 
DNA (gee); lane 10, uncut JBL87 DNA (gee); lane 11, Hindlll-
digested JBL87 DNA (gee); lane 12, uncut JBL88 DNA (ec); lane 
13, Hindlll-digested JBL88 DNA (ec); lane 14, Hindlll-digested 
lambda standard (0.30 ug total). 
All DNAs were extracted via the rapid preparation method 
from cells grown overnight in 10 ml of BHI broth and incubated 
at 34 C without selection, or in the presence of 3 ug/ml of 
gentaraicin (g), or 3 ug/ml of erythromycin and 1 ug/ml of 
chloramphenicol (ec), or 3 ug/ml each of gentamicin and 
erythromycin and 1 ug/ml of chloramphenicol (gee). 
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and 4.7 kb in length; the 11.1 kb fragment of pPQ126 was absent. The 
plasmid present in JBL89 was designated pLUCH89. DNA extracted from JBL87 
(lane 11) contained the 11.1 and 2.5 kb fragments of parental pPQ126. DNA. 
obtained from JBL88 (lane 13) was missing the 2.5 kb Hin fragment of 
pPQ126; however, the 11.1 kb Hin fragment of pPQ126 and an additional 4 
fragments approximately 6.5 kb, 2.9 kb, 2.2 kb, and 1.8 kb in size were 
present. The plasmid present in JBL88 was designated pLUCH88. From Figure 
15, it was apparent that absence of the 2.5 kb Hin fragment was responsible 
for the Gm® phenotype of JBL88. The uncut preparation of JBL88 (lane 12) 
contains a small molecular weight band, that does not harbor a recognition 
site for Hindlll. as evidenced by the presence of a single band at the same 
position in lanes 13 (Hindlll-cut) and 12 (uncut). The relationship of 
this band to plasmid pPQ126 is unknown. 
DNA Hybridizations 
For several reasons, most importantly to further confirm that plasmid 
pPQ126 sequences were chromosomally maintained under non-permissive 
conditions, it was necessary to perform hybridization analyses on several 
DNAs. DNA sequences sharing homology with plasmid pPQ126 were cloned into 
pBR322 for use as hybridization probes. The 4.2-kb HinB fragment of pI258 
(ermB gene of Tn551) and the 2.5-kb HlnF fragment of pPQ58 faacA-anhP gene 
of Tn4001) were cloned separately into the unique HindiII site of pBR322 to 
generate plasmids pLUCH75 (JBL75) and pPQ132 (ISP1872), respectively (John 
B. Luchansky, Department of Microbiology, Iowa State University, Ames, 
Iowa, unpublished data). For convenience, [P]-labeled pLUCH75 and ^^ [P]-
labeled pPQ132 are hereafter referred to as the Em^ and Gm^  probes, 
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respectively. The molecular weights (length in kilobase pairs) of the 
majority of the restriction fragments discussed below are estimations based 
on migration of these fragments compared to PstI- and/or Hindlll-digested 
lambda DNÀ. 
Hybridization of pPQ126 sequences to [P]-labeled pPQ132 and 
32[P].labeled pLUCH75 
Plasmid pPQ126 was digested with different restriction 
endonucleases, and the resulting restriction fragments were fractionated by 
agarose-gel electrophoresis. The fragments were then transferred from 
agarose to Magnagraph membranes and hybridized to [P]-labeled DNA probes 
(Figure 16). Fragments sharing homology with either pLUCH75 (Emf probe) or 
pPQ132 (Gmf probe) were detected by autoradiography. Allowing for the 
presence of an additional 2.5-kb HindiII fragment (the Gm^  determinant of 
Tn4001), the digestion profile of pPQ126 in panel A (Figure 16) compares 
exactly to the published restriction map of the parental plasmid (pTVl^ g; 
see Figure 5). 
Digestion of pPQ126 with Xbal produced fragments 12.15 kb and 1.45 kb 
in length (lane 2, panel A), and the 12.15-kb fragment hybridized to both 
the Gm^  and Em^ probes (lane 2, panels B and C, respectively). Although 
the 1.45-kb Xba fragment harbors a portion of the erm-distal arm of Tn917. 
the terminal-repeat segment therein (38 base pairs) did not provide 
sufficient homology for hybridization (see lane 2, panel C). This result 
was not surprising, however, because the erm-distal inverted repeat of 
Tn917 is not entirely homologous to the erm-proximal inverted repeat 
(Perkins and Youngman, 1984). 
Figure 16. Hybridization of ^ ^[P]-labeled pPQ132 and [P]-labeled pLUCH75 
to restriction endonuclease-digested pPQl26 
Panel A: Agarose gel electrophoresis of plasmid pPQ126 
after restriction endonuclease digestion. Lane 1, PstI digest 
of phage lambda DNA (0.75 ug total); lanes 2 through 9, plasmid 
pPQ126 digested with Xbal, Hindlll, Aval, Xbal/Hindlll, 
Xbal/Aval. EcoRI. Sail. and EcoRl/Sall. respectively. 
Panel B: Hybridization of ^ ^[P]-labeled pPQ132 to pPQl26 
DNA, following electrotransfer of the gel in Figure 16A to 
Magnagraph; lane contents are the same as Figure 16A. 
Panel C: Hybridization of ^ ^[P]-labeled pLUCH75 to pPQ126 
DNA, following electrotransfer of the gel in Figure 16A to 
Magnagraph; lane contents are the same as Figure 16A. 
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An 11.1-kb and a 2.5-kb fragment resulted from digestion of pPQ126 
with HindiII (lane 3, panel A). As expected, the 11.1-kb fragment 
(containing Tn917 DNA) hybridized exclusively with the Em^ probe (lane 3, 
panel C), and the 2.5-kb fragment (containing Tn4001 DNA) hybridized 
exclusively with the Gm^  probe (lane 3, panel B). 
Four fragments (6.45, 4.65, 1.75, and 0.75 kb) were visible following 
digestion of pPQ126 with Aval (lane 4, panel A). The 4.65-kb Ava fragment 
contains segments of pPQ126 homologous with both probes; therefore, this 
fragment hybridized to both pPQ132 and pLUCH75 (lane 4 of panels B and C, 
respectively). The 1.75-kb Ava fragment (the erm-proximal arm of Tn912) 
hybridized exclusively to the pLUCH75 probe (lane 4, panel C). 
Lane 5 (panel A) contains pPQ126 DNA digested with both Xbal and 
Hindlll. Three of the expected four fragments are clearly visible (9.42 
kb, 2.5 kb, and 1.44 kb). The fourth fragment, approximately 0.24 kb, 
either exited the gel or was not present in sufficient concentration to be 
visualized. The 9.42-kb Xba/Hin fragment encompasses the erm gene of Tn917 
and hybridized, therefore, to the Em^ probe (lane 5, panel C). The 2.5-kb 
product (the aacA-anhP gene of Tn4001) of the Xba/Hin double digestion 
hybridized exclusively to the Gm^ probe (lane 5, panel B). 
Lane 6 (panel A) of Figure 16 shows the results for digestion of 
pPQ126 with both Xbal and Aval. At least four distinct bands (6.45, 3.94, 
1.75, and 0.58 kb in length) are discernible. Based on the restriction map 
of pPQ126 (see Figure 12), digestion with both Xbal and Aval would be 
expected to produce 6 bands, approximately 6.45, 3.94, 1.75, 0.78, 0.58, 
and 0.10 kb in length. The total concentration of DNA in the 0.10 kb 
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fragment was probably below the limits of resolution for this band to be 
visualized. It is possible that due to incomplete digestion, the 0.78-kb 
fragment remained associated with a higher-molecular weight fragment, or 
that reaction conditions promoted further digestion (e.g., star activity) 
of this fragment to a smaller-molecular weight species. Restriction 
endonucleases, most notably EcoRI. have been observed to cleave sequences 
that are similar (though not identical) to their defined recognition 
sequences. Conditions supporting this star activity include, high 
endonuclease concentration, low ionic strength, and high concentrations of 
glycerol or DMSO (Dr. Joan Brooks, New England Biolabs, Beverly, MA, 
personal communication). 
Digestion of pPQ126 with enzymes that cut only once (e.g., EcoRI and 
Sail) generated a single 13,6-kb fragment that hybridized with both probes 
[lanes 7 (EcoRI) and 8 (Sail). panels A, B, and C, respectively]. Double 
digestion of pPQ126 with both EcoRI and Sail yielded the 2 expected 
fragments, approximately 9.62 kb and 3.98 kb in length (lane 9, panel A). 
Careful inspection of lane 9 (panel A) shows the presence of an additional 
band approximately 7.5 kb in length. This band probably arose due to star 
activity of EcoRI. Although not seen in Figure 16 but discernible in the 
original autoradiogram, the 7.5-kb "star" fragment demonstrated weak (faint 
band present) hybridization to the Em^ probe (data not shown). The 3.98-kb 
Eco/Sal fragment, which includes the Gm^ determinant but not the Em^ 
determinant of pPQ126, hybridized only with the pPQ132 probe (lane 9, panel 
B). Conversely, the 9.62-kb fragment, which includes the erm gene of 
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pPQl26 but not the aacA-aphP gene, hybridized only with the pLUCH75 probe 
(lane 9, panel C). 
Hybridization of restriction endonuclease-digested chromosomal DNAs from 
JBL70, JBL71, and JBL74 to 32[P]-labeled pPQ132 and 32[P]-labeled pLUCH75 
After confirming the hybridization pattern of the pLUCH75 and pPQ132 
probes to autonomous pPQ126 DNA, these same probes were hybridized to bulk 
chromosomal DNA which putatively contained integrated pPQ126. CsCl-
purified chromosomal DNAs from JBL70, JBL71, and JBL74 (three Em^ isolates 
obtained following transformation of ISP5 with chromosomal DNA extracted 
from a population of cells of ISP1846 grown at 43 C; see Table 18) were 
digested separately with HindiII and with EcoRI. The resulting fragments 
were transferred to Magnagraph membranes and hybridized to the Em^ and Gm  ^
probes as described previously. The results of these analyses are 
presented in Figure 17. 
As shown in panel A, digestion of pPQ126 with HindiII (lane 1) 
produced fragments 11.1 kb and 2.5 kb in length, and digestion of this 
plasmid with EcoRI (lane 5) produced a single 13.6-kb fragment. As 
expected, the 11.1-kb Hin fragment hybidized only to the Em^ probe (panel 
C, lane 1), and the 2.5-kb Hin fragment hybridized only to the Gm^  probe 
(panel B, lane 1). Lane 5 of panels B and C demonstrated hybridization of 
both probes to the single 13.6-kb EcoRI fragment of pPQ126. 
Digestion of CsCl-purified DNAs from JBL70, JBL71, and JBL74 with 
either HindiII (panel A, lanes 2, 3, and 4) or EcoRI (panel A, lanes 6, 7, 
and 8) generated the expected ladder of chromosomal fragments. 
Hybridization of EcoRI-digested DNA from the transformants to the Em^ probe 
Figure 17. Hybridization of [P]-labeled pPQ132 and [P]-labeled pLUCH75 
to restriction endonuclease-digested total DNA from JBL70, 
JBL71, and JBL74, and plasmid pPQ126 
Panel A: Agarose gel electrophoresis of chromosomal DNA 
isolated from JBL70, JBL71, and JBL74, and plasmid pPQ126 DNA, 
after restriction endonuclease digestion. Lanes 1 through 4, 
HindiII digests of: lane 1, pPQ126; lane 2, JBL70; lane 3, 
JBL71; lane 4, JBL74. Lanes 5 through 8, EcoRI digests of: 
lane 5, pPQ126; lane 6, JBL70; lane 7, JBL71; lane 8, JBL74. 
Panel B: Hybridization of 32[P]-labeled pPQ132 to the DNA 
restriction fragments shown in Figure 17A, following 
electrotransfer of this gel to Magnagraph; lane contents are 
the same as Figure 17A. 
Panel C: Hybridization of [P]-labeled pLUCH75 to the DNA 
restriction fragments shown in Figure 17A, following 
electrotransfer of this gel to Magnagraph; lane contents are 
the same as Figure 17A. 
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(panel C, lanes 6, 7, and 8) yielded a single high-molecular weight 
(greater than 15 kb) band for each isolate. The band for EcoRI-digested 
JBL74 that hybridized to the Em^ probe (panel C, lane 8) was of lower 
molecular weight than the bands for JBL70 and JBL71 (panel C, lanes 6 and 
7, respectively). Hybridization of Hindlll-digested DNAs from these 
transformants to the Em^ probe (panel C, lanes 2, 3, and 4) generated a 
band approximately 4.65 kb for JBL70 and JBL71 (panel C, lanes 2 and 3, 
respectively), and a band approximately 3.5 kb for JBL74 (panel C, lane 4). 
Hybridization of Hindlll- and EcoRI-digested JBL70, JBL71, and JBL74 
DNAs to the Gm^  probe demonstrated the absence of homology (no 
hybridization signal) for JBL70 (panel B, lanes 2 and 6, respectively), and 
a different EcoRI pattern for JBL71 compared to JBL74 (panel B, lanes 7 and 
8, respectively). The Gm® phenotype of JBL70 probably resulted from 
deletion of the Gm^  portion of pPQ126 during integration and/or 
transformation. The band for EcoRI-digested JBL74 that hybridized to the 
Gm^ probe (panel B, lane 8) was of lower molecular weight than the 
corresponding band for JBL71 (panel B, lane 7). 
Hybridization of Hindlll-digested pLUCH88 and pLUCH89 DNA to ^ ^[P]-labeled 
pPQ132 and ^ 2[p].labeled pLUCH75 
To further clarify the derivation of the additional fragments present 
in the Em^ isolates obtained by transforming competent cells of ISP5 with 
DNA extracted from a population of cells of JBL85 grown at 43 (see Table 
19), the Em^ and Gm^  probes were hybridized to pLUCH88 and pLUCH89 DNA. As 
shown in panel A of Figure 18, Hindlll-digested DNAs from .ISP1565 (lane 2) 
and ISP5 (lane 3) produced a ladder of bands, and pPQl26 (lane 4) generated 
Figure 18. Hybridization of [P]-labeled pPQ132 and [P]-labeled pLUCH75 
to HindiII digests of plasmids pPQ126, pLUCH88, and pLUCH89, 
and total DNA from ISP1565 and ISP5 
Panel A: Agarose gel electrophoresis of plasmid and total 
DNA digested with the restriction endonuclease Hindlll. Lane 
1, PstI digest of phage lambda DNA (0.75 ug total); lane 2, 
ISP1565; lane 3, ISP5; lane 4, pPQ126; lane 5, pLUCH88; lane 6, 
pLUCH89. 
Panel B: Hybridization of [P]-labeled pPQ132 to the DNA 
restriction fragments shown in Figure 18A, following 
electrotransfer this gel to Magnagraph; lane contents are the 
same as Figure 18A. 
Panel C: Hybridization of 32[P]-labeled pLUCH75 DNA to the 
DNA restriction fragments shown in Figure 18A, following 
electrotransfer this gel to Magnagraph; lane contents are the 
same as Figure 18À. 
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the 11,1-kb and 2.5-kb fragments. The Gm^  probe (panel B, lane 2) 
hybridized to a 2.5-kb fragment of Hindlll-digested ISP1565 DNA [a fragment 
derived from the chromosomal insertion of Tn4001 (w[Chr;;Tn4001]1210) in 
ISP1565]. The Em^ probe did not hybridize to ISP1565 (panel C, lane 2). 
As expected, ISP5 DNA did not hybridize to either probe (panels B and C, 
lane 3). For Hindlll-digested pPQ126 DNA, the 11.1-kb fragment hybridized 
to the Em^ probe (panel C, lane 4), and the 2.5-kb fragment hybridized to 
the Gm^  probe (panel B, lane 4). 
Digestion of pLUCH88 with HindiII produced 5 distinct bands: 11.1 kb, 
6.5 kb, 2.9 kb, 2.2 kb, and 1.8 kb (panel A, lane 5). The 11.1-kb fragment 
hybridized to the Em^ probe (panel C, lane 5), and the two smallest 
fragments (2.2 kb and 1.8 kb) hybridized to the Gm^  probe (panel B, lane 
5). The 6.5- and 2.9-kb fragments of Hindlll-digested pLUCH88 did not 
hybridize to either of the probes tested (panels B and C, lane 5). 
Digestion of pLUCH89 with Hindlll generated 4 distinct fragments, 
approximately 8.5, 7.5, 4.7, and 2.5 kb in length (panel A, lane 6). The 
two smaller fragments (4.7 kb and 2.5 kb) hybridized to the Gm^  probe 
(panel B, lane 6), and the two larger fragments (8.5 kb and 7.5 kb) 
hybridized to the Em^ probe (panel C, lane 6). 
Hybridization of ISP5, pPQ126, and pLUCH88 DNAs to 32[P]-labeled pLUCH88 
To determine the origin of the additional fragments present in pLUCH88 
(JBL88), CsCl-purified plasmid pLUCH88 DNA was labeled with 32[p]-dCTP and 
probed to chromosomal DNA from ISP5 and plasmids pPQ126 and pLUCH88 (Figure 
19). Uncut pPQ126 (panel A, lane 2) contained a dominant CGC band, and 
trace amounts of linear, OC, and multimeric configurations. Digestion of 
Figure 19. Hybridization of [P]-labeled pLUCH88 to uncut and Hindlll-
digested preparations of total DNA from ISP5 and plasmids 
pPQ126 and pLUCH88 
Panel A: Agarose gel electrophoresis of plasmids pPQ126 
and pLUCH88 and chromosomal DNA from ISP5. Lane 1, HindiII 
digest of phage lambda DNA (0.75 ug total). Lanes 2 through 4, 
uncut preparations of: lane 2, pPQ126; lane 3, ISP5; lane 4, 
pLUCH88. Lanes 5 through 7, Hindlll digests of: lane 5, 
pPQl26; lane 6, ISP5; lane 7. pLUCH88. 
Panel B: Hybridization of [P]-labeled pLUCH88 to the gel 
in Figure 19A, following electrotransfer of this gel to 
Magnagraph; lane contents are the same as Figure 19A. 
183 
A B 
1  2 3 4 5 6 7  1  2 3 4 5 6 7  
K b  
2 3  . 7  
9 . 5  
6 .6 
4  . 2  
2  . 3  
2 .0 
i w 
0 .6 —-
184 
pPQl26 with Hindlll (panel A, lane 5) generated the 11.1-kb and 2.5-kb 
fragments. 
Several plasmid bands were present in the uncut preparation of pLUCH88 
DNA (panel A, lane 4). Although the origin of these additional plasmid 
species remains unknown, it was determined that pLUCH88 bands (panel A, 
lane 4) that migrated faster than (below) the 6.6 kb fragment of Hindlll-
digested lambda DNA did not hybridize to the Em^ or Gm^ probes (data not 
presented), 
As expected, all sequences of uncut and Hindlll-digested pPQ126 and 
pLUCH88 DNAs hybridized to the [P]-labeled pLUCH88 probe (panel B, lanes 
2 and 5 and lanes 4 and 7, respectively). Identical results were obtained 
when [P]-labeled pPQ126 was utilized to probe the gel in Figure 19A (data 
not shown). 
For ISP5 DNA, a single, high-molecular weight band for the uncut 
preparation and a ladder of bands for the Hindlll-digested preparation were 
observed (panel A, lanes 3 and 6, respectively). The pLUCHSS probe did not 
hybridize with ISP5 DNA. These results suggest that plasmid DNA(s) of 
JBL88 were not of chromosomal origin; therefore, these sequences are most 
probably derived from pPQ126, or deleted derivatives of plasmids pPQ126 
and/or pLUCH88. As a control, plasmids pPQ126, pLUCH75, and pPQ132 were 
separately labeled with ^^ [P]-dCTP and separately hybridized to the gel in 
Figure 19A; these probes did not hybridize to ISP5 DNA (data not 
presented). 
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Hybridization of ISP5, ISP1565, pLUCH113, and pPQ126 DNAs to [P]-labeled 
pPQ126 and 32[p].labeled pLUCH113 
Plasmid pLUCHllS was generated by growing JBL113 (contains 
chromosomally integrated pPQ126 when maintained at 39 C) at a permissive 
temperature (30 C) in the presence of 3 ug/ml each of erythromycin and 
gentamicin and 1 ug/ml of chloramphenicol (see Figure 14). To determine 
the origin of the additional 7.0-kb fragment of Hindlll-digested pLUCH113, 
CsCl-purified pLUCH113 and pPQ126 DNAs were labeled with ^ ^[P]-dCTP and 
hybridized to total DNA from ISP5 and ISP1565 and to plasmids pPQ126 and 
pLUCH113 DNAs. As shown in Figure 20A, uncut total DNA from ISP5 and 
ISP1565 yielded a dense, high-molecular weight band (panel A, lanes 2 and 
3, respectively). These same DNAs produced the expected ladder of 
fragments when digested with Hindlll (panel A, lanes 6 and 7, 
respectively). Uncut pLUCH113 (panel A, lane 4) displayed a dominant CGC 
band that migrated to the same relative position as the CGC band of uncut 
pPQ126 DNA (panel A, lane 5). The dominant CGC band for both pLUGH113 and 
pPQ126 occupied the same position in Figure 20A (lanes 4 and 5, 
respectively) as the 9.5-kb fragment of the Hindlll- digested lambda 
standard (panel A, lane 1). Also present in the uncut preparation of 
pLUCH113 was linear, OC, and multimeric configurations; however, there was 
also an additional (higher molecular weight) CGC band. The uncut 
preparation of pPQl26 (panel A, lane 5) showed traces of linear and OC 
conformations, but no additional GGG band. As shown in lane 8 (Figure 
20A), digestion of pLUCH113 DNA with Hindlll yielded the 11.1-kb and 2.5-kb 
fragments, as well as an additional fragment approximately 7.0 kb in size. 
Figure 20. Hybridization of [P]-labeled pPQ126 and [P]-labeled 
pLUCH113 to uncut and Hindi11-di ges ted preparations of total 
DNA from ISP5 and ISP1565 and plasmid pLUCH113, and uncut 
plasmid pPQ126 DNA 
Panel A: Agarose gel electrophoresis of chromosomal DNA 
from ISP5 and ISP1565 and plasmids pPQ126 and pLUCH113. Lane 
1, HindiII digest of phage lambda DNA (0.9 ug total). Lanes 2 
through 5, uncut preparations of: lane 2, ISP5; lane 3, 
ISP1565; lane 4, pLUCH113; lane 5, pPQ126. Lanes 6 through 8, 
HinduI digests of: lane 6, ISP5; lane 7, ISP1565; lane 8, 
pLUCH113. 
Panel B: Hybridization of [P]-labeled pPQ126 to the gel 
in Figure 20A, following electrotransfer of this gel to 
Magnagraph; lane contents are the same as Figure 20A. 
Panel C: Hybridization of [P]-labeled pLUCH113 to the 
gel in Figure 20A, following electrotransfer of this gel to 
Magnagraph; lane contents are the same as Figure 20A. 
187 
188 
Both probes demonstrated weak hybridization (faint signal) to non-
digested ISPS DNA (panels B and C, lane 2). As shown in Table 1, ISP5 does 
not contain chromosomal insertions of either Tn551 or Tn4001 or sequences 
that may share homology with pPQ126; therefore, the signal generated in 
lane 2 of panels B and C was not expected. HirjdIII-digested ISP5 DNA did 
not hybridize to [P]-labeled pPQ126. As a consequence of digestion with 
Hindi!I, it is possible that sequences responsible for hybridization of 
pPQ126 to uncut ISP5 DNA were distributed throughout the ladder of 
fragments and, therefore, were not present in sufficient length and/or 
concentration to generate a hybridization signal. The faint signal in lane 
6 of panel C demonstrated that the pLUCH113 probe hybridized to a high 
molecular-weight fragment (greater than 15 kb) of Hindlll-digested ISP5 
DNA. This fragment was more apparent after longer exposure of Magnagraph 
(containing sequences present in Figure 20A) to additional X-ray films 
(data not presented). Because [P]-labeled pLUCH113 DNA (but not 32[p]_ 
labeled pPQ126 DNA) hybridized to Hindlll-digested chromosomal DNA from 
ISP5, it was concluded that the hybridization signal (panel C, lane 6) was 
mediated by the additional 7.0-kb fragment present in pLUCH113. 
Uncut DNA from ISP1565 hybridized to both probes (panels B and C, lane 
3) due to the presence of a chromosomal insertion of Tn4001 in this strain. 
A 2.5-kb fragment (that included the aacA-aphP gene of Tn4001) was expected 
among the ladder of fragments generated following digestion of total DNA 
from ISP1565 with Hindlll. Both probes, therefore, hybridized to a 2.5-kb 
fragment of Hindlll-digested ISP1565 DNA (panels B and C, lane 7). 
Furthermore, the pLUCHll3 probe hybridized to 2 additional fragments of 
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Hindlll-digested ISP1565 DNA (panel C, lane 7). The larger of the two 
fragments (about 15 kb) occupied the same relative position (migrated the 
same distance) as the fragment of Hindlll-digested ISP5 DNA that also 
hybridized to [P]-labeled pLUCH113. The smaller of the two fragments 
(about 8.0 kb) was unique to ISP1565 DNA. 
Digestion of pLUCH113 DNA with HindiII yielded 3 distinct fragments 
(11.1, 7.0, and 2.5 kb). Although both probes hybridized to the 11.1- and 
2.5-kb fragments, only pLUCH113 hybridized to the additional 7.0-kb 
fragment (compare panels B and C, lane 8). Based on this data, it was 
concluded that the additional 7.0-kb fragment present in pLUCH113 was not 
derived from plasmid pPQ126. 
As a consequence of temperature-downshift [from non-permissive (39 C) 
to permissive (30 C) conditions] in the presence of selective levels of 
erythromycin, gentamicin, and chloramphenicol, plasmid pPQ126 and 
chromosomal DNA were excised from the chromosome (Figures 14 and 20). This 
process is hereafter referred to as plasmid disintegration. 
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DISCUSSION 
Several investigators have utilized integrable plasmids to facilitate 
genomic analysis and gene cloning in B. subtilis (Fahnestock et al., 1986; 
Ferrari et al., 1983; Niaudet et al., 1982; Young, 1983). Plasmid 
insertion vectors have been useful for chromosomal mapping (Haldenwang et 
al., 1980), for cloning and studying genes involved in sporulation 
(Youngman et al., 1984a), for gene replacement studies (Stahl and Ferrari, 
1984), and for complementation analysis (Saunders et al., 1984a). These 
plasmids are inherited by recombination between plasmid sequences and 
homologous DNA present on the chromosome of a Gram-positive host. The 
primary objective of this study was to develop an integrable plasmid to 
facilitate the genomic analysis of S. aureus. 
Initially, efforts were directed to adapt an established insertion 
vector for use in S. aureus. An approach similar in principle to that of 
Youngman et al. (1984a) for constructing vectors to recover chromosomal 
Tn917 insertions was employed in this study. The utility of the insertion 
vector (pLUCH3) was increased by using a portion of a transposon (the ermB 
gene of Tn551) as the homologous segment. Integration could theoretically 
be directed into any region of the chromosome containing a copy of the same 
(Tn55i) or a similar transposon (Tn917). Several insertions of Tn551 were 
available for targeting plasmid integration (Luchansky and Pattee, 1984), 
and several chromosomal insertions of Tn917 have recently been obtained in 
S. aureus (J. B. Luchansky, Department of Microbiology, Iowa State 
University, Ames, Iowa, unpublished data; C. Hasegawa, Department of 
Microbiology, Iowa State University, Ames, Iowa, personal communication). 
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Several genes from plasmid pI258 have been cloned, Including blaZ 
(Saunders et al., 1984a), and the genes encoding for resistance to mercury 
fmerA and merB^ and cadmium f(cadA and cadB): Witte et al., 1986]. Prior 
to cloning the ermB gene of Tn551. however, it was necessary to confirm the 
presence of various restriction sites on plasmids pJHlOl and pI258. The 
results in Figure 6 after digestion of these two plasmids with EcoRI, and 
digestion of pJHlOl with Hindlll. compare well with published results 
(Novick et al., 1979c; Ferrari et al., 1983), The only anomaly was the 
presence of 13 distinct HindiII fragments of pI258, compared to the eleven 
Hindlll fragments reported by Wilson and Baldwin (1978). For the purposes 
of this study, it was only necessary to identify and recover the HinB 
fragment of pI258 (ermB gene). It should also be mentioned that it was not 
possible to enrich for pJHlOl with either spectinomycin (300 ug/ml) or 
chloramphenicol (170 ug/ml). There was no discernible difference in DNA 
concentration between amplified and non-amplified preparations of pJHlOl as 
determined by spectrophotometric and electrophoretic analysis (data not 
shown). These results were not expected because pJHlOl replicates in E. 
coli by using an amplifiable Col El-derived origin of replication (Clewell, 
1972). It is possible that the lower than expected yield of plasmid DNA 
from amplified preparations reflected a decreased source of DNA (fewer 
cells in the amplified compared to the non-amplified preparation because of 
bacteriostatic effects of these antibiotics), and not the inability to 
amplify for pJHlOl. Efforts were not directed to examine the amplification 
process in more detail. 
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The 2.8-md HinB fragment of plasmid pI258 was isolated directly from 
agarose and ligated to CIP-treated, Hindlll-digested pJHlOl to generate 
plasmid pLUCHS. Surprisingly, few E. coli transformants were obtained 
(data not shown). The procedure utilized to transform competent cells of 
E. coli was reported by Dagert and Ehrlich (1979) to routinely yield 2 x 
10^ transformants per ug of pBR322 DNA. This value does not compare 
favorably with the 4,5 x 10^ transformants recovered per ug of pLUCH3 DNA 
(data not presented). At least two explanations can be proposed to explain 
this anomaly. As a consequence of CIP-treatment, one nick would remain 
unligated at each join of pLUCH3, and nicked or open circular molecules 
transform E. coli less efficiently than CGC molecules (Cohen et al., 1973). 
Also, plasmid pLUCH3 (6.39 md) is larger than pBR322 (2.9 md), and the 
transformation frequency decreases as the size of the plasmid increases 
(Hanahan, 1983). Of the 10^ Ap^  transformants obtained, about 7% (7 of 
105) were also Tc®, and only about 2% (2 of 105) contained S. aureus 
passenger DNA (data not shown). Lee and landolo (1985) reported that 
approximately 75% of the E. coli transformants recovered when cloning S,. 
aureus passenger DNA into the BamHI site of CIP-treated pBR322 were 
putative recombinant-containing clones. Ferrari et al. (1983), however, 
reported that only 27% of the Ap^  transformants were Tc® when B. subtilis 
passenger DNA was cloned into the BamHI site of a derivative of plasmid 
pBR322. Because the HindiII site of pJHlOl lies within the Pribnow box of 
the Tc^ gene, many false-negative (Tc^ ) transformants could have resulted 
from the initiation of transcription of the Tc^ gene from a promoter on the 
passenger fragment, or by re-creation of the site upon insertion of 
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passenger DNA. The lowered transformation frequency, as well as the poor 
recovery of recombinant molecules among the transformants that were 
obtained, could be accounted for by sub-optimal conditions for 
transformation, ligation, and CIP-treatment. Although the desired 
recombinant plasmid was obtained (pLUCH3), future efforts should be 
directed to optimize conditions for improved recovery of transformants 
containing recombinant plasmids. 
It is noteworthy that the ermB gene of Tn551 was expressed from 
plasmid pLUCH3 in E. coli. Of the four erythromycin-resistant determinants 
available in S. aureus. only the ermA [(TnSSAI: Murphy and Lofdahl, 1984] 
and ermC [(pE194); Barany et al., 1982] genes have been reported previously 
to be expressed in E. coli. The erm determinant of Tn917 does not express 
at selectable levels in E. coli (Youngman et al., 1984a). Despite 
extensive DNA sequence homology and restriction map similarity (Shaw and 
Clewell, 1985; Perkins and Youngman, 1984), Tn551 and Tn917 encode for 
constitutive and inducible resistance to erythromycin, respectively, in S. 
aureus. The same factors responsible for the regulation of these genes in 
S.. aureus (e.g., different base sequences of the promoter regions) may also 
allow for the recognition and expression of only the ermB gene of Tn551 in 
E. coli. 
Genomic analysis of S. aureus has suffered from the absence of a 
well-defined, high-efficiency system for introducing DNA into competent 
cells. Although comparisons are often made with other Gram-positive 
systems (e.g., B. subtilis). very little is actually known concerning the 
specific mechanism(s) that S."aureus utilizes for binding, internalizing. 
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and processing DNA. Several investigators have transformed competent cells 
of S. aureus with chromosomal or plasmid DNA. (Lindberg and Novick, 1973; 
Lindberg et al., 1972; Lofdahl et al., 1978a; Luchansky and Pattee, 1984; 
Pattee and Neveln, 1975), but it has not been possible to routinely 
transform plasmid DNA into S. aureus in our laboratory (C. D. Bortner and 
J. B. Luchansky, Department of Microbiology, Iowa State University, Ames, 
Iowa, unpublished data). A few transformants were recovered by using 
plasmid pC194; however, transformants were not obtained with plasmids 
pLUCH3 or pI258, despite the fact that ISP130 was competent, as evidenced 
by the recovery of Em^ transformants when chromosomal DNA was used (Table 
4). Lofdahl et al. (1978a) obtained transformants of competent S,. aureus 
at frequencies ranging from 10^ to 10^ per ug of OC or CGC DNA; linear DNA 
produced transformants at 10-fold lower frequency. 
Efforts were made to modify the transformation protocol to more 
closely approximate the conditions used by Lofdahl et al. (1978a), but 
these alterations did not result in improved recovery of plasmid-containing 
transformants (data not shown). Attempts to introduce linear and CGC 
plasmid molecules into competent cells that contained a homologous plasmid 
(e.g., marker-rescue transformation), were also unsuccessful (C. D. 
Bortner, Department of Microbiology, Iowa State University, Ames, Iowa, 
personal communication; J. B. Luchansky, Department of Microbiology, Iowa 
State University, Ames, Iowa, unpublished data). It is likely that several 
factors [e.g., DNA purity, the presence of extracellular nuclease(s), or 
characteristics of the recipient strain] contributed to low recoveries of 
transformants in this study. Although the plasmid DNA preparations used 
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for transformations were not purified by CsCl centrifugation, other 
investigators have obtained transformants by using bulk DNA isolated from 
plasmid-containing S. aureus donor strains (Lindberg and Novick, 1973). 
Most strains of S. aureus produce an extracellular DNase and various 
restriction enzymes, any of which could degrade exogenously supplied DNA. 
A DNase-minus, restrictionless strain of S. aureus has been constructed to 
circumvent this problem (Kondo and Yoshizawa, 1985). Sjostrom et al. 
(1979) also obtained better recovery of plasmid DNA by using a 
restriction-deficient recipient strain of S. aureus for competent-cell 
transformation. 
After repeated failures to introduce pLUCH3 into S. aureus via 
competent-cell transformation, efforts were directed toward the 
transformation of protoplasts with plasmid DNA. Lindberg (1981) obtained a 
10-fold increase in the total number of plasmid-containing transformants 
for protoplast transformation compared to competent-cell transformation of 
S. aureus : however, protoplasts of S. aureus are not transformed with 
chromosomal or linear DNA (Lindberg, 1981; O'Reilly et al., 1986). A 
protoplast transformation system based on the Chang and Cohen (1979) 
protocol for transforming protoplasts of B. subtilis with plasmid DNA was 
adapted for use in this study. As shown in Table 5, pC194 and pI258 
transformed protoplasts of ISP130 at frequencies of 1.18 x 10^ and 8.6 x 
10^ , respectively. When competent-cell transformation of ISP130 (Table 4) 
is compared with protoplast transformation of ISP130 (Table 5), it is 
obvious that protoplasts of S. aureus take up plasmid DNA more readily than 
whole cells take up plasmid DNA. It was not possible, however, to 
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introduce the insertion vector pLUCH3 into S. aureus by either procedure. 
Nevertheless, based on the encouraging results of some preliminary 
experiments, I decided to optimize the protoplast transformation protocol 
to enhance the uptake of plasmid DNA by aureus. 
Two critical parameters of the protoplast transformation protocol were 
the plating regimen and the medium employed to plate the protoplast-DNA 
mixture. As shown in Table 6, R agar routinely yielded more transformants 
than DM3 agar. More pC194 transformants were recovered on R agar 
containing chloramphenicol supplied in an agar overlay than R agar with 
chloramphenicol directly incorporated into the medium. When DM3 agar was 
used, however, more pC194 transformants were recovered when chloramphenicol 
was incorporated directly into the medium than when it was omitted. Chang 
and Cohen (1979) selected for pCl94 transformants on DM3 agar containing 
chloramphenicol, but Lindberg (1981) employed an agar overlay selection 
when adapting this protocol to S. aureus. presumably because it produced 
higher frequencies. For transformation of Streptococcus lactis protoplasts 
with plasmid DNA, Kondo and McKay (1984) determined that agar overlays 
stimulated recovery of transformants (possibly by enhancing the 
regeneration frequency), and negated the variability in results obtained 
when spread plates were used. Regardless of the regeneration medium or the 
manner in which the selective agent was applied, more transformants were 
recovered when the protoplast-DNA mixture was allowed to incubate at 30 C 
for 3.5 h prior to plating (plating method 2), than when this mixture was 
plated immediately (plating method 1). Based on the data in Table 5 (and 
because R agar without an overlay was considerably less time-consuming and 
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less complicated to prepare), the protoplast-DNA mixture was plated on R 
agar plus the selective agent after a 3.5-h incubation at 30 C to enable 
phenotypic expression of plasmid-borne determinants. It was also 
determined that R agar containing 10 ug/ml of chloramphenicol significantly 
reduced the amount of background growth and yielded more transformants than 
R agar containing 3 ug per ml of chloramphenicol. Protoplasts require a 
solid support to initiate cell wall synthesis, and regenerating protoplasts 
are inhibited ("crowded out") by the presence of early-forming colonies 
(Chen et al., 1986; Stahl, 1982; Stahl and Pattee, 1983a). Furthermore, 
chloramphenicol (5 ug/ml) inhibits regeneration of S. aureus protoplasts 
(Gruss and Novick, 1986). Elimination of non-protoplasted units and 
plasmid-free protoplasts precluded the "crowding out" of protoplasts that 
could tolerate elevated levels of chloramphenicol (bona fide pC194-
containing protoplasts). 
CsCl-purified preparations of pC194 and pTVl^-g yielded significantly 
more transformants than crude preparations (Table 7). CsCl equilibrium 
density centrifugation removes contaminating chromosomal DNA that would 
compete with plasmid DNA for cell-surface DNA binding sites, and 
contaminating nucleases that would nick CCC molecules. Dialysis of plasmid 
DNA to remove cesium chloride also removes residual SLS, and protoplasts 
are highly sensitive to even trace amounts of detergent. Any of the above 
consequences of CsCl purification could account for the enhanced recovery 
of protoplast plasmid transformants when using CsCl-purified DNA. As shown 
in Table 7, more transformants were recovered following induction for gene 
expression, and for a small plasmid (pC194) compared to a large plasmid 
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(pTVl^s)• For transformation of protoplasts of S. carnosus. the number of 
transformants obtained per ug of pCl94 (2.9 kb) was at least two orders of 
magnitude higher than the number of transformants obtained with pI258 
[(28.2 kb); Gotz et al., 1983]. Smaller plasmlds also transformed 
protoplasts of S treptococcus lactls at significantly higher frequencies 
than larger plasmlds (Kondo and McKay, 1984). 
Heat treatment of recipient cells prior to the addition of phage 
lysates (Asheshov and Jevons, 1963) or plasmid DNAs (Sjostrom et al., 1979) 
resulted in higher transfer frequencies, probably because of thermal 
Inactlvation of restriction/modification enzymes. When the data in Table 8 
for plasmlds pTV20 (isolated from B. subtilisé and pTVl^ g (isolated from S. 
aureus) are compared, it is evident that the origin of the DNA. largely 
determines if protoplasts of S. aureus can be transformed with a particular 
plasmid. Heat treatment of protoplasts prior to the addition of plasmid 
DNA increased the efficiency of heterologous plasmid transformation (for 
pTV20 Isolated from B. subtilis), and increased the frequency at which 
large plasmlds were internalized (pI258). 
Depending on the recipient strain and the conditions of the 
experiment, pC194-containing transformants were recovered at frequencies as 
high as 3.08 x 10^  (ISP1047; Table 7). This value is considerably higher 
than frequencies previously reported from this laboratory [(10% to 10^ 
transformants per ug of CsCl-purlfied pC194); Jones, 1985], and slightly 
higher than the 2.6 x 10^ transformants per ug of pC194 DNA reported by 
Lindberg (1981). Plasmid pC194 transforms protoplasts of B. subtilis at a 
frequency of 1.8 x 10^  per ug of DNA (Chang and Cohen, 1979). The higher 
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frequency of transformation for B. subtilis could be accounted for by the 
higher regeneration frequency exhibited by protoplasts of B. subtilis (50%) 
compared to protoplasts of S. aureus [(10 to 22%); Gruss and Novick, 1986; 
Stahl, 1982; Stahl and Pattee, 1983a]. 
After defining the optimal conditions for protoplast transformation, 
several experiments were repeated in attempts to introduce pLUCH3 into 
various protoplasted recipient strains of aureus : however, these were 
not successful. Any or all of the following may have contributed to the 
failure to introduce and/or establish pLUCHS in S. aureus : digestion by 
extracellular and/or intracellular nucleases; low efficiency of 
transformation; and insufficient production of chloramphenicol acetyl 
transferase due to a single copy (chromosomally integrated pLUCHS) of the 
cat gene. To assure that vector DNA was established in an appropriate 
recipient strain prior to insisting that this DNA integrate into the 
chromosome, a temperature-sensitive insertion vector (based on plasmid 
pTVlj-g) was constructed. In preliminary experiments, a severe reduction in 
recovery of pTVl^ g transformants was observed when selecting on R agar plus 
chloramphenicol compared to erythromycin (Table 9). Upon further analysis, 
the transformants recovered from the chloramphenicol selection plates were 
found to comprise three distinct phenotypic classes, and two of these 
classes harbored deleted derivatives of pTVl^ -g (Table 10 and Figure 8) . 
Assuming that only segments involved in plasmid maintenance, replication, 
and incompatibility must be conserved to avoid hereditary instability, all 
other segments of a plasmid are subject to genetic rearrangements. 
Repetitive sequences, transposons, and site-specific recombination systems 
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all have been implicated in causing deletions (Kleckner, 1981; Murphy and 
Novick, 1980; Novick et al., 1980; Novick et al., 1984). Given the 
precedence for such rearrangements, it seems plausible that Tn917 sequences 
mediated deletions of pTVl^-g when selection was made for resistance to 
chloramphenicol. The fact that both JBLIO and JBUl (classes I and II, 
respectively) were Em® further supports the hypothesis that Tn917 was 
involved. Deletions were not observed when selection was made for 
resistance to erythromycin, because these conditions insist for retention 
of Tn917 sequences. The decreased transformation frequency for 
chloramphenicol selection can be attributed to deletions in pTVl^ g that 
were lethal. Deleted derivatives of pTVlj-g (pLUCHlO and pLUCHll) were 
resistant to higher levels of chloramphenicol than the parental plasmid. 
In S. aureus. pC194 (a 2.9 kb plasmid present at 40 copies per cell in S. 
aureus) encodes for resistance to 50 ug/ml of chloramphenicol. The cat 
gene from pC194 when present on the 12.4 kb plasmid pTVl^s (copy number at 
30 C of 6 per cell in B. subtilisé encodes for resistance to about 12 to 15 
ug/ml of chloramphenicol in S,. aureus. It follows that the smaller size 
and higher copy number of plasmids pLUCHlO and pLUCHll resulted in elevated 
levels of resistance to chloramphenicol. In subsequent experiments, R agar 
plus erythromycin was used to select for pTVl^s (or derivatives of pTVl^ g) 
to avoid the loss of plasmid material via deletion. 
The basic premise was to direct the insertion of pTVl^ g into the 
chromosome under non-permissive conditions via homologous recombination 
between plasmid-borne Tn917 and a specific chromosomal copy of Tn551. To 
adapt pTVlgg for use as an insertion vector, however, it was necessary to 
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inactivate the transposition functions of Tn917 (to facilitate the 
isolation and analysis of plasmid insertion events apart from transpostion 
events), and to add a readily selectable marker (to permit positive 
selection of cells containing an integrated plasmid). A different 
selectable marker was required for two reasons; 1) chloramphenicol 
selection resulted in decreased recovery and deletions of pTVl^g; and 2) 
most recipient strains would already be resistant to erythromycin because 
of the presence of the chromosomal Tn551 target. It was possible to both 
add a selectable marker to pTVl^ -g and to inactivate the transposition 
functions of Tn917. This was accomplished by removing the 1.3-kb HindiII 
fragment of pTVl^-g and replacing it with the 2.5-kb gentamicin-resistance 
HindiII fragment from pPQ58. As described previously, a ligation mixture 
of Hindlll-digested pPQ58 and Hindlll-digested, CIP-treated pTVl^-g was 
presented to protoplasts of ISP1658 to generate the temperature-sensitive 
insertion vector pPQ126. The use of a restriction-deficient recipient 
strain (ISP1658), the selection for Em^ and not Cm^ transformants, and the 
improved protoplast transformation system, all were critical for recovery 
of pPQ126. Based on the results shown in Figure 11, pPQ126 is a 13.6-kb 
plasmid composed of an 11.1-kb Hindlll fragment (containing replication 
functions and genes encoding for chloramphenicol and erythromycin 
resistance from plasmid pTVl^g), and a 2.5-kb Hindlll fragment (containing 
the gene encoding for gentamicin resistance from Tn4001 on plasmid pPQ58). 
The gentamicin-resistance determinant can also be used to direct the 
integration of pPQ126 into a chromosomal copy of Tn4001. 
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Table 11 lists the transposition frequencies for Tn4001. Tn551. and 
Tn917 from various temperature-sensitive delivery vehicles. The 
transposition frequency of Tn917 (from pTVl) in B. subtilis was estimated 
at 5 X 10"5 to 5 X 10"^  (Youngman, 1985). Frequencies of 1.46 x 10"^  
(ISP1483; Table 11) and 2.43 x lO'S (ISP1578; Table 16) were recorded for 
transposition of Tn917 from pTVl^-g in S. aureus. The increase in 
transposition frequency for Tn917 in S. aureus could be accounted for if a 
transposition event occurred by chance early (e.g., lag phase), and 
subsequent growth allowed the insertion to attain an abnormally high level 
among the total population. It should be mentioned, however, that 
transposition of Tn917 from pTVl in B. megaterium occurs at frequencies as 
high as 1.5 x 10"% (Bohall and Vary, 1986). For the purposes of this 
study, it was only necessary to confirm that the altered derivatives' of 
Tn917 and Tn4001 present on pPQ126 were transpositionally defective. When 
pPQ126-containing cells (ISP1844) were plated on BHI plus erythromycin and 
incubated at 39 C, transposition of Tn917 was not observed (Table 11). 
Similarly, when cells of strain ISP1844 were plated on BHI plus gentamicin, 
it was not possible to detect transposition events of the 2.5-kb HindiII 
fragment of Tn4001. The transposition experiments with ISP1844 also 
demonstrated that pPQ126 harbored a temperature-sensitive replication 
defect. When cells of strain ISP1844 were plated on erythromycin or 
gentamicin-containing media, a 5- to 6-log difference was observed between 
total cfu recovered at 30 C compared to 39 C (Table 11). 
Both Tn551 and Tn4001 transpose at a frequency of about 10"^  
(Luchansky and Pattee, 1984; Lyon et al., 1984). The transposition 
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frequencies (Table 11) of 1.63 x 10"^ (ISP479) and 8.95 x 10"^ (ISP1801) 
for Tn551 and Tn4001. respectively, are in agreement with published 
results. Strain ISP1504 (containing plasmid pPQ58) provided the unique 
opportunity to test simultaneously for transposition of Tn551 and Tn4001. 
Although Tn551 transposed at a "normal" frequency (3.59 x 10'^), 
transposition of Tn4001 from pPQ58 was not detected (Table 11). It is 
possible that one or both ends of Tn4001 were altered as a consequence of 
insertion onto pPQ58, or that the presence of Tn551 prohibited 
transposition of Tn4001 (e.g., transposon immunity). Since Tn4001 
structurally resembles a Kleckner Class I transposable element (1.35-kb 
terminal repeats), and transposon immunity has been demonstrated only among 
Class II elements, it is more likely that damage to the ends of Tn4001 
precluded transposition. From the results in Table 11, it was concluded 
that Tn917 and Tn4001 sequences cannot transpose from plasmid pPQ126. 
To test the behavior of plasmid pPQ126 in different genetic 
backgrounds, pPQl26 was introduced into a recipient strain that lacked a 
chromosomal target (ISP1844), and recipient strains that contained a 
chromosomal target (ISP1846 and JBL85). A recombination-deficient strain 
(JBL177) was also used. Both phenotypic and molecular criteria were 
employed to determine if pPQ126 was maintained as an integrated replicon 
when the above strains were grown under non-permissive conditions. Cells 
possessing pPQ126 were resistant to 10 ug/ml each of erythromycin and 
gentamicin. In addition, cells containing autonomous pPQ126 were resistant 
to higher levels of chloramphenicol (between 11 and 14 ug/ml) than cells 
that contained a chromosomal copy of pPQ126 (about 10 ug/ml of 
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chloramphenicol), or cells that lost the plasmid (about 6 ug/ml of 
chloramphenicol). When the DNA from cells containing autonomous pPQ126 
[Em^ Gm^ Cm^(14 ug/ml)] was analyzed, both the 11.1-kb and 2.5-kb HindiII 
fragments of pPQ126 were discernible. When DNA extracted from cells that 
were resistant to 6 or 10 ug/ml of chloramphenicol was subjected to 
electrophoretic analysis, a typical chromosomal DNA digestion pattern was 
obtained, confirming the absence of autonomous pPQ126. Isolates that 
retained an integrated copy of plasmid pPQ126 were identified by their 
resistance to about 10 ug/ml of chloramphenicol, and by the absence of 
autonomous plasmid DNA. 
Although there was no significant difference between the total number 
of cells recovered at 30 C compared to 39 C, plasmids pPQ125 and pTVIj-g 
were lost at elevated temperature on non-selective media (Tables 12 through 
16). Colonies screened from the 39 C BHI plates were differentiated in two 
ways from their 30 C counterparts: 1) electrophoretic analysis demonstrated 
that autonomous pPQ126 was absent; and 2) the tolerance to chloramphenicol 
dropped from at least 11 ug/ml to only 6 ug/ml. In all strains tested, 
except JBL85, plasmid pPQ126 was lost from 5 to 8% of the cells grown on 
non-selective media at the permissive temperature (30 C). Even when 
erythromycin or gentamicin were included in the media, pPQl26 was 
eliminated from a population of cells grown at 39 C if homologous 
chromosomal sequences were not present (ISP1844; Table 12). Conversely, 
plasmid pPQ126 was retained by cells grown at 39 C on media containing 
either gentamicin or erythromycin, provided that Tn551 or Tn4001 target 
sequences were available as integration sites (Tables 13, 14, and 15). 
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pPQ126 integrated into a chromosomal Tn4001 target at a frequency of 5.76 x 
10"2 in a recombination-proficient host (JBL85), and at a frequency of 1.2 
X 10"5 in a recombination-deficient host (JBL177). These results suggest 
that integration of plasmid pPQ126 is highly dependent upon the 
recombination functions of the host cell. Retention of other integrable 
plasmids is also dependent on a functional rec"*" gene (Haldenwang et al., 
1980; Niaudet et al., 1982). Considerably more Em^ cfu were recovered at 
39 C from JBL85 (4.35 x 10?) when compared to ISP1844 (<1 x 10^), because 
pPQ126 was retained in JBL85 due to integration into the Tn4001 target 
(compare Tables 13 and 15). 
It was possible to test the effect of selection (gentamicin or 
erythromycin) on the integration of pPQ126 by using strain ISP1846 which 
contains the ermB317 mutation within Tn551. As shown in Table 15, the 
integration frequency was 2.2 x 10"^ when selection was made for resistance 
to erythromycin, and 3.26 x 10"^  when selection was made for resistance to 
gentamicin. The combination of gentamicin and elevated temperature retards 
the growth of cells containing an insertion of Tn4001 (J. B. Luchansky, 
Department of Microbiology, Iowa State University, Ames, Iowa, unpublished 
data; G. G. Mahairas, Department of Microbiology, Iowa State University, 
Ames, Iowa, personal communication), and this may explain the lowered 
frequency when selection was made for resistance to gentamicin. When 
possible, integration events were selected for on erythromycin-containing 
media to avoid this problem. 
Since the frequency of integration (recombination) is also related to 
the extent of chromosomal homology (Duncan et al., 1978), it was not 
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surprising that pPQ126 did not integrate at an appreciably different rate 
into a chromosomal Tn551 target versus a Tn4001 target. Tn551. Tn917. and 
Tn4001 are about the same size, and comparable lengths of Tn917 and Tn4001 
are available on pPQ126 to direct integration. Integration of pPQ126 
occurred at similar frequency in JBL85 (5.76 x 10'2; Tn4001) and ISP1846 
(2.2 X 10"2; Tn551) when selection was made for erythromycin resistance. 
In general, the integration frequency of pPQl26 was higher than the 
transposition frequency of Tn551. Tn917. or Tn4001 (compare Tables 11 and 
17). An obvious advantage of a temperature-sensitive insertion vector is 
the high yield of cells containing an integrated plasmid. Once the vector 
is established (presumably in multiple copies), each cell should experience 
an integration event under non-permissive conditions. For typical 
insertion vectors (e.g., pJHlOl), recovery of an integrated plasmid is 
dependent upon the frequency of transformation, and competent-cell 
transformation of B. subtilis occurs at low efficiency (Dubnau, 1983; 
Gryczan, 1982). 
Chromosomal DNA containing integrated pPQ126 (ISP1846) was transformed 
under non-permissive conditions into a plasmid-free recipient (ISP5) to 
determine if pPQ126 would transfer and remain integrated. Because 
competent cells of S. aureus are not readily transformed by plasmid DNA 
(Table 4), transformants possessing plasmid markers could only result from 
transformation with chromosomally integrated (not autonomous) pPQ126. 
Thirty-three transformants, comprising 8 distinct phenotypic classes, were 
recovered (Table 18). About 40% (13 of 33) demonstrated transfer of pPQ126 
markers only, but the remainder harbored plasmid markers as well as other 
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donor markers (trp. or tvr. or thr). The co-transfer of donor markers from 
the region of the Tn551 target suggests that pPQl26 was integrated at the 
specific Tn551 site in ISP1846. Furthermore, electrophoretic analysis 
demonstrated that pPQl26 remained integrated in these transformants. These 
results suggest that elevated temperature (39 C) selects and maintains 
pPQ126 in an integrated state. 
To determine if integrated pPQl26 would transfer and remain integrated 
under permissive conditions, competent cells of ISP5 were transformed with 
high molecular weight DNA prepared from JBL85, and all incubations were 
carried out at 34 C. Three classes of transformants were obtained. All 
three classes contained some form of autonomous plasmid DNA (Table 19 and 
Figure 15). It was not clear, however, if pPQ126 integrated into the host 
chromosome prior to becoming autonomous, or if the plasmid cirularized 
immediately upon entry. The recovery of these autonomous plasmids under 
permissive conditions further demonstrates the effects of temperature for 
the establishment and maintenance of integrated pPQ126. 
A strain containing an integrated copy of plasmid pPQ126 (JBL113) was 
grown at 30 C to determine if pPQ126 would revert to the autonomous state 
under permissive conditions. As a consequence of excision, a 7-kb HindiII 
fragment (in addition to the 11.1-kb and 2.5-kb fragments of pPQ126) was 
observed following digestion of plasmid DNA extracted from cells of strain 
JBL113 grown at 30 C (Figure 14). Most recently, temperature-dependent 
integration/excision of plasmid pTRA117 (14.3 kb; Km^ ) was reported in B. 
stearothermophilus (Koizumi et al., 1986). In the presence of kanamycin, 
cells grown at 48 C harbored autonomous pTRA117, whereas cells grown at 63 
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C contained pTRAll7 integrated into the host chromosome. When cells 
containing integrated pTRAll? were grown at 48 C, a new and larger plasmid 
(designated pTRZll?) was observed. Plasmid pTRZ117 consists of pTRAll? 
plus an additional 1.8- kb segment from the host chromosome. Unlike the 
parental plasmid, pTRZ117 is stably maintained at 65 C. The 
pTRA117/pTRZ117 system (believed to be the first report of 
temperature-dependent integration into, and excision from, the host 
chromosome) appears similar to the situation described above with JBL113 
(see below). 
The restriction analyses of plasmid pPQ126 (Figure 16A) compared 
exactly with the published restriction map of the parental plasmid 
(pTVl^s)I after adjustment for the presence of the additional 2.5-kb 
HindiII fragment (the aacA-aohP gene of Tn4001). Ultimately, it was 
necessary to confirm that pPQ126 sequences were chromosomally integrated; 
however, the avidities of 32[p]-labeled pPQ132 and [P]-labeled pLUCH75 
were initially tested against autonomous pPQ126. The Gm^  (pPQ132) and Em^  
(pLUCH75) probes were determined to be highly specific for only those 
sequences of pPQ126 that were precisely homologous to the aacA-aohP gene of 
Tn4001 and the ermB gene of Tn551 (Figure 16, panels B and C, 
respectively). The specificity of the Em^ probe was most evident; ^^ [P]-
labeled pLUCH75 did not hybridize with the 1.45-kb Xba fragment, even 
though this fragment contained the erm-distal terminal repeat of Tn917 
(Figure 16C, lane 2). Although both ends of Tn917 (38 base-pairs inverted 
repeats) share some homology, the erm-proximal inverted repeat resembles 
the inverted repeats of Tn551 (which are identical) more closely than the 
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erm-distal inverted repeat of Tn917 (Perkins and Youngman, 1984). The data 
in Figure 16 demonstrated the high specificities of both probes 
(particularly pLUCH75) for homologous sequences of pPQ126. 
The Gm^  (panel B) and Em^ (panel C) probes confirmed the presence of 
pPQ126 as an integrated replicon in JBL70, JBL71, and JBL74 (see Figure 
17). Furthermore, the results in Figure 17 suggested that plasmid pPQ126 
exists in either a different orientation or in a different position in the 
genome of JBL74 compared to JBL70 or JBL71. The differences in 
hybridization to JBL74 versus the other isolates may reflect; 1) a deletion 
occurred within pPQ126 or the adjacent chromosomal DNA as a consequence of 
integration and/or transformation, or 2) pPQ126 was integrated in the 
opposite orientation. It was also interesting to correlate the Gm® 
phenotype of JBL70 with the absence of hybridization to [P]-labeled 
pPQ132 (panel B, lanes 2 and 6). As mentioned previously, the Gm® 
phenotype most probably resulted from deletion of the aacA-anhP gene of 
pPQ126 during integration and/or transformation. 
The Gm^  and Em^ probes were also utilized to determine the origin of 
the additional HindiII fragments present in pLUCH88 and pLUCH89. From the 
results presented in Figure 18, it was concluded that all HindiII fragments 
of pLUCH89 were derived from plasmid pPQ126, or deleted derivatives of 
pPQ126 and/or pLUCHB9 (lane 6, panels B and C). The hybridization data of 
Figure 18 did not, however, delineate the origin for 2 fragments of 
Hindlll-digested pLUCHSS (lane 5, panels B and C). It is possible that the 
6.5-kb and/or the 2.9-kb fragments of Hindlll-digested pLUCH88 (or segments 
of these fragments) originated from the chromosome. To test this 
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hypothesis, [P]-labeled pLUCH88 was hybridized to ISP5 DNA. As shown in 
Figure 19, pLUCH88 did not hybridize with uncut or Hindlll-digested ISP5 
DNA (panel B, lanes 3 and 6, respectively). Because plasmid pLUCH88 DNAs 
were not of chromosomal origin, one must presume that this DNA was derived 
from pPQ126, or deleted derivatives of plasmids pPQ126 and/or pLUCH88. 
Plasmid pPQ126 plus chromosomal DNA (pLUCHll3) was excised from a 
chromosomal locus following growth of JBL113 at 30 C in the presence of 
erythromycin, gentamicin, and chloramphenicol (Figures 14 and 20). This 
process was designated plasmid disintegration. In addition to bands 
representing linear, DC, and multimeric configurations of pLUCH113, the 
uncut preparation of pLUCH113 contained 2 dense-staining (e.g., CGC) bands 
(Figure 20A, lane 4). It is possible that 2 plasmid species were generated 
following growth of JBL113 at 30 C: 1) the parental plasmid (pPQ126) 
resulting from precise disintegration; and/or 2) the parental plasmid (or a 
derivative thereof) plus an additional 7.0-kb segment of chromosomal DNA 
resulting from imprecise disintegration. Because the 7.0-kb fragment did 
not hybridize to pPQ126 sequences and because pLUCH113 DNA (but not pPQ126) 
hybridized to Hindlll-digested fragment(s) of total DNA from ISP5 and 
ISP1565, it was concluded that the 7.0-kb fragment was derived from the 
chromosome (see Figure 20). The recovery of plasmid DNA plus chromosomal 
passenger fragments directly in S. aureus obviates cleavage of chromosomal 
DNA (containing integrated pPQ126) with restriction endonuclease(s) 
followed by religation and transformation into a Gram-positive host to 
clone S. aureus DNA using an integrable plasmid system. 
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Future studies should be directed to examine the location and 
mechanism of integration of pPQ126, and to characterize the additional 
plasmid DNA present following transformation and/or growth of cells 
containing integrated pPQ126 under permissive conditions. As described 
above, pPQ126 integrates into homologous chromosomal target sequences in 
response to elevated temperature, and pPQ126 is maintained as an integrated 
replicon at elevated temperature (Tables 13, 15, and 18, and Figure 17). 
It is also clear that pPQ126 excises from the chromosome under permissive 
conditions, and that excision can result in derivatives of pPQ126 (Table 
19, and Figures 15, 18, and 19). Integration of pPQ126 into a defined 
locus followed by temperature-induced excision should prove to be a rapid 
and efficient means to clone specific segments of the S. aureus genome. 
The successful cloning of pPQ126 directly in £. aureus greatly facilitates 
the subsequent transfer (via transduction) of this vector into different 
genetic backgrounds. Compared to other mechanisms for transferring plasmid 
DNA, transduction is more efficient, less tedious, less expensive, and less 
time consuming to perform. The construction of a temperature-sensitive 
insertion vector that can be directed to multiple sites on the chromosome, 
should greatly facilitate genomic analysis of S. aureus. 
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SUMMARY 
For several reasons, most notably a low-efficiency transformation 
system, digestion by nucleases, and the reliance on selection for 
resistance to chloramphenicol, it was not possible to adapt a 
well-characterized B. subtills integrable plasmid (pJHlOl) for use in S. 
aureus. In an attempt to circumvent these problems, various parameters of 
the standard protoplast transformation protocol were modified to obtain 
higher transformation frequencies. The following conditions resulted in 
the greatest numbers of transformants: CsCl-purified plasmid DNA was 
presented to protoplasts that were heated at 56 C for 45 seconds 
immediately prior to the addition of DNA. Following a 3.5-h incubation at 
30 C, the resulting mixture was plated onto R agar containing the selective 
agent incorporated directly into the medium. Frequencies as high as 3.08 x 
10^ transformants per ug of pC194 DNA were obtained with the improved 
protocol, compared to a frequency of 1.18 x 10^  obtained with the 
unmodified procedure. 
The improved protoplast transformation system and the use of a 
restriction-deficient recipient strain facilitated the isolation of the 
recombinant molecule pPQ126 directly in S. aureus. Plasmid pPQ126 is, a 
novel, temperature-sensitive integrable plasmid composed of an 11.1-kb 
Hindi!I fragment from pTVl^ s (encoding for resistance to erythromycin and 
chloramphenicol, and containing a temperature-sensitive origin of 
replication) and a 2.5-kb HindiII fragment from transposon Tn4001 (encoding 
for resistance to gentamicin). When a population of cells containing 
pPQ126 is grown under non-permissive conditions (39 C) and selection is 
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made for retention of the plasmid (selection for resistance to gentamicin, 
erythromycin, and chloramphenicol), isolates can be obtained in which 
pPQ126 has integrated into homologous chromosomal target sequences. 
Portions of Tn917 and Tn4001 on pPQ126 direct the homology-dependent 
integration into specific chromosomal copies of Tn551 or Tn4001. Plasmid 
pPQ126 integrates at frequencies of 2.2 x 10'^  and 5.76 x 10"^  into 
chromosomal Tn551 and Tn4001 targets, respectively. Integration of pPQ126 
does not occur in cells lacking homologous target sequences. Integration 
of pPQ126 occurs at significantly reduced frequency in a 
recombination-deficient host. Elevated temperature is required to 
establish and maintain pPQ126 as an integrated replicon. Under permissive 
conditions, plasmid pPQ126 can excise from the chromosome, and excision can 
produce derivatives of pPQ126 that harbor DNA fragments of chromosomal 
origin. As a new approach for genetic transfer and analysis, pPQ126 should 
prove useful for both mapping and cloning various genes in S. aureus. 
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